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Thesis Abstract  
According to the Australian Institute of Health and Welfare, 2 in 3 Australian men are 
overweight or obese. Sperm oxidative stress is a common factor in various forms of male 
infertility including obesity, and can lead to increased sperm intracellular reactive oxygen 
species (ROS) and oxidative DNA lesions (8-OHdG), impaired sperm function, reduced 
implantation and live birth rates and the transgenerational inheritance of disease for up 
to two generations. According to Cochrane Reviews, the use of dietary micronutrient and 
antioxidant supplementation has been shown efficient in improving live birth rates in 
infertile men despite recent reports suggesting the evidence is of low quality. There is 
limited research however, regarding the effectiveness of dietary micronutrient 
supplements in the growing population of obese males. Therefore, the aim of this thesis 
was to establish the impact of a combination of dietary micronutrient supplements on 
male reproductive health outcomes in obese men and diet-induced obese mice.  
In the mouse model, male mice were fed a control diet (CD, 6% fat) or a high fat diet 
(HFD, 21% fat) for 10 weeks to induce obesity and then assigned to one of three dietary 
micronutrient supplement (selenium, vitamin C, lycopene, vitamin E, zinc, folic acid 
green tea extract) treatment durations: (i) 10 weeks; (ii) 5 weeks or (iii) 10 days in 
conjunction with their initially allocated control or HFD. In all three treatment durations, 
sperm morphology, intracellular ROS, 8-OHdG lesions, sperm-oocyte binding and 
fertilization rates were increased with micronutrient supplements in HFD-fed males 
compared to the un-supplemented HFD-fed mice. HFD-induced obese males treated with 
micronutrient supplementation for 10 days were mated with normal weight females and 
implantation rates were increased in addition to increased fetal weights. Also, 
immunofluorescence showed that 8-OHdG lesions were reduced in developing testicular 
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spermatogenic cells and the paternal pronucleus of the subsequent embryo in males fed 
a HFD supplemented with micronutrients.  
In the retrospective and prospective studies, fertility treatment outcomes and sperm 
oxidative stress were assessed in non-smoking couples attending an infertility clinic 
whereby the male partner was aged <45 years old, of normal weight, overweight or obese 
BMI, and the female partner was non-obese and aged <38 years old. Couples were 
stratified by the male partner’s BMI and whether they were consuming micronutrient 
supplements (Menevit or multivitamins) at the time of treatment. Retrospective data 
showed that fertilization rates and on-time embryo development were increased with 
micronutrient supplement intake in obese men compared to obese men not consuming 
dietary supplements. Also, implantation and live birth rates were improved with 
micronutrient supplementation in all men regardless of their BMI. The prospective data 
showed similar results in addition to reduced sperm intracellular ROS in obese men and 
reduced sperm 8-OHdG lesions in all men despite BMI with micronutrient supplement 
intake.  
Overall, these findings demonstrate that micronutrient supplementation can increase 
implantation and live birth rates in obese males and lessen the inheritance of oxidative 
lesions in the male germline highlighting the importance of paternal preconception 
health. These studies warrant further research into potential molecular mechanisms in 
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Obesity is defined by the World Health Organization (WHO) as a body mass index (BMI) 
of 30kg/m2 or greater (WHO 2015). The prevalence of obesity in men has more than 
doubled in the past 20 years across the globe (WHO 2015). Reports from the Australian 
Institute of Health and Welfare state that obesity has overtaken smoking as the leading 
cause of premature death emphasizing that this common and often preventable disease is 
of public health importance (AIHW 2016). According to the WHO, infertility is the third 
most serious health condition after cancer and cardiovascular disease. Infertility is a 
complex and multifactorial condition that can involve both the male and female partner 
and is defined as a failure to achieve a clinical pregnancy after 12 or more months of 
regular unprotected sexual intercourse (WHO 2016). Infertility affects approximately 
15% of couples globally with up to 50% of cases attributed the male partner (Kefer et al. 
2009). Interestingly, the increase in the prevalence of obesity and the rise in infertility are 
simultaneous (Swan et al. 2000).  
 
Based on current literature, there is an undeniable association between male obesity and 
compromised reproductive health characterized by reduced pregnancy and live birth rates 
in addition to elevated likelihood of miscarriage in their partners (Campbell et al. 2015). 
This compromise in male reproductive health is mainly measured by conventional sperm 
parameters including sperm motility, concentration and morphology. However, there is 
increasing evidence that conventional sperm parameters are only modestly affected by 
obesity (Campbell et al. 2015) and the larger impact of obesity is on an intracellular level 
in the form of sperm oxidative stress and oxidative DNA lesions (Bisht et al. 2017). 
Sperm cells are particularly susceptible to oxidative stress, which is characterized by the 
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accumulation of reactive oxygen species (ROS) and/or the loss of antioxidant capacity. 
This susceptibility is due to shedding of the cytoplasm and thus subsequent loss of 
antioxidant enzymes as part of their maturation process during sperm cell generation and 
development (Gharagozloo and Aitken 2011).  
 
Sperm oxidative stress is a common mediator for defective male reproductive potential 
(Aitken et al. 2014) with some major consequences including impaired DNA integrity 
and lipid peroxidation of the sperm plasma membrane. These factors collectively limit 
the fertilizing potential of sperm cells and if fertilization does occur, contribute to the 
transmission of impaired paternal DNA integrity to the embryo (Soubry et al. 2014) and 
increases the susceptibility of disease to potential offspring (Aitken et al. 2014; Lane et 
al. 2014). Micronutrient and antioxidant supplementation in an infertile population has 
been proposed as an effective treatment to ameliorate sperm oxidative stress and DNA 
damage, which has been demonstrated to increase pregnancy and live birth rates 
(Gharagozloo and Aitken 2011; Showell et al. 2014). However, the effectiveness of 
micronutrient and antioxidant supplementation treatment on the reproductive health of 
obese males is unknown (Barratt et al. 2017). Further, the optimal duration of supplement 
intake remains to be elucidated, as well as whether supplementation affects germ cell 
development during spermatogenesis and/or sperm maturation during epididymal transit. 
This chapter will review the implications of obesity and sperm oxidative stress on 
reproductive health and how micronutrient supplementation may protect against the 




1.2 Obesity and Male Infertility 
 
1.2.1. Spermatogenesis  
Spermatogenesis is a complex process that occurs in the testis and epididymis by which 
diploid cells become haploid through meiosis that occurs concomitantly with major 
changes in both the structure and function of the sperm cell, ultimately generating mature 
haploid sperm (Guerriero et al. 2014). Spermatogenesis is comprised of a chronological 
series of events initiating in the seminiferous tubules of the testis and concluding with 
sperm maturation in the epididymis (Figure 1.1) and is regulated by several endocrine 
factors (Figure 1.2). The first phase of spermatogenesis occurs in the testis. The testis is 
composed of lobules that contain several seminiferous tubules. Seminiferous tubules 
consist of germ cells, Leydig cells, and Sertoli cells (Figure 1.1). Sertoli cells surround 
germ cells and their main functions include the nutrition of the developing spermatogenic 
germ cells, phagocytosis of spermatid remains, and the formation of the blood-testis 
barrier (BTB) (Griswold 1998). Leydig cells are located between the seminiferous 
tubules and their primary function is testosterone production. The epididymis, the site of 
the final phase of sperm maturation, extends from the upper to the caudal end of the testis 
(Figure 1.1) and is composed of the coiled epididymal duct lined by an epithelium with 
cilia and microvilli. The main functions of the epididymis include sperm maturation, 







Figure 1.1: Illustration depicting the location of the seminiferous tubules within the testis. The cross-section of the seminiferous tubules 
shows the structure of the tubule and the location of the developing sperm cells (green), Sertoli cells (yellow) and Leydig cells (pink).  




















1.2.2. Hormonal regulation of spermatogenesis disrupted with obesity 
The production of mature sperm from primordial germ cells is regulated by hormones 
from the hypothalamus, pituitary gland, and locally from the testes. The hypothalamus 
secretes gondadotropin-releasing hormone (GnRH), which acts on the anterior pituitary 
gland to stimulate the release of follicle-stimulating hormone (FSH) and luteinizing 
hormone (LH), which act on Sertoli cells and Leydig cells, respectively (Figure 1.2). In 
response to FSH, Sertoli cells release the hormone inhibin, which acts on the anterior 
pituitary gland to inhibit the production of FSH generating a negative feedback loop 
(Figure 1.2) (Griswold 1998). Leydig cells located in the interstitial tissue of the testes 
are endocrine cells that produce testosterone and release it locally into the testis and also 
into blood (Mendis-Handagama 1997). Testosterone acts on Sertoli cells to regulate 
sperm differentiation. Testosterone concentrations in the body are relatively consistent 
due to a negative feedback loop that acts on the hypothalamus and pituitary gland 
inhibiting LH production and consequently, inhibiting the further release of testosterone 
(Figure 1.2) (Mendis-Handagama 1997). Serum testosterone is frequently measured to 
assess the fertility status of men as testosterone is essential for sperm production and 
maturation (Walker 2011), albeit that serum testosterone does not always reflect intra-
testicular testosterone levels limiting is clinical utility (Coviello et al. 2004). 
 
Hormonal and endocrine changes with male obesity can dysregulate the hypothalamic-
pituitary-gonadal (HPG) axis (Figure 1.2) and subsequently perturb the hormonal 
regulation of spermatogenesis. The most common and well-established hormonal 
changes with obesity are reduced concentrations of testosterone and sex hormone binding 
globulin (SHBG) and elevated concentrations of estradiol (Aggerholm et al. 2008; 
Chavarro et al. 2010; Jensen et al. 2004; Macdonald et al. 2013; Pauli et al. 2008; Tunc 
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et al. 2011). Although the specific mechanisms contributing to the impact of obesity on 
alterations to the concentrations of these hormones are still unclear, some explanations 
include hypogonadotropic hypogonadism, a reduction in SHBG production and elevated 
adipocyte aromatase activity resulting in an increase in the conversion of testosterone to 
estradiol leading to altered hypothalamic and pituitary feedback (Chambers and Richard 
2015; Pasquali et al. 2007). Given that obesity is often a result of a long-term imbalance 
between caloric input and inadequate energy expenditure, each component of the HPG 
axis may be modified by altering the pulsatile secretion of GnRH and subsequently 
perturbing further levels of the HPG axis resulting in reduced serum SHBG and 
testosterone concentrations (Hill et al. 2008). Further, the increase in estradiol and 
reduction in testosterone and SHBG concentrations may be a result of the increased 
aromatization of testosterone (Mammi et al. 2012), and the increased conversion of 
androgens into estrogens due to increased adiposity and high bioavailability of these 
aromatase enzymes (Roth et al. 2008).  
 
Overall, changes to the male reproductive hormone profile and endocrine disruptions that 
result from an increased BMI and increased adiposity may ultimately impact upon the 
process of spermatogenesis, acting via testosterone, thus compromising sperm quality 





Figure 1.2: The Hypothalamic-Pituitary-Gonadal (HPG) Axis: hormonal regulation of 
spermatogenesis and the impact of obesity on male reproductive hormones. 
Spermatogenesis is regulated by gondadotropin-releasing hormone (GnRH), follicle-
stimulating hormone (FSH), luteinizing hormone (LH) and by testosterone, estradiol and 
inhibin produced in the testis. In obesity, the increased concentrations of estradiol from 
white adipose tissue and from the aromatization of testosterone alter the normal 
























1.2.3. Stages of spermatogenesis perturbed with obesity  
In mice, one spermatogenic cycle occurs over approximately 34.5 days (Oakberg 1957) 
whereas in humans, one cycle occurs over approximately 74 days (Clermont 1972; Heller 
and Clermont 1963). Spermatogenesis is comprised of three main stages: mitosis, 
meiosis, and spermiogenesis. Firstly, the mitosis stage allows the proliferation of type A 
spermatogonia (renewing stem cells) into type B spermatogonia (differentiating 
progenitors) forming two daughter cells with the same DNA and chromosomal content 
as the original cell (Figure 1.3) (Clermont 1966). Secondly, meiosis occurs in type B 
spermatogonia, which progress into primary and secondary spermatocytes and then into 
early round spermatids, which generates four haploid gametes (Figure 1.3) (Sharpe 
2010). Finally, spermatogenesis ends with spermiogenesis, a crucial stage involving vital 
changes to the structure and function of spermatids. During spermiogenesis, spermatids 
differentiate into sperm cells, whereby early round spermatids are converted to elongated 
spermatids with the shedding of excess cytoplasm and eventually form spermatozoa 
(Figure 1.3) (O'Donnell et al. 2011). Peritubular myoid cells, contractile cells that 
surround seminiferous tubules, expel sperm from the seminiferous tubule into the 
epididymis (O'Donnell et al. 2011).  
 
Obesity, inflammation and elevated scrotal temperature can disturb the process of 
spermatogenesis. Sperm cells cannot mature appropriately at core body temperature and 
therefore optimal scrotal temperature is 1-3 degrees lower than internal body temperature 
(Paul et al. 2009; Shiraishi et al. 2010). Given that the processes of spermatogenesis in 
the testis and sperm maturation during epididymal transit are highly susceptible to 
structural and functional damage, it is vital that spermatogenic and mature sperm cells 
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are exposed to optimal temperatures (Aitken and Baker 2002; Aitken and Curry 2011b; 




Figure 1.3: Stages of spermatogenesis. The process of spermatogenesis is divided into 
three main stages; mitosis, meiosis and spermiogenesis. Briefly, type A spermatogonia 
proliferate into type B spermatogonia during the mitosis stage. Type B spermatogonia 
advance into primary and secondary spermatocytes and through meiotic divisions into 
early round spermatids generating four haploid gametes. In the final stage, 
spermiogenesis, early round spermatids are converted to elongated spermatids, which 
eventually form spermatozoa.  
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1.2.4. Spermiogenesis compromised by obesity   
Spermiogenesis is the final stage of spermatogenesis and primarily occurs in the testes 
and this stage of development has been hypothesized to be one of the sites of perturbation 
of obesity. Spermiogenesis is mainly comprised of four phases including nuclear 
condensation, acrosome formation, flagellum formation, and cytoplasmic reduction, and 
the impact of obesity for each stage is addressed below. 
 
1.2.4.1. Nuclear condensation  
Nuclear condensation is a key process of spermiogenesis in which the sperm nucleus is 
condensed and compacted. The nuclear condensation process involves the gradual 
removal of the chromatin’s original histone-based structure and substitution with smaller 
protamines (Braun 2001; Dadoune 1995; Miller et al. 2010; Rathke et al. 2013). The 
exact processes involved in chromatin re-organization and protamine substitution is not 
yet completely understood but it has been proposed that the compact protamine-based 
chromatin structure may be necessary for the protection of the paternal genome from 
chemical and physical damage (Braun 2001; Carrell et al. 2007). Although the majority 
of sperm chromatin is condensed and protaminated during spermiogenesis, 
approximately 1% of the mouse genome and 10% of the human genome remain as 
histone-bound DNA (Miller et al. 2010). It is proposed that the retention of these histones 
is not random; these histone-bound regions of the paternal genome are associated with 
genes necessary for embryo development (Hammoud et al. 2011), are enriched in genes 
essential for DNA replication events post-fertilization and paternal genome transcription 
activation in the onset of embryo development (Shaman et al. 2007). Alterations in the 
numbers and placement of these histones in sperm has been associated with altered gene 
expression in the 2-cell embryo (Ihara 2014). Moreover, any alterations made to the 
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histone-bound regions of the paternal genome may be inherited by the embryo as these 
histone-bound regions are not replaced by the oocyte following fertilization and therefore 
would remain in the developing embryo (Ward 2010). In obese men, the nuclear 
condensation process during spermatogenesis is compromised and results in exposed and 
decondensed chromatin (Hammoud et al. 2011). It is therefore suggested that obesity 
compromises sperm DNA integrity from early germ cell development stages. 
 
1.2.4.2. Acrosome formation  
Acrosome formation is the formation of a cap (acrosome) containing enzymes that allow 
sperm penetration through the zona pellucida of the oocyte at fertilization. The acrosome 
is derived from proteins from the Golgi apparatus that create vesicles that then merge into 
a larger formation, which finally inverts itself, similar to a cap, over the largest part of 
the nucleus (Figure 1.4) (Wassarman 1999; Yasuno et al. 2013). After ejaculation, sperm 
undergo capacitation, an activation process, in the female tract to penetrate the zona 
pellucida of the oocyte and fuse with the oocyte plasma membrane to ultimately achieve 
successful fertilization. Although the mechanisms are unknown, sperm from high-fat diet 
(HFD)-induced obese male mice have shown to have reduced acrosome reaction and 
consequent reduced fertilizing potential (Bakos et al. 2010; Fan et al. 2015; Palmer et al. 
2012b). These findings highlight the deleterious effects of obesity on sperm cell 
acrosomal function for successful acrosome reaction and subsequent fertilization. 
 
1.2.4.3. Flagellum formation 
Flagellum formation is the generation of the sperm tail, whereby one centriole is 
assembled consisting of a bundle of nine peripheral double microtubules and two single 
microtubules in the centre (Carvalho-Santos et al. 2012). The rotation of the nucleus and 
	
	 44	
acrosomal vesicle controls flagellum development until the flagellum lies on the opposite 
side of the acrosome (Figure 1.4) (Wassarman 1999). Normal flagellum formation and 
morphology is required for progressive sperm motility, which is reduced with obesity in 
men and in diet-induced obese male rodent models (Hammoud et al. 2008; Palmer et al. 
2012a). Also, obesity is associated with abnormal sperm tail morphology in mice (Ghosh 
and Mukherjee 2018) suggesting that obesity and its co-morbidities may affect the 
spermiogenesis stage, in particular morphogenesis of the sperm tail before it is released 
into the lumen of the seminiferous tubule for epididymal transit. 
 
1.2.4.4. Cytoplasmic reduction  
Cytoplasmic reduction is the removal of excess cytoplasm and organelles from the 
spermatids by Sertoli cell phagocytosis (Ho 2010). Cytoplasmic reduction is vital for the 
structural conversion of a spermatid into a functioning sperm cell. Interruptions to 
spermiogenesis and to cytoplasmic extrusion/ reduction via Sertoli cell phagocytosis can 
lead to excess residual cytoplasm in sperm cells and subsequently increased ROS 
production (Rengan et al. 2012; Sprando and Russell 1987). Obesity is often associated 
with increases in sperm intracellular ROS, which may be due to the limited availability 
of antioxidants and disruption of spermiogenesis by obesity-induced systemic metabolic 
changes and/or adiposity-induced elevated scrotal heat and temperature (McPherson and 




Figure 1.4: The structure of a mature sperm cell. The head contains a condensed 
protamine based nucleus and is capped anteriorly with the acrosome. Mitochondria are 





1.2.5. Epididymal maturation and transit altered with obesity 
Following the release of sperm into the lumen of the epididymis (to undergo the final 
stages of maturation), sperm are immobile and do not have fertilizing capacity until the 
completion of the maturation process that occurs during epididymal transit. During sperm 
epididymal transit, sperm acquire progressive motility (Bedford et al. 1973; Soler et al. 
1994) and develop the capacity to undergo acrosome reaction, to ultimately bind and fuse 
with the zona pellucida of the oocyte (Lakoski et al. 1988). Sperm enter the epididymis 
via the testicular fluid and are transported throughout the epididymis by the muscular 
contractions lining the epididymis tubule. The minimal time required for sperm to mature 
and to transit through the epididymis is approximately 10 days regardless of the animal 
species (Robaire et al. 2006). Sperm are then stored in the epididymis until ejaculation 
and therefore; environmental factors such as elevated heat or inflammation, which can 
cause ROS, may impact sperm quality and function during their maturation period. Obese 
men commonly have fat deposits in the suprapubic and inner thigh areas which can cause 
both scrotal inflammation, including epididymitis, as well as increasing temperature 
ultimately altering the epididymal environment, epididymal function and sperm 
maturation likely contributing the observed elevated ROS (Katib 2015).  
 
1.2.6. Blood-testis and blood-epididymal barrier atrophy with obesity 
Sertoli cells of the seminiferous tubule are bound to each other by tight junctions, gap 
junctions, adhesion junctions, and other junctional complex proteins to form the BTB 
(Jiang et al. 2014; Mruk and Cheng 2015). The BTB creates a specialized and 
immunologically privileged micro-environment that isolates developing germ cells from 
the cardiovascular and lymphatic systems (Mruk and Cheng 2015). The cellular junctions 
allow the entry of nutrients, hormones, and electrolytes into the seminiferous tubule but 
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block the entry of toxicants (Jiang et al. 2014). It is crucial that the cellular junctions of 
the BTB are fully functional and its integrity is not compromised as disturbances to the 
BTB caused by heat or toxins, result in reduced sperm count (Fan et al. 2015). Testicular 
structure and integrity have been shown to be compromised with obesity in rodent 
models. Normal testicular structure is illustrated by abundant seminiferous tubules with 
large diameters and intact basement membranes with normal spermatogenic cells. HFD-
induced obese male mice had disorganized and atrophic seminiferous tubules with a 
disruption in cell adhesion between Sertoli cells and spermatogenic cells ultimately 
indicating impaired cell junctions and compromised BTB integrity (Fan et al. 2015). In 
HFD-fed rats, there was a reduced number of spermatogonia, Sertoli cells, and Leydig 
cells in testicular tissue in addition to small atrophic and distorted seminiferous tubules 
with a loss of testicular membrane integrity (Yan et al. 2015). The blood barrier extends 
past the testis and to the epididymis where tight junctions between epididymal epithelial 
cells form the blood-epididymis barrier (BEB). The BEB restricts the entry of certain 
ions, solutes, and macromolecules across the epididymal epithelium and into the lumen 
so that an appropriate environment surrounds sperm as they travel through the different 
segments of the epididymis (Turner 1991). The integrity of the BEB, has been shown to 
be compromised under stress conditions such as aging (Levy and Robaire 1999). 
Although the effects of obesity on the BEB integrity have not been investigated, the 
stressors associated with obesity may be similar to that found with aging. Inflammatory-
associated pathologies such as interstitial inflammation of the epididymis have been 
shown to disrupt the BEB on both a structural and functional level (Gregory and Cyr 
2014), which may be similar to obesity as obesity has been described as a constant state 




1.2.7. Obesity and conventional sperm parameters 
Clinical human studies have examined the effects of male BMI on conventional sperm 
parameters, including sperm concentration, motility and morphology, with conflicting 
findings (Eisenberg et al. 2014). The lack of consensus may be due to the age of the men, 
as advanced male age is also known to reduce sperm quality (Johnson et al. 2015), or due 
to uncontrolled confounding lifestyle factors such as diet, cigarette and marijuana 
smoking, regular alcohol consumption, and drug abuse, which also independently alter 
sperm quality (MacDonald et al. 2010). Additionally, the metabolic status of the male 
including leptin insensitivity, insulin resistance, glucose intolerance or diabetes may 
contribute to the conflicting data (Teerds et al. 2011). Moreover, the study design, sample 
size, patient recruitment, and methodology also differ between these studies and may 
contribute to the discrepancies (MacDonald et al. 2010). A systematic review of 5 studies, 
including a total of 6,800 men, reported no association between BMI and sperm 
concentration and sperm motility (MacDonald et al. 2010). However, an updated meta-
analysis of 30 studies and a total of 115,158 men indicated a negative relationship 
between BMI and normal sperm morphology and motility despite the heterogeneity of 
the male participant population including general and subfertile populations (Campbell 
et al. 2015).  
 
To avoid lifestyle factors that can confound human studies, controlled rodent models 
have been developed to investigate the effects of diet-induced obesity on conventional 
sperm parameters. In these studies, male obesity is associated with a reduced percentage 
of motile sperm, reduced sperm concentration, and increased abnormal sperm 
morphology (Bakos et al. 2010; Fullston et al. 2012; Ghanayem et al. 2010; Ibrahim et 
al. 2012; Palmer et al. 2012b; Palmer et al. 2011). However, these compromised 
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conventional sperm parameters with obesity vary to different degrees across studies 
unlike sperm oxidative stress, which is fairly consistent across the literature.  
 
1.2.8. Obesity and sperm oxidative stress 
Some recent studies suggest that underlying sperm measures beyond conventional sperm 
parameters including sperm oxidative stress markers: intracellular ROS and oxidative 
DNA lesions, and molecular changes to sperm DNA are changed with obesity which is 
significant as it may be passed to the embryo and affect resultant offspring (McPherson 
et al. 2016; Stuppia et al. 2015). Although the literature reports conflicting observations 
regarding the relationship between obesity and conventional sperm parameters, there is a 
consensus that obesity is associated with increased sperm oxidative stress. A positive 
relationship between BMI and sperm oxidative stress has been reported whereby sperm 
ROS production, measured using a photometric nitro blue tetrazolium (NBT) assay was 
increased in men with a BMI>28 kg/m2 (overweight and obese men) in addition to 
reduced clinical pregnancy rates (Qian et al. 1986; Yang et al. 2016). Obesity has been 
described as a chronic state of inflammation and systemic oxidative stress (Furukawa et 
al. 2004; Ozata et al. 2002) resulting from the production of pro-inflammatory cytokines 
from increased adipose tissue mass, which stimulate leukocyte generation of ROS 
ultimately inducing oxidative stress (Das et al. 2009), which is likely to extend to the 
testicular micro-environment (Tunc et al. 2011). Few studies have investigated the 
impact of metabolic syndrome, a common characteristic in obese men, on sperm 
parameters and seminal oxidative stress (Leisegang et al. 2014; Rosety et al. 2014) and 
only two studies have investigated the impact of obesity alone on seminal plasma (Tunc 
et al. 2011) and sperm oxidative stress (Yang et al. 2016). One study by Rosety et al. 
reports that men with metabolic syndrome have reduced sperm concentration, motility, 
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and normal morphology in addition to an increase in seminal malondialdehyde (MDA), 
a byproduct of lipid peroxidation compared with control healthy men (Rosety et al. 
2014). Another study showed that obese and morbidly obese men with metabolic 
syndrome had reduced sperm concentration and motility compared to normal weight and 
overweight non-metabolic syndrome control group (Leisegang et al. 2014). However, 
smokers were included in this study, which may have led to confounding results given 
that there is a strong correlation between smoking and increased sperm oxidative stress 
(Fraga et al. 1996; Kovac et al. 2015). Only two human studies have investigated the 
effect of obesity on seminal oxidative stress and showed a positive relationship between 
an elevated BMI and seminal oxidative stress markers (Taha et al. 2016; Tunc et al. 
2011). One study showed that this was primarily due to an increase in seminal 
macrophage activation which was reportedly mediated by an increase in local genital 
tract infections, however, this study did not conduct any bacteriology testing to confirm 
this link (Tunc et al. 2011). Also, this study did not report essential patient demographics 
including age and lifestyle factors such as smoking, in addition to no specifications of the 
BMI group sample size except a total participant number of 81 patients (Tunc et al. 2011). 
Another study that reported the number of non-smoking participants in each BMI group 
with no difference in mean age among them demonstrated increased seminal ROS in 
overweight and obese men compared to normal weight men, ultimately highlighting a 
positive association between BMI and sperm oxidative stress (Taha et al. 2016).  
 
Mouse models have shown a positive relationship between adiposity and sperm 
intracellular ROS levels demonstrated by increased mitochondrial ROS and total ROS 
production (Bakos et al. 2010; Fullston et al. 2015; Fullston et al. 2013; Palmer et al. 
2012b). Further, sperm oxidative stress in HFD-induced obese mice is correlated with 
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compromised sperm quality, including increased DNA damage (Palmer et al. 2012b). In 
rats, HFD-induced obesity resulted in increased MDA and nitric oxide (NO) radical 
production in sperm (Chen et al. 2013). Also, this study showed reduced antioxidant 
enzyme activity of superoxide dismutase (SOD) and glutathione peroxidase (GPx) in 
sperm from rats fed a HFD, indicative of increased oxidative stress and sperm plasma 
membrane lipid peroxidation (Chen et al. 2013). 
 
The link between increased sperm oxidative stress levels and obesity may be due to 
elevated systemic levels of lipids, including fatty acids and cholesterol, which affect the 
environment that sperm is exposed to during spermatogenesis and ultimately altering the 
content and function of sperm (Bakos et al. 2010; Palmer et al. 2012a). Also, increased 
serum concentrations of cytokines and ROS, common characteristics with obesity, may 
be causative factors for sperm oxidative stress as it has been suggested that serum 
cytokines and ROS may pass the BTB and/or the seminal fluid through seminal vesicles 
and into the testicular tissue where inflammatory cytokines and ROS may perturb sperm 
morphology, development, and DNA integrity (La Vignera et al. 2012).  
 
1.2.9. Obesity and sperm DNA damage 
The majority of studies that have assessed the effects of obesity on sperm DNA damage 
report an increase in DNA fragmentation and DNA lesions within sperm from obese men 
(Chavarro et al. 2010; Dupont et al. 2013; Fariello et al. 2012; Kort et al. 2006; La 
Vignera et al. 2012). DNA damage in sperm has been correlated with various pregnancy 
pathologies such as miscarriage (Kleinhaus et al. 2006), cancer in children (Ji et al. 1997; 
Lee et al. 2009) and neurological defects including autism, spontaneous schizophrenia, 
bipolar disease and epilepsy in children fathered by men with elevated DNA damage 
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(Frans et al. 2008; Reichenberg et al. 2006; Sipos et al. 2004). A recent meta-analysis of 
the effect of male obesity on sperm DNA fragmentation further supports the positive 
relationship between BMI and DNA fragmentation (Campbell et al. 2015). Therefore, 
suggesting that elevated BMI in men could be linked with poorer health outcomes for 
their offspring. 
 
The link between male obesity and impaired sperm DNA integrity has also been shown 
in mouse models of diet induced obesity with all studies confirming a positive 
relationship between adiposity and/or body mass and sperm DNA fragmentation (Duale 
et al. 2014; Fullston et al. 2013; Mitchell et al. 2011b; Palmer et al. 2012b). In mice fed 
a HFD, sperm DNA fragmentation correlated positively with mitochondrial ROS and 
negatively with sperm motility, normal morphology and sperm-oocyte binding (Palmer 
et al. 2012b) with perturbations in germ cell gene expression (Duale et al. 2014).  
Overall, these studies demonstrate that obesity leads not only to reduced sperm quality 
(conventional sperm parameters) but also to impaired DNA integrity, which may have 
lasting impacts on offspring health.  
 
1.2.10. Obesity, sperm function and fertilization 
In couples undergoing ART treatment, the relationship between male BMI and successful 
fertilization seems to depend on the fertilization method; standard insemination versus 
intracytoplasmic sperm injection (ICSI). The standard insemination method is conducted 
by placing cumulus-oocyte complexes (COCs) with sperm, whereas ICSI involves the 
injection of a single sperm directly into an oocyte, thereby by-passing sperm binding 
processes. Some clinical studies report no relationship between paternal BMI and 
successful fertilization however, these couples used the ICSI method to fertilize oocytes, 
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which may mask the sperm binding capacity of sperm (Bakos et al. 2011; Umul et al. 
2015). Two studies have analyzed fertilization rates using the standard insemination 
method in 651 men and demonstrated that fertilization rates were lower among 
overweight and obese men compared to normal weight men (all men had a female partner 
with normal BMI) (Keltz et al. 2010; Yang et al. 2016). This difference in fertilization 
success based on the ART insemination method suggests a detrimental impact of obesity 
on the capacity of sperm to undergo capacitation, acrosome reaction, and sperm-oocyte 
binding as these events are by-passed using ICSI.  
 
Animal models of obesity have investigated the fertilization process in more detail with 
the capacitation and acrosome reaction status of sperm examined. Capacitation is a 
process sperm must undergo for successful fertilization; and the proportion of capacitated 
sperm and acrosome-reacted sperm were reduced in HFD-fed male mice with reduced 
subsequent sperm-oocyte binding and fertilization rates (Bakos et al. 2010; Palmer et al. 
2012b). These studies, both clinical and animal models, suggest that obesity impairs 
sperm capacitation, which in turn may contribute to the delay or interruption of the 
acrosome reaction and compromise subsequent sperm-oocyte fusion to ultimately perturb 
successful fertilization. 
 
1.2.11. Obesity and embryo development 
In couples undergoing ART treatment where the male partner is overweight or obese, 
most studies report no effect on cleavage stage embryo development assessed on day 3 
post insemination (Bakos et al. 2011; Colaci et al. 2012; Schliep et al. 2015). However, 
there is one study that reports that high quality embryo morphology on day 3, defined as 
embryos with 6-8 cells with no or minimal fragmentation, was reduced with an increased 
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paternal BMI (Yang et al. 2016). The reduction in day 3 embryo quality with an 
increasing paternal BMI may be explained by the activation of the paternal genome which 
mainly occurs on day 3 (the 8-cell stage), which is generally accepted as there is limited 
transcription from the paternal genome at this stage and that embryo development to this 
stage is primarily influenced by maternal factors  (Braude et al. 1988). However, after 
the 8-cell stage and embryonic genome activation is completed, embryo development is 
entirely dependent on embryonic transcripts. Analysis of embryo development after the 
8-cell stage has shown a linear decrease in on-time and expanded blastocyst development 
on day 5 of embryo culture with an increasing paternal BMI (Bakos et al. 2011).  
 
Mouse models of diet-induced paternal obesity are quite valuable as they enable a more 
detailed analysis of embryos which is limited in the human due to the observational nature 
and ethical restrictions of human studies. Delayed embryo development was reported 
from mice fed a HFD compared with mice fed a control diet (CD) at both the post-
embryonic genome activation cleavage stages of development (Binder et al. 2012; 
McPherson et al. 2013; Mitchell et al. 2011b) and development to the morula and early 
blastocyst stages (McPherson et al. 2013; Mitchell et al. 2011b). Of the embryos that 
reached the blastocyst stage, inner cell mass (ICM) and trophectoderm (TE) cell numbers 
were reduced in blastocysts produced from HFD-fed male mice (McPherson et al. 2013; 
Mitchell et al. 2011b). Further, the number of  epiblast cells within the ICM (the cells 
which ultimately form the fetus) were reduced in blastocysts sired by HFD-induced obese 
mice (McPherson et al. 2013; McPherson et al. 2015). Interestingly, obese men also have 
an increase in early pregnancy loss and sac only implantations lacking a fetal pole, 
suggesting that a similar mechanism may also occur in humans (Bakos et al. 2011; 




1.2.12. Obesity and pregnancy outcome 
Overweight and obese men with a female partner of normal BMI have an increased odds 
ratio for time to conceive compared to couples with normal weight men (Nguyen et al. 
2007; Ramlau-Hansen et al. 2007). The majority of studies that have investigated the 
effect of male obesity on achieving a clinical pregnancy and live birth in couples 
undergoing infertility treatment report a reduced clinical pregnancy rate with an 
increasing male BMI (Bakos et al. 2011; Keltz et al. 2010; Umul et al. 2015) (Table 1.1) 
and reduced live birth rate for obese men compared with normal weight men (Bakos et 
al. 2011; Colaci et al. 2012; Petersen et al. 2013; Umul et al. 2015) (Table 1.1). This 
reduction in live birth rate was detected despite differences in the reporting of live birth 
including live birth per oocyte retrieval or live birth per embryo transfer.  
 
In mouse models, it is possible to examine the fetuses generated from control and obese 
mice and by using blastocyst transfer into a pseudo-pregnant mother and control for any 
maternal gestational impacts on fetal growth. Blastocysts derived from in vitro 
fertilization with sperm from diet-induced obese mice had a reduced implantation rate 
following transfer (Binder et al. 2012). Also, fetal and placental weights were reduced 
from that sired by a HFD-fed male mice in addition to retarded limb morphology and 
decreased crown-rump length of the resultant fetuses (Binder et al. 2012). Embryos 
derived from in vivo fertilization by HFD-induced obese male mice also implanted at 
significantly lower rates compared with embryos produced by CD-fed males (McPherson 
et al. 2013; Mitchell et al. 2011b). Of the embryos that implanted successfully, 
significantly fewer went on to form a fetus with one study reporting reduced fetal weights, 
fetal lengths, and placental weights in those sired by HFD-induced obese mice 
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(McPherson et al. 2013) while another reported no difference (Mitchell et al. 2011b). The 
most likely explanation for this discrepancy between McPherson et al. and Mitchell et al. 
may be the differences in durations of diet exposure; 18 weeks versus 8 weeks, suggesting 
that duration of diet intake and subsequent increases in adiposity and metabolic syndrome 














each BMI (kg/m2) 
Pregnancy Outcomes 
with increasing BMI  
Potential Confounders 
or Limitations 




290 38 <24.9 n=62 
≥25 n=228 
¯ clinical pregnancy 
rates 
BMI was self-reported 




305 36 <24.9; n=63 
25-29.9; n=148 
≥30; n=94 
¯ clinical pregnancy 
and live birth rates 
Lifestyle factors were not 
reported e.g. smoking 




114 37 <.9; n=38 
25 -29.9 n=53; 
≥30; n=23 









¯ live birth rates (with 
IVF not ICSI) 
Smokers included 




735 34 <24.9; n=224 
25 -29.9 n=334; 
≥30; n=177 
No effect Lifestyle factors were not 
reported e.g. smoking 




155 34 <24.9; n=52 
25 -29.9 n=75; 
≥30; n=28 
¯ clinical pregnancy 
and live birth rates 
Lifestyle factors were not 
reported e.g. smoking 
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1.2.13. Paternal obesity and offspring health 
In recent years there has been an increasing number of reports linking paternal health,  at 
conception and the programming of their offspring’s health. Examples of paternal 
conditions that have been demonstrated to impact on offspring health include occupation 
exposures to solvents; pesticides; toxic fumes, advanced age, smoking, diet, as well as 
obesity (El-Helaly et al. 2011; Frans et al. 2008; Gianicolo et al. 2010; Johnson et al. 
2015; Li et al. 2009).  
 
In epidemiological studies, paternal obesity at conception is associated with alterations 
in  fetal growth and disease in offspring in a sex specific manner including lower birth 
weight in babies (McCowan et al. 2011), increased body fat in pre-pubertal daughters 
(Figueroa-Colon et al. 2000) and early mortality from chronic diseases in sons (Pembrey 
2010; Pembrey et al. 2006). Also, ultrasound measurements in late gestation including 
head circumference, abdominal diameter, abdominal circumference and pectoral 
diameter, and birth weight in male newborns are correlated positively with an increased 
paternal BMI (Chen et al. 2012). Infants from obese fathers had elevated growth curves 
from birth to 3.5 years old compared with children from normal weight fathers (Linabery 
et al. 2013). Paternal metabolic syndrome together with obesity has been shown to be 
associated with the development of polycystic ovary syndrome in their daughters (Leibel 
et al. 2006), identifying another example of paternal non-genetic transmission of disease 
to the next generation. Recently, the National Institutes of Health (NIH) found that 
children of obese fathers were 75% more likely to fail measures of personal-social 
functioning in a study that involved approximately 5000 children (Yeung et al. 2017). 
However, it should be noted that these measures were tested using a questionnaire 
completed by parents at home after performing a series of activities with their children 
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and therefore may be potentially biased (Yeung et al. 2017). Taken together, evidence is 
accumulating that an obese father transmits perturbed health cues to their children. 
 
Animal models have enabled the rapid assessment of the impacts of male obesity on 
multiple generations including the assessment of invasive measures, which are not able 
to be performed in an investigative clinical setting. Female rat offspring sired by diet-
induced obese and diabetic fathers developed early onset impaired insulin secretion, 
glucose intolerance, and altered expression of multiple genes related to normal pancreatic 
function (de Castro Barbosa et al. 2016; Ng et al. 2010). In a mouse model of paternal 
diet induced obesity in the absence of diabetes, perturbed metabolic health including 
glucose intolerance and insulin resistance were observed in two generations of both 
female and male offspring (Fullston et al. 2013). Moreover, the same model of paternal 
obesity at conception resulted in female offspring who produced oocytes with reduced 
meiotic competence and reduced mitochondrial membrane potential (Fullston et al. 
2012). Further, male offspring produced sperm with reduced motility, increased sperm 
ROS, and increased DNA damage with many changes evident in the second generation 
(Fullston et al. 2012). 
 
Overall, these findings suggest a link between paternal obesity at conception and delayed 
embryo development and impaired subsequent offspring health (de Castro Barbosa et al. 
2016). Given that the prevalence of male obesity continues to rise with evidence that 
paternal health and BMI before conception influence the development and health of the 
fetus, infant and child, strategies to address and intervene are warranted to maintain 
optimal childhood health.  
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1.3 Sperm Oxidative Stress – A Proposed Mechanism 
 
ROS and reactive nitrogen species (RNS) are molecules that have one or more unpaired 
electrons and are able to modify molecules such as membrane lipids, proteins, and nucleic 
acids by transferring these unpaired electrons to other molecules causing oxidation. 
Examples of ROS and RNS include superoxide, hydrogen peroxide, hydroxyl, peroxyl, 
nitric oxide and peroxynitrite. Oxidative stress is defined as an imbalance between ROS 
and/or RNS and antioxidant levels, and occurs when the concentration of ROS and/or 
RNS exceeds the concentration of antioxidants and overwhelms the antioxidant free 
radical scavenging protective systems (Agarwal et al. 2006), leading to loss of function 
and is some cases apoptosis (Agarwal et al. 2006).  
 
1.3.1 Main sources of ROS  
 
1.3.1.1. Mitochondria 
ROS are a normal by-product of mitochondrial metabolism and are required for normal 
physiological sperm cell functions, such as sperm capacitation and acrosome reaction 
(Leclerc et al. 1997). In normal cell metabolism, ROS is predominately produced from 
mitochondrial Complex I whereas in sperm cells, Koppers et al. found that stimulation 
of Complex I and Complex III of the inner mitochondrial matrix increased superoxide 
formation (Koppers et al. 2008) (Figure 1.5). Superoxide is then rapidly dismutated to 
hydrogen peroxide via SOD antioxidant enzymes, and subsequently released into the 
cytoplasm of sperm which can result in peroxidative damage to the mid-piece of the 
sperm leading to a loss of motility as a consequence of membrane lipid peroxidation 
(Amaral et al. 2013; Koppers et al. 2008) (Figure 1.5). Further, aldehydes generated from 
	
	 61	
sperm membrane lipid peroxidation have been shown to disrupt the mitochondrial 
electron transport chain ultimately inducing more ROS generation in a self-perpetuating 






Figure 1.5: Mitochondria are a main source of ROS in sperm. Several complexes within 
the inner mitochondrial matrix results in superoxide formation, which is then dismutated 





1.3.1.2. Leukocytes and seminal oxidative stress  
Leukocytes, particularly neutrophils and macrophages, are considered a major source of 
the production of ROS found in semen. Infection and/or inflammation of the male organs 
contribute to oxidative stress as leukocytes are generated in response to infection and 
inflammation (Tremellen and Tunc 2010). Although the exact mechanism for how 
seminal leukocyte ROS production impacts sperm is unknown, it is postulated that 
hydrogen peroxide, produced by leukocytes, can penetrate the sperm plasma membrane 
and cause intracellular damage whereas other ROS such as superoxide and hydroxyl 
radicals cannot permeate the sperm plasma membrane or their short half-lives can be 
difficult to detect (Henkel et al. 2005). Hydrogen peroxide exposure can induce further 
intracellular ROS production via transition metal reactions such as Fenton type reaction 
or reaction with other ROS and can thus damage DNA integrity. This mechanism has 
been shown to be active in vitro as adding hydrogen peroxide to a sperm suspension 
resulted in increased DNA fragmentation (Ramos and Wetzels 2001). However, non-
permeable leukocyte-derived ROS such as superoxide or hydroxyl radicals can damage 
sperm structure and function by oxidizing the lipids of the sperm plasma membrane 
resulting in lipid peroxidation (Henkel et al. 2005), thereby reducing sperm-oocyte fusion 
and fertilization capacity (Lackner et al. 2010; Sharma et al. 2001). 
 
1.3.1.3. Excess residual cytoplasm 
During sperm maturation, excess residual cytoplasm may remain in the morphologically 
abnormal sperm heads and contribute to oxidative stress (Rengan et al. 2012; Sprando 
and Russell 1987). Immature sperm, particularly sperm with excess cytoplasmic retention 
and abnormal head morphology, contain high ROS concentrations (Gomez et al. 1996). 
This emphasizes the notion that oxidative stress is considered a paradox that involves 
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both favorable and unfavorable consequences. The crux of this paradox is that the 
cytoplasm is shed as part of their maturation process, reducing susceptibility to ROS 
generation but in doing so, their antioxidant defense mechanisms are also reduced, as 
antioxidant enzymes are mainly located in the cytoplasm (Aitken and Curry 2011a). In 
stress conditions such as obesity, the physiological levels of antioxidants in sperm with 
excess residual cytoplasm cannot counteract the surplus production of ROS ultimately 
limiting the sperm cell’s capacity to eliminate the excess ROS (Rengan et al. 2012). 
 
1.3.1.4. Lipid peroxidation 
Lipid peroxidation is considered to be both a source of ROS production and consequence 
of increased ROS and oxidative stress (Storey 1997). The sperm plasma membrane 
contains an abundance of polyunsaturated fatty acids, which are vulnerable to lipid 
peroxidation, generating a cascade of lipid peroxides and aldehydes resulting in the rapid 
immobilization of sperm (Jones et al. 1979). Lipid peroxidation of the sperm plasma 
membrane is a cascade of self-propagating oxidative reactions composed of three main 
steps: initiation, propagation, and termination initiated by hydroxyl (OH) radicals 
(Henkel 2011). Lipid peroxidation is initiated by hydrogen atom abstraction from the 
lipid molecules of the polyunsaturated fatty acids in the sperm plasma membrane (Figure 
1.6). The abstraction of hydrogen atoms from the unconjugated carbon double bonds 
results in free radical formation. These free radicals react with fatty acid chains and form 
lipid radicals, which then react with oxygen to form peroxyl radicals (Figure 1.6). The 
peroxyl radicals react with hydrogen to form lipid peroxides in the propagation stage 
resulting in the formation of cytotoxic aldehydes and the destabilization of the sperm 
plasma membrane (Henkel 2011), ultimately impairing the structure and function of the 
sperm plasma membrane and its membrane proteins (ATP-dependent ion pumps and 
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voltage-regulated ion channels) that are critical for sperm motility (Lundbaek and 
Andersen 1994). During the propagation stage, the peroxyl and alkyl radical byproducts 
are regenerated until they react with each other to form stable end products and 
lipoproteins (Figure 1.6). When stable lipoproteins are formed, lipid peroxidation is at 
the termination stage, ultimately resulting in the generation of electrophilic lipid 
aldehydes including 4-hydroxynonenal (4HNE), acrolein, and MDA (Moazamian et al. 











Figure 1.6: Lipid peroxidation of the sperm plasma membrane is a cascade of self-propagating oxidative reactions composed of three main 
steps: initiation, propagation and termination. Initiation is triggered by free radical hydrogen atom abstraction from the unsaturated lipid 
molecules resulting in the formation of lipid radicals. Lipid radicals react with oxygen to form lipid peroxyl radicals, which then react with 
more unsaturated lipids from the sperm plasma membrane during the propagation stage. Lipid peroxidation is terminated when peroxyl 

















1.3.2. Oxidative stress and sperm function 
The cellular generation of ROS in human sperm was first reported in 1943 whereby 
hydrogen peroxide generation by sperm was concomitant with a reduction in sperm 
motility (MacLeod 1943). There are various ROS that at physiological concentrations are 
responsible for and modulate sperm capacitation including hydrogen peroxide (Aitken et 
al. 1995; Rivlin et al. 2004), superoxide anion (de Lamirande and Gagnon 1993) and the 
peroxynitrite radical (Herrero and Gagnon 2001). However, at pathological levels, 
inducing oxidative stress results in a loss of sperm motility likely due to the by-products 
of lipid peroxidation as described in more detail above, which form adducts with the 
flagellar proteins resulting in a loss of flagellar function and ultimately loss of progressive 
motility (Baker et al. 2015; Moazamian et al. 2015). Also, the aldehyde, 4HNE, has the 
capacity to bind to mitochondrial proteins in sperm, which triggers mitochondrial 
electron leakage and leads to additional ROS generation (Koppers et al. 2010). An over-
abundance of ROS dysregulate protein tyrosine phosphatase activity, leading to the 
dephosphorylation and deactivation of phospholipase A2, which is necessary for the 
fluidity of the sperm plasma membrane and ultimately sperm-oocyte fusion (Calamera et 
al. 2003). Many studies have established that impaired sperm function is induced by 
oxidative stress, affecting capacitation, acrosome reaction, and sperm-oocyte fusion 
(Aitken et al. 1991; Kao et al. 2008; Morielli and O'Flaherty 2015; Sanocka et al. 1996; 
Sharma and Agarwal 1996).  
 
1.3.3. Oxidative stress and sperm DNA damage 
In addition to impaired sperm function, sperm oxidative stress can also damage the 
intracellular components of sperm, in particular DNA. Sperm chromatin integrity is 
compromised by high concentrations of sperm intracellular ROS (Aitken et al. 2003; De 
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Iuliis et al. 2009). Sperm DNA damage can be initiated by oxidative damage  (De Iuliis 
et al. 2009) that forms oxidative base adducts such as 8-hydroxy-2’deoxyguanosine (8-
OHdG) (De Iuliis et al. 2009; Noblanc et al. 2013) (Figure 1.7). 8-OHdG is an oxidized 
guanine residue within sperm DNA, resulting from the oxidant attack of ROS by such 
molecules as hydroxyl radicals and hydrogen peroxide (Noblanc et al. 2013) (Figure 1.7). 
This then leads to a loss of the affected guanine base with an abasic site, which has a 
strong destabilizing effect on the DNA backbone and the DNA strand eventually breaks 
(Mitchell et al. 2011a), which may explain the increase of single and double stranded 
breaks observed in obese men (Campbell et al. 2015).  
 
Sperm cells do not have the capacity to repair their DNA damage and base modifications, 
as sperm possess only one enzyme from the base excision repair (BER) pathway: 8-
oxoguanine DNA glycosylase (OGG1) (Bruner et al. 2000; Smith et al. 2013). The 
enzyme OGG1 actively excises the 8-OHdG base adduct and releases it into the 
extracellular space however, sperm do not have the remaining components of the BER 
pathway: apurinic endonuclease 1 (APE1) and X-ray repair cross-complementing protein 
1 (XRCC1) (Smith et al. 2013). As a result of this reduced DNA repair capacity, abasic 
sites are formed at locations affected by 8-OHdG generation leading to not only 
fragmentation of the DNA but also potential mutagenic base lesions (Bruner et al. 2000; 
Smith et al. 2013). 8-OHdG generation can also lead to the transmission of abasic sites 
into the oocyte for continuation of the repair pathway immediately after fertilization 
(Gawecka et al. 2013; Lord and Aitken 2015; Shimura et al. 2002). Moreover, 8-OHdG 
lesions are co-localized to chromatin regions of sperm that have less compacted and 
condensed chromatin, which are associated with loci that have retained histones (Noblanc 
et al. 2013). The relatively more exposed histone-bound regions in the paternal genome 
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are thus more susceptible to oxidative damage (Noblanc et al. 2013), but are also 
necessary for paternal genome transcription activation and paternal DNA replication 
(Shaman et al. 2007). Alterations or damage to the DNA bound to these histones in the 
paternal genome may be transmitted to the embryo without repair, resulting in delayed 
embryo development and blastocyst cell differentiation, and ultimately impaired health 





                                                                    
 
 
Figure 1.7: Formation of the oxidative base adduct: 8-hydroxy-2’-deoxyguanosine (8-OHdG). 8-OHdG is a common oxidized base 







1.3.4. Transmission of paternal DNA damage  
Current literature suggests that sperm intracellular ROS leads to oxidative damage to not 
only DNA but RNA, proteins, and microRNA. As a result, this damage may trigger 
paternal programming by alterations to the genome and/or epigenome of sperm (Aitken 
and Baker 2002; Aitken and Curry 2011a). Epidemiological studies demonstrate that 
there is a range of environmental and lifestyle factors that can impair DNA integrity in 
the male germ line due to increased sperm oxidative stress, which may induce subsequent 
DNA mutations in the embryo and ultimately perturb offspring health (Figure 1.8). High 
levels of ROS in seminal plasma and elevated levels of oxidative DNA modifications 
(e.g. 8-OHdG) in sperm DNA were observed in sperm from smokers compared to the 
sperm of non-smokers (Fraga et al. 1996). The oxidative DNA modifications and DNA 
fragmentation in sperm cells have been associated with elevated levels of childhood 
cancer in their offspring (Ji et al. 1997). Oxidative damage to sperm DNA such as 
deletions, abasic sites, and oxidative base change, have been proposed to contribute to an 
increased mutational load in the embryo (Trasler 2009). These mutational changes would 
be created in the fertilized oocyte as a result of abnormal DNA repair during DNA 
replication in the first cleavage division, highlighting a potential pathway for genetic 
damage to be transmitted through the male germ line, which may then impact offspring 
health.  
 
In mice, treatment of sperm with hydrogen peroxide to induce elevated intracellular ROS 
did not affect fertilization but delayed on-time embryo development at the 8-cell stage, 
reduced the ratio of blastocyst ICM to TE cells, reduced embryo implantation rates, and 
reduced fetal: placental weights (Lane et al. 2014). Furthermore, sex-specific impacts on 
offspring were demonstrated, whereby female offspring were smaller in size, glucose 
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intolerant, and accumulated increased levels of adipose tissue when born from sperm 
treated with hydrogen peroxide-treated sperm compared to female offspring sired by 
sperm not treated with hydrogen peroxide. Male offspring however, did not display the 
phenotypes found in female offspring. Interestingly, sex-specific changes in the 
phenotype of offspring are similar to those reported in other models of paternal obesity 
and offspring programming (Fullston et al. 2013; Fullston et al. 2012; Ng et al. 2010) 
whereby many of the measured outcomes in female offspring were similar to that 
reported for obesity. 
 
Overall, amongst the proposed mechanisms contributing to the transmission of paternal 
DNA damage, sperm oxidative stress is a prime central candidate mechanism that enacts 





Figure 1.8: A summary of the impact of sperm oxidative stress on offspring health in 
mice. Sperm oxidative stress and elevated intracellular ROS levels increases oxidative 
DNA modifications (8-OHdG), which in turn increases the incidence of DNA mutations 
in the subsequent embryo. Further, if a pregnancy and live birth is achieved, perturbed 





1.4 Dietary Micronutrient Supplementation  
 
Oxidative stress and the production of damaging ROS within cells can be alleviated with 
antioxidants and antioxidant enzymes such as SOD, catalase and GPx. However, there is 
increasing interest in dietary impacts of antioxidants including micronutrients such as 
vitamins and minerals. Current literature is mixed with some supporting dietary 
micronutrient supplementation to treat sperm oxidative stress and improve sperm 
function in subfertile men (Showell et al. 2014), whilst others claim the evidence is of 
low quality (Barratt et al. 2017). The data in support of dietary micronutrient 
supplementation is considered as poor quality due to the inconsistencies in study design, 
patient phenotype, investigative outcomes, duration of intake and the intake of a single 
micronutrient versus a combination of micronutrients. Further, some micronutrients are 
not antioxidants but have anti-oxidative properties that combat oxidative stress indirectly 
(Table 1.2). Although the general functional capacity of these micronutrients during 
oxidative stress is understood (Table 1.2), the exact mechanism(s) involved in dietary 
supplements and improved sperm function is not known albeit proposed mechanisms via 





Table 1.2: Commonly studied micronutrients (including antioxidants and elements) as dietary supplements for treatment of male subfertility and 
their anti-oxidative functions. 
Compound Micronutrient type Proposed Anti-oxidative function/ mechanism 
Vitamin E Antioxidant (lipophilic) Inhibits lipid peroxidation primarily of the plasma membrane 
Vitamin C Antioxidant (hydrophilic) Electron donor and neutralizes free radicals  
Zinc  Element  Inhibits ROS production through redox-active transition metals  
Selenium  Element  Major constituent of antioxidant enzyme glutathione peroxidase (GPx) 
Lycopene Carotenoid (lipophilic) Scavenges ROS primarily singlet oxygen  
Folic acid Antioxidant (B vitamin) Free radical scavenger 
Co-enzyme Q10 Antioxidant (lipophilic) Inhibits lipid peroxidation and superoxide formation during cellular metabolism 
N-acetyl cysteine Amino acid Indirectly as a precursor of glutathione peroxidase (GPx) and directly as a free radical scavenger 





1.4.1. Dietary micronutrient supplementation in normal weight males or subfertile 
men with unspecified BMIs 
 
1.4.1.1 Sperm oxidative stress and DNA integrity 
Gharagoozloo and Aitken evaluated 20 trials that investigated the effects of various oral 
micronutrient supplements on sperm oxidative stress and DNA damage in men 
undergoing ART treatment. They found that 19 of the 20 trials reported reduced sperm 
oxidative stress or DNA fragmentation with micronutrient intake (Gharagozloo and 
Aitken 2011). Sperm oxidative stress has been shown to be reduced with a range of 
dietary micronutrient supplementation despite the variance in the types of micronutrients 
used, the duration of intake and other variables and potential confounders. This may be 
due to the indirect and direct anti-oxidative pathways and properties of micronutrients, 
which include antioxidants and trace elements (Table 1.2). 
  
Zinc is a trace element that indirectly functions as an antioxidant by reducing hydroxyl 
radical formation from hydrogen peroxide through the antagonism of redox-active 
transition metals (Powell 2000). In asthenozoospermic men, the intake of various zinc-
based supplements were compared including zinc only, zinc with vitamin E and zinc in 
combination with vitamins E and C supplementation for 3 months (Omu et al. 2008). 
Antioxidant enzyme concentrations of SOD and GPx (antioxidant enzymes) in both 
serum and semen in men taking all variations of these zinc supplements were increased 
compared to no treatment control with no differences in outcome measures when 
comparing the three different types of zinc-variant supplements, suggesting that the zinc 




Vitamin E is a readily diffused lipophilic antioxidant primarily localized in the cell’s 
plasma membrane. The major and direct anti-oxidative function of vitamin E is the 
inhibition of lipid peroxidation to maintain membrane fluidity and integrity (Traber and 
Atkinson 2007). In men undergoing ART treatment, vitamin E supplementation for 6 
months was associated with reduced lipid peroxidation observed by reduced sperm MDA 
concentrations (byproduct of lipid peroxidation) compared to placebo-treated patients 
(Suleiman et al. 1996). Vitamin C (ascorbic acid) is a hydrophilic antioxidant, which 
neutralizes free radicals by electron donation. Vitamin C in cells protects against protein, 
lipid and DNA damage by directly reducing radical species to maintain intracellular and 
DNA integrity (Padayatty et al. 2003). The protective role of dietary intake of vitamin C 
on sperm oxidative stress and sperm DNA integrity was demonstrated when the dose of 
vitamin C supplementation was reduced from 250mg to 5mg/day, sperm 8-OHdG lesions 
increased after 28 days (Fraga et al. 1991). In couples undergoing ART treatment, men 
with elevated sperm DNA fragmentation were selected to consume both vitamin C and 
vitamin E supplementation or a placebo and following 2 months, men treated with 
vitamin C and vitamin E supplementation had reduced sperm DNA fragmentation 
compared to placebo treated patients (Greco et al. 2005). Furthermore, protection against 
sperm DNA fragmentation has been also demonstrated with in vitro lycopene 
supplementation. Lycopene is a lipophilic carotenoid with high singlet oxygen-
quenching potency (Rao et al. 2006). Sperm DNA fragmentation from fertile men was 
reduced in hydrogen peroxide-treated sperm by treatment with lycopene for 2 hours in 
vitro highlighting the protective role of lycopene in maintaining DNA integrity (Zini et 




The protection of micronutrient supplement intake has also been shown in animal models 
whereby oral green tea extract supplementation, a catechin and natural antioxidant 
reduced sperm oxidative stress by increasing catalase and SOD antioxidant enzyme 
activity in sperm from rats compared to sperm from the no treatment control (Awoniyi et 
al. 2012). Given that sperm are transcriptionally and translationally silent, this alteration 
in gene expression and protein synthesis must have occurred during the early stages of 
spermatogenesis. In mice fed a restricted diet to mimic under-nutrition, the intake of a 
combination of micronutrient supplements (selenium, lycopene, vitamin E, vitamin C, 
green tea extract, zinc and folic acid) reduced levels of sperm 8-OHdG lesions compared 
to sperm from under-nourished controls (McPherson et al. 2016). In mice, an epididymis 
specific GPx5-knockout model was generated to have the hydrogen peroxide-scavenging 
activity of GPx5 in the epididymis nullified to expose maturing sperm to hydrogen 
peroxide-mediated oxidative stress (Chabory et al. 2009). In this model, sperm 8-OHdG 
lesions were reduced with a 8 week intake of a combination of micronutrient 
supplementation consisting of a carnitine blend, folic acid, lycopene, selenium, vitamin 
C, vitamin E, and zinc (Gharagozloo et al. 2016). Overall, these studies suggest an 
important role of micronutrient supplementation in combating oxidative stress in the male 
germ line and reducing sperm oxidative stress byproducts including oxidative DNA 
damage and DNA fragmentation. Interestingly, these mouse models suggest that 
micronutrient supplementation may have a vital role in both the testes and epididymis in 
protecting against sperm oxidative stress. 
 
1.4.1.2 Conventional sperm parameters 
Current literature suggests that the consumption of micronutrient supplements in 
subfertile men is not only associated with improved sperm oxidative stress and DNA 
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integrity but also improved conventional sperm parameters. The largest meta-analysis of 
48 randomized-controlled trials is a Cochrane systematic review by Showell et al. that 
included 4,179 couples and compared any type or dose of micronutrient supplement with 
a placebo or no treatment (Showell et al. 2014). These micronutrients included 
antioxidants and trace elements (Table 1.2). The overall findings from the systematic 
review reported that data were inconsistent to draw conclusive findings regarding 
conventional sperm parameters due to the extremely high heterogeneity between studies. 
However, when analyzing studies with low heterogeneity, the systematic review reported 
a combination of micronutrients and antioxidants for 3 months increased sperm motility 
compared to placebo or no treatment (Showell et al. 2014). 
 
The impact of a variety of dietary micronutrient and antioxidant supplementation on 
sperm motility for different durations has been previously investigated. An increase in 
sperm motility was found after three months of N-acetyl cysteine, vitamin E and 
selenium, zinc or selenium supplement intake in infertile and asthenozoospermic men 
(Ciftci et al. 2009; Keskes-Ammar et al. 2003; Nozha et al. 2001; Omu et al. 1998; Scott 
et al. 1998), six months of carnitine, co-enzyme Q10 or vitamin E supplementation in 
infertile and oligoasthenoteratozoospermic men (Balercia et al. 2005; Cavallini et al. 
2004; Lenzi et al. 2003; Lenzi et al. 2004; Safarinejad 2009; Safarinejad and Safarinejad 
2009; Suleiman et al. 1996), and nine months of co-enzyme Q10 in infertile men 
(Balercia et al. 2009). N-acetyl cysteine and selenium are vital for the synthesis of the 
antioxidant enzyme GPx, whereby n-acetyl cysteine is a precursor and selenium is a 
major constituent through selenoproteins, which are required for flagellum formation and 
maintain progressive sperm motility (Aruoma et al. 1989; Boitani and Puglisi 2008). 
Whereas carnitines have direct and indirect anti-oxidative properties by neutralizing free 
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radicals and inhibition of fatty acid oxidation endogenously (Agarwal and Said 2004). 
Similar to vitamin E, endogenous co-enzyme Q10 is an antioxidant primarily located in 
the plasma membrane and inhibits lipid peroxidation and ROS formation, primarily 
superoxide (Crane 2001). Collectively, these micronutrients are examples of compounds 
that have indirect and direct anti-oxidative functions in free radical scavenging, which 
maintain sperm cell mitochondrial metabolism and support progressive sperm motility 
which is regulated by the mitochondria. Further, one study showed an improvement in 
sperm motility after vitamin C supplementation of three weeks (Dawson et al. 1990). 
Given that a full round of spermatogenesis is approximately 3 months in men, 
improvement in sperm motility over a much shorter time would suggest that 
micronutrient supplementation can modify sperm during sperm maturation during 
epididymal transit, which is of a much shorter duration (10 days).  
 
The concentration of lycopene in the testes is relatively high compared to other parts of 
the body (Zini et al. 2010), which suggests that lycopene may have a vital role in sperm 
morphogenesis during spermatogenesis. An increase in sperm concentration and normal 
morphology was also reported after six months of carnitine or co-enzyme Q10 in infertile 
men (Cavallini et al. 2004; Lenzi et al. 2003; Safarinejad 2009; Safarinejad and 
Safarinejad 2009) and lycopene intake was positively associated with normal sperm 
morphology in young healthy men (Zareba et al. 2013). A double-blinded, randomized, 
controlled trial found that sperm motility, concentration and normal morphology were 
increased with folic acid combined with zinc for 6 months in both fertile and subfertile 
men to similar extents (Wong et al. 2002). Although the underlying mechanisms are 
unknown, it is likely that the anti-oxidative properties of folic acid and zinc in scavenging 
free radicals and inhibition of ROS production respectively, may contribute to normal 
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spermatogenesis as micronutrient concentrations were elevated in blood and seminal 
plasma of men taking dietary folic acid and zinc supplementation (Wong et al. 2002).  
 
The impact of micronutrient supplement intake on conventional sperm parameters have 
also been studied in various animal models. A study in cyclophosphamide treated rats, a 
chemotherapy drug, investigated the protective role of lycopene on sperm morphology 
and found that dietary lycopene consumption significantly improved normal sperm 
morphology compared to rats that did not consume lycopene (Ceribasi et al. 2010). Some 
studies report that certain forms of garlic (allitridum) when added to epididymal sperm 
in vitro have dose dependant deleterious effects on sperm motility from various species 
including ram, hamster and rat (Chakrabarti et al. 2003; Qian et al. 1986). In contrast, 
beneficial effects of garlic oil intake have been reported whereby an increase in sperm 
count was found when adding garlic to drinking water in mice (al-Bekairi et al. 1990), 
which may be due to the antioxidants, allicin, alliin, allyl disulfide and allyl cysteine, 
found in garlic compounds (Chung 2006). The discrepancies between these studies may 
be due to the differences in use of garlic in vitro (adding it to collected epididymal sperm) 
and in vivo (adding it to drinking water) in addition to the differences in doses and 
concentrations of garlic used. Green tea extract has been shown to improve sperm 
motility and normal morphology in nicotine-induced oxidative stress in rats (Mosbah et 
al. 2015). Also in rats, selenium deficiency was associated with reduced sperm motility 
and concentration, and abnormal sperm morphology (Olson et al. 2004). Overall, these 
animal models highlight the effectiveness of dietary micronutrient supplement intake in 
improving conventional sperm parameters including sperm motility, concentration and 




1.4.1.3 Sperm function and pregnancy outcome 
The impact of dietary micronutrient supplementation on sperm function including sperm-
oocyte binding and fertilization rates in men has also been assessed. In a blinded, 
randomized controlled trial, otherwise healthy men but who presented with high levels 
of seminal ROS received either vitamin E supplements or a placebo for three months. 
After three months, blood serum vitamin E concentrations were increased in men taking 
the vitamin E supplementation with a concomitant increase in sperm-oocyte binding 
(Kessopoulou et al. 1995). Also, vitamin E supplementation for one month was 
associated with increased fertilization rates from 15 normospermic men that had low 
fertilization rates in their previous IVF cycles (Geva et al. 1996). An similar increase in 
fertilization rates has also been reported with zinc supplementation in asthenozoospermic 
men after one month of intake (Omu et al. 1998).  
 
The association between dietary micronutrient supplementation and pregnancy rates has 
been reviewed and the majority of studies report a positive relationship between 
micronutrient supplementation in men and pregnancy rates after undergoing ART 
treatment (Gharagozloo and Aitken 2011; Showell et al. 2011; Showell et al. 2014). The 
micronutrients used in these studies included vitamin E in asthenozoospermic men 
(Suleiman et al. 1996), L-carnitine/ acetyl L-carnitine in oligoasthenozoospermic men 
(Cavallini et al. 2004; Li et al. 2005) and a combination of micronutrients including 
selenium, zinc, folic acid, vitamin E, vitamin C, lycopene, and garlic oil in men with 
severe male factor infertility (Tremellen et al. 2007).  
 
The increase in pregnancy rates with micronutrient supplementation persisted into 
increased live birth rates whereby a Cochrane systematic review found that 3 of 34 
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randomized controlled trials investigated the correlation between supplement intake and 
live birth rates and found that all 3 studies showed an increase in live birth rate compared 
to the control group (Showell et al. 2011). Dietary vitamin E supplementation (Suleiman 
et al. 1996) and zinc supplementation in asthenozoospermic men (Omu et al. 1998), and 
a combination of micronutrients including selenium, zinc, folic acid, vitamin E, vitamin 
C, lycopene, and garlic oil in men with severe male factor infertility (Tremellen et al. 
2007) increased live birth rates after IVF compared to placebo or no treatment. 
 
Overall, the efficacy of dietary micronutrient supplementation has been established in 
normal weight or sub-fertile men whereby improved conventional sperm parameters and 
reduced sperm oxidative stress, oxidative DNA damage, and DNA fragmentation were 
observed.  
 
1.4.2. Dietary micronutrient supplementation in obese males 
Despite being a disease of over-nutrition, obesity is commonly associated with a 
micronutrient-poor diet (Gillis and Gillis 2005). Increased adiposity and BMI are 
associated with reduced serum concentrations of essential vitamins and minerals with 
anti-oxidative properties including vitamin C, vitamin E, selenium, folate and zinc 
(Aasheim et al. 2008; Ernst et al. 2009; Garcia et al. 2012; Gobato et al. 2014). In men 
with unspecified BMIs, micronutrient deficiencies have been associated with subfertility, 
such as selenium deficiency, which is associated with increased abnormal sperm 
morphology (Krol et al. 2012), and reduced sperm motility and concentration, (Hardy 
and Hardy 2004; Olson et al. 2004; Sanchez-Gutierrez et al. 2008) and increased sperm 
oxidative damage (Sanchez-Gutierrez et al. 2008). Also, men with vitamin C deficiency 
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have demonstrated increased 8-OHdG in their sperm, which is reduced with vitamin C 
supplementation (Fraga et al. 1991). 
 
To date, there have been no studies that have investigated the impact of dietary 
micronutrient supplement intake on male fertility in overweight and obese men. 
However, in animal models, particularly rodent models, the benefits of micronutrient 
supplementation on sperm quality and function in HFD-induced obese males have been 
demonstrated to a certain extent. In 2012, Ibrahim et al. used a mouse model of obesity 
and hyperlipidemia induced by a HFD (15% fat) and showed that a HFD supplemented 
with selenium for approximately 11 weeks reduced the number and degree of irregular 
and collapsed seminiferous tubules, increased the number of spermatocytes, increased 
testosterone levels, sperm motility and count, and improved sperm morphology (Ibrahim 
et al. 2012). In rats, a HFD consisting of approximately 60% fat supplemented with 
vitamin E, vitamin C, and astaxanthin (carotenoid) for 12 weeks increased sperm count, 
motility, and normal morphology in addition to increases in the number of 
spermatognonia and Sertoli cells in testicular tissue compared to rats that consumed an 
un-supplemented HFD (Mortazavi et al. 2014). Further, the rats fed the un-supplemented 
HFD had increased serum triglyceride and cholesterol concentrations compared to that 
treated with dietary vitamin E, vitamin C, and astaxanthin supplementation suggesting 
that systemic metabolic issues may also contribute to impaired reproductive health in 
these rats (Mortazavi et al. 2014). Thymoquinone, an anti-inflammatory and antioxidant 
compound found in plants was injected daily and intraperitoneally into rats fed a 40% fat 
diet and after 6 weeks, the treated rats showed no differences in sperm concentration or 
motility but displayed increased levels of normal sperm morphology in addition to a 
reduction in testicular and seminiferous tubule structural atrophy, and an increase in the 
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number of spermatogenic and Leydig cells compared to the non-treatment control (Tufek 
et al. 2015).  
 
Overall, these studies suggest that that micronutrients may improve male fertility 
compromised by obesity. However, the optimal duration for administration and whether 
embryo development and pregnancy is improved is unclear. It is also not clear whether 
the effect is related to obesity or related metabolic disorders such as hyperinsulinemia or 
hyperlipidemia. Importantly, no studies to date have examined the impact of 
micronutrient supplement intake on sperm oxidative stress and pregnancy outcomes in 
men with an increased BMI. Therefore, investigations regarding  the impact of commonly 
used dietary micronutrient supplements on pregnancy and fertility treatment outcomes in 
addition to the potential underlying oxidative stress markers in sperm from obese males 





1.5 Conclusion  
 
The prevalence of male obesity and its detrimental effects on both male reproductive 
health and the health of their offspring is becoming more evident. The improvement of 
methods for the diagnosis, management, and prevention of obesity and male mediated 
reproductive failure is crucial. This literature review emphasizes the significant and 
central role that sperm oxidative stress plays in the induction of defective sperm quality 
and function, loss of DNA integrity, and transmission of disease to offspring. Methods 
for the treatment and prevention, with appropriate micronutrients, to reduce the severity 
of oxidative damage to sperm need to be investigated to try and improve sperm function, 
pregnancy outcomes and ultimately the health of offspring.  
 
Dietary micronutrient supplementation can improve sperm function and even improve 
pregnancy rates after ART in sub-fertile men. However, whether micronutrient 
supplementation can reverse or minimize the detrimental downstream effects of obesity 
on sperm remains unknown, or how this influences the embryo and pregnancy. This area 
of research requires studies to establish an understanding of the correlation between 
dietary micronutrient supplementation and obese male reproductive health, and the 
mechanisms for improvements of not only sperm quality and function and oxidative 
markers, but also subsequent pregnancy outcomes.  
 
Therefore, my hypothesis is: dietary micronutrient supplementation in obese males 
improves fertilization rates, embryo development, implantation, and pregnancy rates by 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Materials and Methods 
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2.1 MOUSE EXPERIMENTAL METHODS 
	 108	
2.1.1 Animal ethics approval  
The use and care of all mice were approved by The University of Adelaide’s Animal 
Ethics Committee (project number M-2013-165B) and were handled in accordance with 
the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes 
(NHMRC, 2013). 
 
2.1.2 Animals and the initial dietary regimen  
Five-week old male C57BL6 mice (n=144) were randomly assigned to the first phase of 
the dietary regimen; a control diet (CD) or high fat diet (HFD) for a duration of 10 weeks 
(Specialty Feeds, Perth, Australia, Figure 2.1). Mice were housed individually and were 
maintained in a 14:10 hour light:dark cycle with ad libitum access to food and water. 
Individual body weights were recorded weekly. 
 
2.1.3 Animals and the intervention dietary regimen  
After 10 weeks of the initial dietary regimen, male mice were assigned to the second 
dietary phase; one of four diets whereby mice initially fed a CD either (i) continued a 
CD, or were fed a (ii) CD supplemented with micronutrients (CD+S; Specialty Feeds, 
Table 2.1), and mice initially fed a HFD either (iii) continued a HFD or were fed a (iv) 
HFD supplemented with micronutrients (HFD+S; Specialty Feeds, Table 2.1).  
 
Mice were fed the second dietary regimen for one of 3 time periods: 
(i) 10 weeks to approximate the duration of two rounds of spermatogenesis (Oakberg, 
1957) (Figure 2.1); or 
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(ii) 5 weeks to approximate the duration of one round of spermatogenesis (Oakberg, 
1957) (Figure 2.1); or 
 
(iii) 10 days to approximate the duration of sperm epididymal transit (Robaire, et al., 





Figure 2.1: The distribution of mice to different durations of dietary intervention of 
micronutrient supplementation. All mice were allocated to a first dietary phase of a CD 




















































(a) 10 week intervention 
(b) 5 week intervention 
(c) 10 day intervention 
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intervention control group (CD, HFD) or a micronutrient supplementation intervention 
group (CD+S, HFD+S) for (a) 10 weeks, (b) 5 weeks or (c) 10 days. CD, control diet; 
HFD, high fat diet; CD+S, control diet plus micronutrient supplements; HFD+S, high fat 
diet plus micronutrient supplements.
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Table 2.1: The micronutrients used to supplement the control diet and high fat diet. 
Vitamins, minerals and micronutrients (mg/kg)  
Zinc (zinc sulphate monohydrate) 9.0 
Selenium 0.14 
Lycopene 0.3 
Vitamin E (alpha-tocopherol acetate) 14.0 
Vitamin C (ascorbic acid) 700 
Folic acid 0.5 





2.1.4 Metabolic assessment 
 
2.1.4.1 Glucose tolerance and insulin tolerance tests 
An intraperitoneal (ip) glucose tolerance test (GTT) and an ip insulin tolerance test (ITT) 
were performed at 9-10 weeks of the first dietary regimen and again at the end of the 
second dietary period (10 weeks, 5 weeks or 10 days). The GTT was conducted after 6 
hours of fasting by ip injection of 2 g/kg 25% glucose solution (Sigma-Aldrich, St. Louis, 
MO, USA, Appendix; A1 and A2) and the ITT was conducted by ip injection of 0.75 
IU/kg insulin (Actapid; Novo Nordisk, Bagsvaerd, Denmark, Appendix; A1 and A3) 
(Fullston, et al., 2013). Tail blood glucose concentrations were measured using a 
glucometer (HemoCue, Angelholm, Sweden) at 0 (pre-injection), and 15, 30, 60 and 120 
minutes post-injection. Data were expressed as means of blood glucose concentration per 
group as area under the curve (AUC) for the GTT or area above the curve (AAC) for the 
ITT. 
 
2.1.5 Body composition using DEXA 
At 9-10 weeks of the first dietary regimen, whole body composition including adipose 
tissue content, lean mass, and bone mass were measured in male mice using a dual-
emission X-ray absorptiometry machine (DEXA; Piximus, Ge Lunar, Wisconsin). Male 
mice were fasted for 4 hours before administration of the anesthetic 0.02% Avertin (2-2-
2 tribromethanol; Sigma-Aldrich, Appendix; A4) before their length was measured and 
then placed into the DEXA machine in the prone position. The DEXA machine provides 
quantitative data for fat tissue content, lean tissue content, and the total tissue mass based 
on the attenuation of two energy levels of X-ray absorptiometry (Nagy and Clair, 2000). 




2.1, Piximus). After the analysis, each mouse was returned to their original housing and 
monitored until they were fully conscious. 
 
2.1.6 Body composition assessment at post-mortem  
At the end of their second dietary regimen, mice were fasted overnight, killed via cervical 
dislocation, and then underwent a post-mortem assessment blinded to supplementation 
status. Perirenal fat, retroperitoneal fat, dorsal fat, omental fat, gonadal fat, testes, seminal 
vesicles, soleus, vastus lateralis, liver, kidneys, and pancreas were dissected, collected, 
and weighed. Body organ and adipose tissue mass were expressed in absolute values and 
as a proportion of total body weight. 
 
2.1.7 Serum metabolite assessment  
At post-mortem, fasted blood samples were collected via a cardiac puncture and serum 
was isolated. For metabolites, serum was diluted 1:2 in Milli-Q water (Merck Millipore, 
Darmstadt, Germany) and glucose, cholesterol, high-density lipoproteins (HDLs), 
triglycerides, and non-esterified free fatty acids (NEFAs) concentrations were assessed 
using a COBAS Mira automated sample system (Roche Diagnostics, Basel, Switzerland) 
by an accredited pathology laboratory at the University of Adelaide.  
 
2.1.8 Serum testosterone 
Serum was diluted 1:10 in a dilution buffer (provided by the ELISA kit) and testosterone 
concentrations were measured using a commercially available ELISA kit (R&D Systems, 
Minneapolis, MN, USA) at 540nm absorbance as per the manufacturer’s instructions 





2.1.9 Serum C-reactive Protein 
Serum C-Reactive Protein (CRP) concentrations were measured by diluting the serum 
1:10 in a dilution buffer (provided by the ELISA kit) and using a commercially available 
ELISA kit (Abcam, Cambridge, UK) at 450nm absorbance as per the manufacturer’s 
instructions (<10% intra-assay and inter-assay coefficients of variation). 
 
2.1.10 Mature sperm isolation 
At post-mortem, mature sperm was collected from the vas deferens and caudal 
epididymis from each mouse. The vas deferens was cut approximately 0.5cm away from 
the epididymis, and the epididymis was dissected away from the gonadal fat pad and the 
testis and placed into a dish of warmed handling media (G-MOPS Plus; Vitrolife AB, 
Göteborg, Sweden). The dissected vas deferens and caudal epididymis were transferred 
into a dish containing 1 ml of pre-equilibrated G-IVF +10% human serum albumin (HSA; 
Vitrolife) whereby forceps were glided along the vas deferens to release sperm and the 
epididymis was punctured to release additional sperm. Sperm dishes were incubated at 
37°C for 10 minutes in 5% O2, 6% CO2 and 89% N2 for sperm to disperse.  
 
2.1.11 Conventional sperm parameters assessment  
Sperm assessments were conducted after 10 minutes of incubation in G-IVF +10% HSA 
(Vitrolife) at 37°C to allow for dispersion of the sperm. All sperm assessments were 
performed blinded to the dietary treatment groups as mice from different diet groups were 







2.1.11.1 Sperm motility 
Two drops of 10μl of sperm were loaded onto a slide and sperm motility was determined 
manually under x40 magnification by counting duplicate samples of 200 sperm for 
categorization as motile, non-progressive motile, or immotile (WHO, 2010). Sperm 
motility was expressed as a percentage of motile and non-progressive motile sperm per 
sample.  
 
2.1.11.2 Sperm concentration 
Sperm concentration was assessed using a Neubauer haemocytometer in accordance with 
the World Health Organization (WHO) guidelines (WHO, 2010). Sperm were 
immobilized by mixing 5μl of sperm with 95μl of water, and 10μl of the immobilized 
sperm mixture was loaded on the top and bottom chambers of the haemocytometer. Five 
squares of both the top and bottom haemocytometer chambers were counted and averaged 
to calculate the concentration of each sperm sample. 
 
2.1.11.3 Sperm morphology  
Sperm slides were fixed in 3:1 methanol:acetone (Sigma-Aldrich) for 10 minutes, air 
dried and stained with haematoxylin and eosin. Slides were stained in haematoxylin 
(Abcam) for 2-3 minutes, washed in running tap water and then stained with eosin 
(Abcam) for 3-5 minutes. Sperm morphology was determined by assessing 200 
individual sperm per mouse and classified as normal, having an abnormal tail, or an 






(a) (b) (c)             (d) (e)                   (f) 
Figure 2.2: Sperm morphology classifications; (a) normal, whereas (b)-(f) are classified 
as morphologically abnormal sperm. Sperm (b) lack the usual hook, (c) have a banana-





2.1.12 Sperm intracellular reactive oxygen species  
 
2.1.12.1 Global measure of sperm intracellular reactive oxygen species 
Sperm intracellular reactive oxygen species (ROS), including peroxynitrite and hydroxyl 
radicals (Purdey, et al., 2015), were assessed by incubating progressively motile sperm 
with 1μM 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA; Molecular Probes, 
Eugene, USA) for 20 minutes at 37°C (Bakos, et al., 2010, Fullston, et al., 2012, Lane, 
et al., 2014). Sperm were then washed twice in phosphate buffered saline (PBS, Sigma-
Aldrich) and imaged individually using a fluorescence microscope with a photometer 
attachment. Sperm samples were assessed as a ratiometric analysis to 5-(and 6-) carboxy-
2’,7’-dichlorofluorescein diacetate (carboxy- H2DCFDA; Molecular Probes) as a 
measure of sperm intracellular esterase activity, which controls variation in cellular 
esterase that may affect H2DCFDA as a probe (Halliwell and Whiteman, 2004). The 
mean relative fluorescence was measured for a minimum of 20 motile sperm per mouse 
and expressed in mean fluorescence units normalized to the CD (i.e. CD was set to 1.0).  
 
2.1.12.2 Sperm intracellular superoxide 
Sperm mitochondrial superoxide production was assessed by incubating sperm in 
MitoSOX Red (2μM in dimethyl sulfoxide (DMSO); Molecular Probes) for 30 minutes 
at 37°C (Koppers, et al., 2008). Sperm were then centrifuged for 5 minutes at 200 g, the 
supernatant was removed, sperm were washed in 500μl of G-MOPS (Vitrolife) for 5 
minutes at 200 g and finally re-suspended in 200μl of G-MOPS. MitoSOX Red (MSR) 
fluorescence was measured on a fluorescence-activated cell sorting (FACS) Canto flow 
cytometer (BD Bioscience, North Ryde, Australia). A sample of DMSO in G-MOPS was 




examined per mouse and results were expressed as a percentage of sperm positive for 
MSR.  
 
2.1.13 Sperm capacitation 
Sperm were incubated in G-IVF + HSA to allow spontaneous capacitation for 1 hour in 
5% O2, 6% CO2, and 89% N2 at 37°C. Sperm were then washed in PBS before incubation 
in Arachis hypogaea (peanut) agglutinin (Lectin PNA) Alexa 594 antibody (Molecular 
Probes) at 1:100 in PBS for 45 minutes and counter-stained with Hoechst to identify 
sperm nuclei (Baker, et al., 2004). A minimum of 200 sperm were classified as 







Figure 2.3: Changes in Arachis hypogaea (peanut) agglutinin (Lectin PNA) fluorescence 
with the colour green depicting fluorescent staining patterns of sperm membrane 





2.1.14 Sperm binding and fertilization 
 
2.1.14.1 Cumulus-oocyte complex collection 
C57BL/6 x CBA/ca (B6 CBAF1) female mice at 4-5 weeks old were administered an ip 
injection of 5 IU pregnant mare serum gonadotrophin (PMSG; Folligon, Intervet, 
Bendigo East, Australia), followed 48 hours later with an ip injection of 5 IU human 
chorionic gonadotrophin (hCG; Pregnyl, Organon, Australia) to induce ovulation 
(Gardner, et al., 2004). 
 
Twelve-thirteen hours post hCG (Pregnyl) injection, mice were killed via cervical 
dislocation and oviducts were dissected from each female mouse and placed in warmed 
handling media (G-MOPS Plus; Vitrolife) immediately after dissection. The cumulus 
oocyte complexes (COCs), located in the oviduct, were expelled into G-IVF + 10% HSA 
(Vitrolife) after tearing the swollen ampulla region of the oviduct using forceps and 
COCs were placed in 80μl drops of pre-equilibrated G-IVF + 10% HSA in 5% O2, 6% 
CO2 and 89% N2 at 37°C. 
 
2.1.14.2 Sperm-oocyte binding and fertilization 
Sperm samples from males were collected from the vas deferens and capacitated for 1 
hour in G-IVF + 10% HSA (Vitrolife) medium as described above in 2.1.10. After 1 hour, 
COCs were inseminated with 1 × 104/ml of motile sperm and co-incubated in 5% O2, 6% 
CO2 and 89% N2 for 4 hours at 37 °C. At 4 hours post-insemination, sperm binding was 
assessed by counting the number of sperm bound to the zona pellucida of each oocyte 





Following oocyte insemination as described above in 2.1.14.2, oocytes were washed once 
in both G-IVF + 10% HSA (Vitrolife) and G1 Plus (Vitrolife) media to finally be placed 
in G1 Plus media for culture in 5% O2, 6% CO2 and 89% N2 at 37°C. At 24 hours post 
insemination, fertilization rates were assessed by the presence of a two-cell embryo and 
expressed as a percentage of the total number of oocytes inseminated. 
 
2.1.15 Female mice superovulation and mating 
C57BL6 female mice at 3-4 weeks old were superovulated with an ip injection of 5 IU 
PMSG (Folligon), followed 48 hours later with an ip injection of 5 IU hCG (Pregnyl) to 
induce ovulation (Gardner, et al., 2004). Following the hCG injection, female mice were 
housed individually with a C57BL6 male mouse from the 10-day dietary intervention 
regimen overnight (Figure 2.1). Mating was assessed by the presence of a vaginal plug 
the following morning.  
 
2.1.16 Pronuclear-staged embryo collection 
Pronuclear-staged embryos were collected at 18-19 hours post hCG (Santos, et al., 2002) 
by dissecting the oviducts from each female and tearing the oviduct in G-MOPS Plus 
(Vitrolife) at 37°C to expel the embryos. The embryos were then denuded of cumulus 
cells by 1 minute incubation with 0.5 mg/ml hyaluronidase and fixed overnight in 4% 
paraformaldehyde at 4°C.  
 
2.1.17 Embryo culture and development 
Following 22–24 hours of the hCG (Pregnyl) injection, oviducts were dissected from 
each female mouse and placed in G-MOPS Plus (Vitrolife) at 37°C and cumulus-enclosed 




and once in G1 Plus medium (Vitrolife) before culture in 20μl drops (up to 10 zygotes 
per drop) of G1 Plus culture medium in 5% O2, 6% CO2 and 89% N2 at 37°C (Gardner, 
et al., 2004). On day 3 of embryo culture (67 hours post hCG administration), embryos 
were washed and cultured in G2 Plus culture medium (Vitrolife) to the blastocyst stage. 
All embryo culture dishes were prepared at least 4 hours prior to embryo culture to allow 
for gassing and temperature equilibration. 
 
2.1.17.1 Embryo morphology 
Fertilization was denoted by day 2 cleavage to the 2-cell stage (Figure 2.4) at 43 hours 
post hCG. On-time embryo development assessments were evaluated for 8-cell 
development (Figure 2.5) at 67 hours post hCG (day 3). On-time blastocyst development 
(Figure 2.6) was determined at 98 hours post hCG (day 4) in which embryos containing 
a blastocoel cavity were classified as blastocysts. At 115 hours post hCG (day 5); 
blastocyst expansion and hatching blastocysts (Figure 2.7) were assessed whereby 
hatching blastocysts were identified by herniation of the trophectoderm through the zona 
pellucida of the blastocyst. Day 3, 4 and 5 of embryo development was expressed as a 















Figure 2.5: A representative image of day 3 embryo development with (a) 6-cell, (b) 8-










Figure 2.6: A representative image of day 4 embryo development with (a) early 








Figure 2.7: A representative image of day 5 embryo development with (a) expanded and 







2.1.18 8-OHdG DNA lesion detection in mature and testicular sperm  
 
2.1.18.1 Sperm 8-OHdG immunocytochemistry  
At postmortem, mature sperm collected from the vas deferens and caudal epididymis 
from each mouse was fixed on slides with 3:1 methanol:acetone (Sigma Aldrich) for 10 
minutes. Slides were permeabilised in 0.5% Triton X-100 (Sigma Aldrich) and washed 
in PBS (Sigma Aldrich). Slides were incubated in decondensing buffer (1M hydrogen 
chloride (HCl), 10mM Tris buffer of 5mM dithiothreitiol, Sigma Aldrich) for 60 minutes 
at 37°C. Sperm DNA was then denatured with a denaturing buffer (6M HCL, 0.1% Triton 
X-100 in H2O, Sigma Aldrich) at room temperature for 45 minutes and then neutralized 
with a neutralizing buffer (100uM Tris HCl in H2O, Sigma Aldrich) for 20 minutes. 
Slides were washed and then incubated overnight at 4oC in 1:100 mouse anti-8-
hydroxyguanosine (8-OHdG) antibody (ab48508; Abcam) in 10% donkey serum 
(Abcam) whereas the negative control was incubated in 1:100 mouse serum. On the 
second day, slides were washed and incubated in 1:100 biotin-SP-conjugated AffiniPure 
donkey anti-mouse IgG (Jackson ImmunoResearch, Baltimore, PA, USA) for 2 hours at 
room temperature. Slides were then washed in PBS and incubated in 1:100 Cy3-
conjugated streptavidin (Jackson ImmunoResearch) for 1.5 hours at room temperature 
followed by a nuclear counter stain with Hoechst. Finally, slides were loaded in ProLong 
Gold and glycerol solution (2 drops of ProLong Gold in 0.5ml glycerol; ProLong Gold, 
Molecular Probes; glycerol, Sigma-Aldrich) and imaged under fluorescence microscopy. 
Using ImageJ (Version 1.48, National Institutes of Health (NIH), USA), 30 sperm per 
mouse were assessed by quantifying 8-OHdG fluorescence. Results were expressed as a 




fluorescence from microspheres to calibrate fluorescent imaging (Molecular Probes) and 
the CD treatment group (i.e. CD was set to 1.0). 
 
2.1.18.2 Testicular 8-OHdG immunohistochemistry  
At post-mortem, the testes of mice were collected and fixed overnight in Bouin’s fixative 
(Sigma-Aldrich). After being washed with PBS, testes were stored in 100% ethanol 
(Sigma-Aldrich) until embedding in paraffin. The paraffin-embedded samples were 
sectioned at 4µm, de-waxed and re-hydrated before being blocked in 10% donkey serum 
(Abcam) in PBS overnight at 4oC. On the second day, slides were incubated in 1:500 
mouse anti-8-OHdG antibody (ab48508; Abcam; antibody validation (positive control, 
Appendix; Figure A5) for 1 hour at 37oC whereas the negative control was incubated in 
1:100 mouse serum. Slides were then washed in PBS and incubated in 1:100 biotin-SP-
conjugated AffiniPure donkey anti-mouse IgG (Jackson ImmunoResearch) for 2 hours at 
room temperature. Slides were then washed and incubated in 1:100 Cy3-conjugated 
streptavidin (Jackson ImmunoResearch) for 1.5 hours at room temperature followed by 
counter-staining with Hoechst. Finally, slides were loaded in ProLong Gold and glycerol 
solution and imaged under fluorescent microscopy. Using ImageJ (Version 1.48, NIH), 
20 seminiferous tubules per mouse were assessed by quantifying 8-OHdG fluorescence 
and each tubule staged (early, middle, or late; I-V, VI-VIII or IX-XII, respectively, Figure 
2.8) (Meistrich and Hess, 2013). Results were expressed as mean fluorescence intensities 
for 8-OHdG (minus background) normalized to fluorescence from microspheres 





(a)  (b)  (c)  
Figure 2.8: Representative images of seminiferous tubules stained with 8-hydroxyguanosine (8-OHdG) of (a) spermatogonia, (b) spermatocytes 





       2.1.19 Pronuclear-staged embryo 8-OHdG immunocytochemistry  
Following fixation in 4% paraformaldehyde, pronuclear-staged embryos were stored in 
PBS containing 3mg/ml PVP (Sigma-Aldrich) at 4°C. Levels of 8-OHdG were assessed 
using an OxyDNA (Merck Millipore) test. Pronuclear-staged embryos were 
permeabilized in 0.25% Triton-X in PBS for 10 minutes at room temperature followed 
by incubation in 1:100 OxyDNA reagent for 1 hour at 37°C (as per the manufacturer’s 
instructions) (Lord and Aitken, 2015). Finally, embryos were counterstained with 
Hoescht (Sigma-Aldrich) for 5 min, mounted on glass slides and imaged using a confocal 
microscope. Z-stacks of 10μm sections were collected of each pronucleus from each 
embryo (1024x1024 pixel size). Using ImageJ (Version 1.48, NIH), confocal image 
stacks were reconstructed and regions of interest (ROI) were defined around both the 
maternal and paternal pronucleus for fluorescence intensity quantification reflecting 8-
OHdG levels for each pronucleus. The size of the ROI (pronucleus) was also computed 
by ImageJ and the smaller of the two pronuclei for each embryo was determined as the 
maternal pronucleus and confirmed with its closer proximity to the polar body than the 
paternal pronucleus (Edwards and Sirlin, 1956, Sirlin and Edwards, 1959) (Figure 2.9). 
Paternal pronucleus 8-OHdG fluorescence intensity quantification was normalized to the 
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Figure 2.9: Pronuclear-staged embryo depicting paternal and maternal pronuclei. 
A Pronuclear-staged embryo with the (a) paternal pronucleus larger in size compared 
with the (b) maternal pronucleus. The (b) maternal pronucleus is also in closer in 
proximity to the (c) polar bodies. 









2.1.20 Blastocyst 8-OHdG detection 
On day 5 of embryo development, blastocysts were fixed overnight in 4% 
paraformaldehyde at 4°C. The following day, blastocysts (full, expanded and hatching 
blastocysts) were stored in PBS containing 3mg/ml polyvinylpyrrolidone (PVP; Sigma-
Aldrich) at 4°C until immunostaining was conducted. Blastocysts were permeabilized in 
0.5% Triton-X in PBS for 10 minutes at room temperature followed by blocking 
overnight in 5% bovine serum albumin (BSA, Sigma-Aldrich) in PBS at 4°C. The 
following day, blastocysts were incubated in 1:100 OxyDNA reagent for 1 hour at 37°C 
(as per the manufacturer’s instructions). Finally, blastocysts were counterstained with 
Hoescht for 5 minutes, mounted on glass slides and imaged using a confocal microscope. 
Z-stacks of 10μm sections were collected of each blastocyst (1024x1024 pixel size). 
Using ImageJ (Version 1.48, NIH), confocal image stacks were reconstructed and ROI 
were defined around cells positive for oxyDNA and 8-OHdG fluorescence intensity was 
quantified. Also, total cell number (TCN) for each blastocyst was recorded by counting 
the number of cells positive for Hoescht. Results were expressed in fluorescent units 
reflecting quantified 8-OHdG fluorescence intensity and as a proportion of cells positive 
for 8-OHdG relative to TCN with an average for each diet group.  
 
2.1.21 Natural mating and fetal development 
C57BL6 naturally cycling female mice at 9-10 weeks old were housed with a C57BL6 
male mouse from the 10-day dietary intervention regimen (Figure 2.1) at 8-12 days post 
intake of the second dietary phase. Each male was allocated a maximum of two females 
for a maximum of four days. Mating was assessed by the presence of a vaginal plug the 
following morning and female mice were maintained on an ad libitum standard chow diet 




dislocation. The number of fetuses and resorption sites per uterine horn were recorded. 
Fetuses were dissected and removed of connective tissue and umbilical cords, weighed 
and crown rump length was measured. Placentas were dissected and removed of 
connective tissue and maternal arterial space, weighed and dimensions were measured. 
 
2.1.22 Statistical analysis 
All data are presented as mean ± SEM. An independent-samples Student’s T Test was 
performed for DEXA body composition. For GTT and ITT data; AUC and AAC, a 
general linear model was performed between treatment by diet and micronutrient 
supplementation status with post hoc comparisons using the Bonferroni test. Weight gain, 
serum metabolite, testosterone, and CRP concentrations, postmortem body compositions, 
conventional sperm parameters, sperm oxidative stress, sperm function measures and 
testes, pronuclear and blastocyst immunofluorescence, embryo, fetal and placental 
development measures were determined using a general linear model between treatment 
by diet and micronutrient supplementation status with a least significant difference (LSD) 
or Dunnett’s post hoc test as appropriate. All statistical analyses were performed in SPSS 











2.2.1 Ethics approval 
The retrospective study, using non-identifiable information, was confirmed as negligible 
risk research by the University of Adelaide and subsequently classified as research 
exempt from Human Research Ethics Committee review. Existing collections of data 
containing non-identifiable information from the fertility clinic, Repromed (Dulwich, 
South Australia) was used in this study with approval from Repromed’s Scientific 
Advisory Committee.  
 
The prospective study was approved by the Women’s and Children’s Hospital Human 
Research Ethics Committee (project number HREC/14/WCHN/15) in addition to 
approval from Repromed’s Scientific Advisory Committee. Written informed consent 
was obtained from all participants. No identifying information was used in this study. 
 
2.2.2 Study population 
The participants for both the retrospective and prospective study were non-smoking 
patients undergoing intracytoplasmic sperm injection (ICSI) and/or standard 
insemination (IVF) as part of their assisted reproduction technology (ART) treatment at 
the fertility clinic, Repromed (Dulwich, South Australia). The female partner was less 
than 38 years of age and the male partner was less than 45 years of age at the time of 
oocyte collection. Couples participating in the donor program, undergoing surgical sperm 
retrieval, or using frozen sperm were excluded. Male patients who had pathological 
conditions capable of affecting sperm quality were also excluded. 
The retrospective study included couples undergoing IVF/ICSI treatment between 2013-





2.2.3 Paternal and maternal body mass index 
Both paternal and maternal height and weight were measured at the clinic before the 
couple’s treatment cycle and converted into BMI (kg/m2). Patients were classified 
according to the following BMI ranges; normal weight: 20-24.9 kg/m2, overweight: 25-
29.9 kg/m2, and obese: 30 kg/m2 and above. Couples with an obese maternal BMI were 
excluded. Couples were stratified by paternal BMI into the three BMI categories: normal 
weight, overweight and obese.  
 
2.2.4 Patient recruitment for prospective study 
Couples undergoing treatment were approached 1-4 days before their oocyte retrieval 
whereby the prospective study was explained and the couples were provided with a 
patient information sheet regarding the study (Appendix; Figure A6). On the day of the 
couple’s oocyte retrieval, the patients were approached again and if the couple consented, 
informed written consent was obtained (Appendix; Figure A7). A unique trial number 
was allocated to each couple after consent to ensure the subsequent experiments and data 
collection were de-identified and blinded.  
 
2.2.5 Lifestyle and micronutrient supplement intake assessment 
Male patients completed a questionnaire after producing their semen sample (Appendix; 
Figure A8). The questionnaire provided information about their lifestyle factors including 
medication, illness and the intake of micronutrient and antioxidant supplements. Men that 
reported the intake of Menevit, Swisse Men’s Multivitamin, or Nature’s Own Men’s 
Multivitamin were included in the study and categorized as men positive for the intake 
of micronutrient supplementation (Appendix; Table A9). Men that reported the intake of 




2.2.6 Conventional semen analysis 
After a recommended abstinence period of 2 to 5 days, semen samples were collected by 
masturbation in sterile containers and were analyzed at room temperature within 1 hour 
of collection. Conventional sperm parameters including sperm motility, concentration, 
and morphology were measured according to the World Health Organization (WHO) 
2010 Laboratory Manual for the Examination of Human Semen and Sperm-Cervical 
Mucus Interaction Methods and Criteria (WHO, 2010).  
 
2.2.6.1 Sperm motility 
Sperm motility was determined manually under ×40 magnification with duplicate 
measures of 200 sperm and expressed as a percentage of motile sperm in a given sample 
(WHO, 2010).  
 
2.2.6.2 Sperm concentration  
A Neubauer hemocytometer was used to determine sperm concentration. The appropriate 
dilution factor was applied to each sample and the number of sperm in the five squares 
of both the top and bottom haemocytometer chambers were counted. This number was 
then averaged to calculate the concentration of each sperm sample according to the WHO 
guidelines (WHO, 2010). 
 
2.2.6.3 Sperm morphology 
The percentage of morphologically normal sperm was calculated by assessing 200 sperm 
per sample using the Diff-Quik staining method as described by the 2010 WHO manual 





Figure 2.10: Human sperm morphology. A schematic adapted from the World Health 
Organization (WHO) laboratory manual for the examination and processing of human 
semen representing abnormal sperm morphology characteristics including (A) head, (B) 






2.2.7 Sperm intracellular reactive oxygen species  
The excess sperm sample, after it was used for insemination and/or injection (depending 
on the couple’s ART procedure), was used for the detection of intracellular ROS. Sperm 
samples were washed in PBS containing 3mg/ml polyvinylpyrolidone (PVP; Sigma-
Aldrich, St. Louis, MO, USA) to remove the G-IVF Plus (Vitrolife) preparation medium. 
An Olympus BX51 fluorescent microscope in conjunction with AnalySIS LS Research 
Imaging software (version 3.1; Olympus Soft Imaging Solutions, Munster, Germany) 
was used to take images of sperm stained with fluorescent ROS probes. 
 
2.2.7.1 MitoSOX Red 
Sperm were incubated in MitoSOX Red (2μM; Molecular Probes, Eugene, USA) in the 
dark for 15 minutes at 37°C (Aitken, et al., 2013, Koppers, et al., 2008). The sample was 
then washed in PBS/PVP for 5 minutes at 500g before incubation in Sytox Green (5μM; 
Molecular Probes), a vitality stain, in the dark for 15 minutes at 37°C. Sperm were 
washed again in PBS/PVP and then centrifuged for 5 minutes at 500g, loaded onto slides 
in 10μl drops and imaged under fluorescent microscopy. At least 100 live sperm (negative 
for Sytox Green) were imaged per male patient blinded. Sperm fluorescence was 
quantified using ImageJ software (Version 1.48, National Institutes of Health (NIH), 
USA) and results were expressed as a mean of fluorescence for MitoSox Red (minus 
background). 
 
2.2.7.2 Dichlorodihydrofluorescein diacetate 
Sperm were incubated in 1μM 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA; 




washed twice in PBS/PVP and centrifuged at 500g for 5 minutes before incubation in 
1μM propidium iodide (PI; Molecular Probes), a vitality stain, in the dark for 5 minutes 
at room temperature. Sperm were washed again in PBS/PVP and centrifuged for 5 
minutes at 500g, loaded onto slides in 10μl drops and imaged under fluorescent 
microscopy. At least 100 live sperm (negative for PI) were imaged per male patient 
blinded. Sperm fluorescence was quantified using ImageJ software (Version 1.48, NIH) 
and results were expressed as a mean of fluorescence for H2DCFDA (minus background). 
Sperm intracellular esterase activity was measured using carboxy-H2DCFDA (Molecular 
Probes) and was not different between men from the different BMI categories (Appendix; 
Table A10). 
 
2.2.8 Sperm 8-OHdG DNA lesion immunocytochemistry 
Sperm were fixed on three polylysine-coated slides labeled with the couple’s study 
number (allocated at the time of consent) and date of consent. Two squares were marked 
on each slide with a DAKO pen (DAKO, Glostrup, Denmark) and 20μl of washed sperm 
sample was spread into each square. Slides were then air-dried, fixed in 3:1 
methanol:acetone (Sigma-Aldrich) for 40 minutes and stored in 4°C until 
immunocytochemistry was conducted.  
Slides were permeabilised in 0.5% Triton X-100/PBS (Sigma Aldrich) for 45 minutes at 
room temperature. Slides were then washed in PBS before incubation in decondensing 
buffer (1M HCl, 10mM Tris buffer of 5mM dithiothreitiol, Sigma-Aldrich) for 60 
minutes at 37°C. Sperm DNA was then denatured with a denaturing buffer (6M HCL, 
0.1% Triton X-100 in H2O, Sigma-Aldrich) for 45 minutes at room temperature and then 
neutralized with a neutralizing buffer (100uM Tris HCl in H2O, Sigma-Aldrich) for 20 




8-hydroxyguanosine (8-OHdG) antibody (Abcam, Cambridge, UK) in 10% donkey 
serum (Abcam) whereas the negative control was incubated in 1:100 mouse serum. The 
following day, slides were washed and incubated in 1:100 biotin-SP-conjugated 
AffiniPure donkey anti-mouse IgG (Jackson ImmunoResearch, Baltimore, PA, USA) for 
2 hours at room temperature.  Slides were then washed in PBS and incubated in 1:100 
Cy3-conjugated streptavidin (Jackson ImmunoResearch) for 1.5 hours at room 
temperature followed by a nuclear counter stain with Hoechst. Finally, slides were loaded 
in ProLong Gold and glycerol solution (2 drops of ProLong Gold in 0.5ml glycerol; 
ProLong Gold, Molecular Probes; glycerol, Sigma-Aldrich) and imaged under 
fluorescent microscopy. At least 100 sperm were imaged per male patient blinded. Sperm 
fluorescence was quantified using ImageJ software (Version 1.48, NIH) and results were 
expressed as a mean of fluorescence for 8-OHdG (minus background) and then 
normalized to fluorescence from microspheres (Molecular Probes). 
 
2.2.9 Data records  
Treatment cycle details were recorded for every couple including female anti-mullerian 
hormone (AMH) and baseline follicle-stimulating hormone (FSH) serum concentrations, 
ART cycle outcomes that included the number of eggs collected, number of eggs 
inseminated and fertilized, embryo grading on days 3-5 of development, number of 
embryos transferred and/or frozen, biochemical and ongoing pregnancy, live birth 
outcomes, and if the embryos underwent pre-implantation genetic testing for aneuploidy 
(PGT-A). Potential co-factors were also recorded including the number of previous 
cycles, the couple’s infertility diagnosis such as unexplained infertility, polycystic 






2.2.10 Data analysis 
Couples were stratified initially into three groups based on the male partner’s BMI: 
normal weight <24.9 kg/m2, overweight 25-29.9 kg/m2, and obese >30 kg m2. Each BMI 
group was then divided into two groups: those who were consuming micronutrient 
supplementation and those who were not. This stratification ultimately generated six 
groups: couples with a male partner that was (i) normal weight without micronutrient 
supplementation, (ii) normal weight with micronutrient supplementation, (iii) overweight 
without micronutrient supplementation, (iv) overweight with micronutrient 
supplementation, (v) obese without micronutrient supplementation, and (vi) obese with 
micronutrient supplementation. The primary outcome measures were biochemical 
pregnancy, implantation rates, ongoing pregnancy, and live birth rates. Semen volume, 
sperm motility, sperm concentration, fertilization rates, embryo development, and 
embryo utilization were also assessed as secondary measures.   
 
2.2.11 Protocols conducted by clinical staff  
2.2.11.1 Ovarian stimulation 
Controlled ovarian stimulation was conducted with the use of recombinant FSH 
(Puregon; Merck Sharp and Dohme, NJ, USA or Gonal-F; Merck Serono, Darmstadt, 
Germany) and a gonadotropin-releasing hormone (GnRH) antagonist. Follicle 
development was monitored by ultrasound and serum estradiol. Ovulation was induced 
with hCG administration (5000 IU Pregnyl; Merck Sharp and Dohme; 250 gm Ovidrel; 
Serono) when two or more follicles ≥17 mm in diameter were present. 
Oocytes were collected by transvaginal oocyte retrieval performed 36 hours after hCG 





2.2.11.2 Sperm preparation for IVF/ICSI cycles 
Based on sperm motility and concentration of the neat semen sample, sperm were 
prepared using the swim-up sperm preparation method as per standard clinical protocol. 
0.2-0.6ml of sperm sample was added to the bottom of 1-4 round bottom tubes 
(depending on initial sperm concentration and motility) containing 1ml of pre-
equilibrated G-IVF Plus (Vitrolife AB, Göteborg, Sweden) at 37°C and 6% CO2. The 
sample was then incubated for 30-60 minutes at 37°C before 0.3ml of sperm was gently 
aspirated from the upper interface of the media and transferred to a clean tube for oocyte 
insemination or injection with a final concentration of 1x106/ml for standard insemination 
and less than 3x106/ml for ICSI. 
 
2.2.11.3 Oocyte insemination 
Insemination was conducted 4-6 hours post oocyte retrieval. Oocytes were inseminated 
with use of conventional IVF or injected via the ICSI procedure or a combination of both 
procedures. For conventional IVF, up to 2 oocytes were placed in 50μL drops of G-IVF 
Plus (Vitrolife) with a concentration of 1 million sperm/ml. For ICSI, a single motile 
sperm was injected into the oocyte and oocytes were cultured in groups of up to 4 oocytes 
in 50μL drops of G1 Plus medium (Vitrolife). 
 
2.2.11.4 Fertilization 
Fertilization was assessed 16–18 hours after insemination and was confirmed by the 
presence of two pronuclei. A medium change from G-IVF Plus (Vitrolife) to G1 Plus 





2.2.11.5 Embryo cleavage 
As per standard clinical protocol, embryo cleavage and morphology were assessed based 
on cell number and degree of fragmentation. Embryos were assessed on day 3 at 66 hours 
± 2 hours after insemination, with on-time development considered for an embryo with 
7-10 cells and <10% fragmentation. An in-house scoring system was applied for day 4 
embryo development as previously described (Feil, et al., 2008). Some embryos were not 
assessed on day 4 of development as the patient was having a day 5 embryo transfer. On 
day 5 of embryo development, blastocyst quality was assessed by the degree of blastocyst 
expansion and the quality of the inner cell mass and trophectoderm as previously 
described by Gardner and Schoolcraft (Gardner and Schoolcraft, 1999). Day 5 embryos 
that were assessed on day 4 and had embryos that were frozen or transferred on day 4 
were not included in the day 5 embryo development analysis to eliminate skewing of 
data. 
 
2.2.11.6 Embryo transfer 
Embryos selected for transfer were based on morphology and grading with the highest 
graded embryos usually selected for transfer.  
 
2.2.11.7 Embryo vitrification 
Embryos that were not transferred and were considered suitable for cryopreservation 
were vitrified using the Rapid-I vitrification system (Vitrolife). 
 
2.2.11.8 Pregnancy determination and clinical definitions  
2.2.11.8.1 Biochemical pregnancy: A pregnancy was classified as a positive biochemical 





Implantation was determined by the detection of a fetal sac (or sacs) in the womb on 
ultrasound examination at 4 to 6 weeks after embryo transfer. 
2.2.11.8.3 Ongoing pregnancy 
A pregnancy was classified as a positive ongoing pregnancy when a viable fetal heartbeat 
was detected on ultrasound examination at 4 to 6 weeks after embryo transfer. 
2.2.11.8.4 Live birth 
Live birth outcomes were recorded including length of gestation, number of infants born, 
and the weight and gender of the infant(s) born. 
2.2.11.8.5 Pregnancy loss 
Pregnancy loss was defined as a loss that occurred between a positive β-hCG test and live 
birth. 
 
2.2.12 Statistical Analysis 
The Kolmogorov–Smirnov test was used to evaluate the normal distribution of all 
variables. For quantitative outcomes with mean values, a generalized linear model was 
performed with BMI and the use of micronutrient supplements as independent factors 
and Bonferroni, Least Significant Difference (LSD) and Dunnett’s post hoc comparisons 
where appropriate. For binary reproductive outcome measures, odds ratio with 95% 
confidence intervals were estimated using binary logistic regression analysis. For 
association analyses, a Pearson or Spearman correlation coefficient was used based on 
normal distribution. Statistical analysis was performed using the SPSS software package 
(Statistical Package for Social Sciences version 23.0, SPSS Inc., Chicago, IL, USA) with 
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3.2 Abstract  
 
Male obesity can lead to increased sperm oxidative stress and impaired sperm function, 
which is associated with reduced fertilization, delayed embryo development and 
compromised offspring health in both humans and mouse models. This study investigated 
the impact of dietary micronutrient supplementation of two different durations (5 weeks 
and 10 weeks reflecting one and two rounds of spermatogenesis respectively) on sperm 
quality and function in a mouse model of diet-induced obesity. Initially, C57BL/6 male 
mice were fed a control diet (CD) or a high fat diet (HFD) for 10 weeks to increase 
adiposity. Mice were then allocated to one of four diets: continuation of the initial CD or 
HFD or the same base diet (CD or HFD) supplemented with micronutrients (CD+S or 
HFD+S) for either 5 or 10 weeks – durations chosen to cover approximately one and two 
rounds of spermatogenesis, respectively. Males fed the HFD supplemented with 
micronutrients for 5 or 10 weeks displayed reduced sperm intracellular reactive oxygen 
species (ROS) and oxidative DNA lesions (8-OHdG), which translated into 
improvements in sperm function with increased sperm binding and fertilization rates. 
Additionally, mice fed a HFD supplemented with micronutrients for 10 weeks also 
displayed improvements in sperm morphology, increased sperm capacitation, and 
reduced testicular 8-OHdG lesions. These results suggest that consuming a combination 
of micronutrients in conjunction with a HFD protects sperm quality from HFD-induced 
impairments, with additional benefits when consumed for a duration that spans two 
rounds of spermatogenesis. 
Key words 
DNA damage, micronutrients, obesity, oxidative stress, ROS, spermatogenesis, sperm 
function, sperm quality, testis 
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3.3 Introduction  
 
The substantial increase in prevalence of overweight and obese men is a global health 
issue, with reports estimating that 37% are overweight or obese worldwide (Ng et al. 
2014). This increase has occurred with a concomitant increase in subfertility in men of 
reproductive age (Sharlip et al. 2002). Overweight and obesity in men can lead to 
impaired reproductive health, often characterized by altered serum hormone profiles 
(Aggerholm et al. 2008; Chavarro et al. 2010; Hofny et al. 2010) and impaired sperm 
quality as measured by reduced sperm concentration, motility and normal morphology 
(Bakos et al. 2011; Campbell et al. 2015; Hammiche et al. 2012; Hammoud et al. 2008; 
Hofny et al. 2010; Jensen et al. 2004; Magnusdottir et al. 2005; Shayeb et al. 2011).  
 
Animal studies further support the link between obesity and reduced sperm quality and 
function. Similar to human studies, diet-induced obesity in rodent models is associated 
with reduced sperm motility, concentration and normal morphology (Bakos et al. 2010; 
Fernandez-Gonzalez et al. 2008; Fullston et al. 2012; Ghanayem et al. 2010; Palmer et 
al. 2012). In addition, HFD-fed males also have increased sperm oxidative stress and 
DNA damage (Bakos et al. 2010; Chen et al. 2013; Duale et al. 2014; Palmer et al. 2012; 
Vendramini et al. 2014; Zhao et al. 2014). Elevated concentrations of reactive oxygen 
species (ROS) are one of the main contributors to sperm DNA damage (Aitken et al. 
2003; De Iuliis et al. 2009), which has been linked to impaired reproductive health via 
reduced fertilization rates, delayed embryo development and reduced pregnancy rates 
(Larson et al. 2000; Lopes et al. 1998; Seli et al. 2004).  
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Moreover, obesity is frequently linked to micronutrient deficiencies resulting from a 
calorie-rich and micronutrient-poor diet (Gillis and Gillis 2005). Serum concentrations 
of essential vitamins and minerals with anti-oxidative properties including vitamin C, 
vitamin E, selenium, folate and zinc are often reduced with increased adiposity (Aasheim 
et al. 2008; Ernst et al. 2009; Garcia et al. 2012; Gobato et al. 2014). Micronutrient 
deficiencies can impair male fertility, for instance, selenium deficiency is associated with 
increased structural defects in sperm (Krol et al. 2012), and reduced sperm motility and 
concentration, (Hardy and Hardy 2004; Olson et al. 2004; Sanchez-Gutierrez et al. 2008) 
and increased sperm oxidative damage (Sanchez-Gutierrez et al. 2008). Men deficient 
for vitamin C show increased sperm oxidative DNA lesions, which is reduced upon 
vitamin C supplementation (Fraga et al. 1991). Vitamin E supplementation has been 
shown to reduce sperm lipid peroxidation, and increase sperm motility and pregnancy 
rates compared to placebo treated patients in asthenospermic men (Suleiman et al. 1996). 
While lycopene supplementation increases the proportion of sperm with normal 
morphology and reduces sperm lipid peroxidation in normozoospermic men (Zareba et 
al. 2013) and rodents (Ceribasi et al. 2010). Combined folic acid and zinc 
supplementation in fertile and subfertile men increased sperm count, motility and normal 
morphology (Wong et al. 2002). Whereas zinc supplementation on its own reduced sperm 
oxidative stress, DNA damage and apoptosis in asthenospermic and fertile men (Omu et 
al. 2008; Wong et al. 2002). In rats, green tea extract supplementation has been shown to 
increase sperm motility and normal morphology (Mosbah et al. 2015) and reduce sperm 
oxidative stress (Awoniyi et al. 2012).  
 
The effects of a combination of dietary micronutrient supplementation on sperm 
oxidative stress, sperm oxidative DNA lesions and essential endpoints of sperm function 
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(e.g. fertilization) in a diet-induced obese model have not been investigated. Moreover, 
no studies to date have examined an optimal duration of supplement intake; specifically 
the efficacy of short or longer-term treatment durations that span one or more rounds of 
spermatogenesis.  
 
Therefore, the aim of this duration based study was to investigate the effects of dietary 
micronutrients, which have previously been shown to have a role in reducing sperm 
oxidative stress in normal weight males, and the impact of duration of intake over one (5 
weeks) or two rounds (10 weeks) of spermatogenesis (Oakberg 1957) on conventional 
sperm parameters, sperm oxidative stress, oxidative DNA damage in both epididymal 
and testicular sperm, sperm function and subsequent fertilization rates in a mouse model 
of male obesity. 
 
	 157	
3.4 Materials and methods 
 
The experimental design is outlined below in Figure 3.1. Please refer to Chapter 2, section 











Fig. 3.1 Experimental design. All mice were allocated to a first dietary phase of a CD or a HFD for 10 weeks and underwent both a glucose 
tolerance test (GTT) and an insulin tolerance test (ITT). For the second dietary phase, mice were allocated to either a no intervention control group 
(CD, HFD) or a micronutrient supplementation intervention group (CD+S, HFD+S) for 5 or 10 weeks. After 5 or 10 weeks, mice underwent a 

















• Body composition 
• Serum metabolites 
• Serum testosterone 
• Sperm motility  
• Sperm concentration 
• Sperm morphology 
• Sperm intracellular ROS 
• Mature sperm 8-OHdG lesions 
• Testicular sperm 8-OHdG lesions 
• Sperm capacitation 
• Sperm oocyte-binding 
• Fertilization rates 
	 159	
and testicular sperm 8-OHdG lesions, sperm capacitation, oocyte binding and fertilization rates. CD, control diet; HFD, high fat diet; CD+S, 





3.5.1 Effect of diet and micronutrient supplementation on body composition, weight 
gain, glucose tolerance and insulin tolerance  
Consistent with previous reports, feeding mice a HFD for 10 weeks increased body fat in 
both absolute values (g) and relative to total body weight (%); and reduced lean mass 
relative to total body weight (DEXA; P<0.001, Table S.3.1) (Ghanayem et al. 2010), with 
no change in fasting blood glucose levels, glucose tolerance or insulin tolerance (P>0.05, 
Fig. S.3.1 and S.3.2) compared to CD fed mice (Bakos et al. 2010; Fullston et al. 2013; 
Fullston et al. 2012).  
 
Micronutrient supplementation of the CD or HFD for 5 or 10 weeks of the second dietary 
period did not have an effect on total body weight or weight gain (Fig. S.3.3). The 
increase in adiposity in male mice fed a HFD during the first dietary period continued to 
increase when mice continued to consume the HFD for a further 5 or 10 weeks observed 
by increases in peri-renal, retroperitoneal, omental, dorsal and gonadal fat relative to total 
body weight compared to mice fed a CD (P<0.05, Tables S.3.2 and S.3.3). Furthermore, 
mice fed the HFD second dietary period for 10 weeks had increased liver weights relative 
to total body weight compared to those fed a CD for the same time period (P<0.05, Table 
S.3.3), while other organs were not affected. Micronutrient supplementation for 5 weeks 
in males fed a HFD (HFD+S) did not alter body composition (P>0.05, Table S.3.2). 
However, mice fed the HFD+S for 10 weeks had a reduced sum of adipose tissues relative 
to total body weight compared to mice fed the un-supplemented HFD (P<0.05, Table 
S.3.3), although still greater than either CD group. 
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There was no effect of diet or micronutrient supplementation for 5 or 10 weeks on glucose 
and insulin tolerance, fasting baseline blood glucose levels, glucose tolerance and insulin 
tolerance compared to the controls (P>0.05, Fig. S.3.4 and S.3.5).  
 
3.5.2 Effect of diet and micronutrient supplementation on serum metabolites, 
testosterone and inflammation 
Serum parameters including cholesterol, HDLs, triglycerides, NEFAs, glucose, 
testosterone and CRP (an inflammatory marker) were measured to provide more 
information about their metabolic, hormonal and inflammatory state. Mice fed a HFD 
had increased serum cholesterol and HDL concentrations (P<0.05, Table S.3.4) compared 
to CD fed animals, with an additional increase in fasted glucose levels in mice fed the 
10-week HFD secondary diet regimen (P<0.05, Table S.3.5). Micronutrient 
supplementation for 5 or 10 weeks in either the CD or HFD did not have an effect on 
serum metabolites. Moreover, there was no difference in serum testosterone or CRP 
concentrations between mice fed a CD and mice fed a HFD; and again this was not 
influenced by micronutrient supplementation (P>0.05, Tables S.3.4 and S.3.5). 
 
3.5.3 Effect of diet and micronutrient supplementation on sperm parameters 
There was no effect of diet, or duration of micronutrient supplementation (5 or 10 weeks) 
on sperm concentration (P>0.05, Tables S.3.6 and S.3.7). Consumption of a HFD for the 
secondary diet period of 5 weeks did not affect sperm motility, however mice fed the 10 
week HFD secondary diet regimen had a reduced percentage of total motile sperm 
compared to CD fed mice (P<0.05, Table S.3.7), which was not improved by 
micronutrient supplementation for this duration of HFD feeding (P>0.05, Table S.3.7). 
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The percentage of morphologically normal sperm was reduced in mice fed a HFD 
compared to mice fed a CD for the respective time periods. When CD fed mice consumed 
supplements (CD+S) for 5 or 10 weeks, the percentage of morphologically normal sperm 
was increased compared to mice fed the CD (P<0.0001), resulting from improvements in 
sperm head morphology (P<0.01, Fig. 3.2). Furthermore, when HFD fed mice consumed 
supplements (HFD+S) for 10 weeks, the percentage of morphologically normal sperm 
increased compared to the mice fed a HFD without supplements (P<0.001) resulting from 
improvements in sperm tail morphology (P<0.05, Fig. 3.2).  
 
3.5.4 Effect of diet and micronutrient supplementation on sperm oxidative stress 
To determine the effect of diet and micronutrient supplementation on sperm oxidative 
stress, a global measure of sperm intracellular ROS levels was initially examined. Mice 
from the 5 and 10 week secondary diet regimen had increased sperm intracellular ROS 
levels compared to CD fed mice (+1.5-fold and +2.5-fold respectively; P<0.01, Fig. 3.3). 
When mice were fed HFD+S for 5 weeks, intracellular sperm ROS levels were reduced 
compared to mice fed the HFD and to a level equivalent to sperm from CD fed mice 
(P<0.01, Fig. 3.3). This reduction in sperm intracellular ROS was also evident in the mice 
undergoing 10 weeks of micronutrient supplementation in conjunction with a HFD 
(P<0.01, Fig. 3.3).  
 
Relative MSR fluorescence intensity reflecting superoxide production in sperm was 
measured, as the superoxide anion is known to contribute to various pathways of 
secondary ROS production (Droge 2002). While, consumption of a HFD did not alter the 
percentage of sperm positive for MSR compared to CD fed mice (P>0.05), 
supplementation with micronutrients in a HFD for 5 weeks (HFD+S) reduced sperm 
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superoxide production compared to mice consuming the HFD (P<0.05, Fig. 3.4). 
However, this reduction was not observed for 10 weeks of supplementation in 
conjunction with HFD (P>0.05, Fig. 3.4).  
 
Sperm 8-OHdG lesions are a marker of oxidative DNA lesions, formed by the 
modification of a guanine base resulting from oxidative attack by ROS (Oger et al. 2003; 
Valavanidis et al. 2009). Sperm 8-OHdG fluorescence was increased in mice fed the 5 
and 10 week HFD secondary diet regimen compared to CD fed mice (+2.3-fold and +2.6-
fold, respectively; P<0.01, Fig. 3.5). However, when mice were fed the HFD+S for 5 or 
10 weeks, sperm 8-OHdG fluorescence was reduced compared to HFD fed mice, 
equivalent to that of CD fed mice (P<0.01, Fig. 3.5). Micronutrient supplementation of 
the CD (CD+S) did not affect 8-OHdG fluorescence. 
 
3.5.5  Effect of diet and micronutrient supplementation on testicular oxidative DNA 
damage 
Given that HFD feeding increased oxidative DNA lesions in mature sperm compared to 
CD, CD+S and HFD+S fed mice, immunofluorescence for 8-OHdG in seminiferous 
tubules was measured to investigate whether diet and micronutrient supplementation had 
an effect on 8-OHdG generation in developing sperm cells during various stages of 
spermatogenesis. In early stages of spermatogenesis (I-V), increased 8-OHdG 
fluorescence was found in spermatogonia from mice fed the 10 week HFD secondary diet 
regimen compared to CD fed mice, with no effect of micronutrient supplementation 
(P<0.05, Table 3.1). Elongated and elongating spermatids from middle (VI-VIII) and late 
stages (IX-XII) of spermatogenesis, respectively, from mice fed the 10 week HFD 
secondary diet regimen, had increased 8-OHdG fluorescence compared to mice fed a CD 
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(P<0.05, Table 3.1). 8-OHdG fluorescence was reduced with 10 weeks of micronutrient 
supplementation (HFD+S) in elongating and elongated spermatids from the early (I-V) 
and middle (VI-VIII) stages of spermatogenesis compared to spermatids from mice fed 
the un-supplemented HFD (P<0.05, Table 3.1). There was no effect of diet or 5 weeks 
supplementation on testicular 8-OHdG fluorescence in spermatogonia, spermatocytes 
and spermatids (Table S.3.8). 
 
3.5.6 Effect of diet and micronutrient supplementation on sperm function 
While mice fed the 5 week HFD secondary diet regimen did not display changes in sperm 
capacitation (P>0.05, Table 3.2), those fed the 10 week HFD secondary diet regimen had 
a reduced percentage of capacitated sperm compared to CD fed mice (P<0.05, Table 3.3). 
Five weeks of micronutrient supplementation to either the CD or HFD did not affect 
sperm capacitation (P>0.05, Table 3.2). However, when mice were fed the HFD+S for 
10 weeks, the proportion of capacitated sperm increased compared to HFD fed mice, 
similar to CD fed mice (P<0.05, Table 3.3).  
 
The study then investigated whether this had an effect on the ability of sperm to bind to 
an oocyte. The mean number of sperm bound to an oocyte was reduced in mice from the 
5 or 10 week HFD secondary diet regimen compared to those that were fed a CD (P<0.05, 
Tables 3.1 and 3.2). Micronutrient supplementation for 5 or 10 weeks increased the mean 
number of sperm bound to an oocyte in HFD+S fed mice compared to mice fed the un-
supplemented HFD (P<0.05, Tables 3.1 and 3.2). In contrast, mice fed the CD+S for 5 or 
10 weeks had no effect on sperm capacitation or sperm binding (P>0.05, Tables 3.1 and 
3.2). 
	 165	
Mice fed the 5 or 10 week HFD secondary diet regimen had a reduced capacity to fertilize 
oocytes compared to CD fed mice (P<0.05, Tables 3.1 and 3.2). Interestingly, mice fed 
the HFD+S for 5 or 10 weeks had an increased fertilization capacity compared to HFD 
fed mice (P<0.05, Tables 3.1 and 3.2). Furthermore, after 10 weeks of supplementation 
to both the CD and HFD (CD+S and HFD+S), the percentage of fertilized oocytes was 





This study demonstrates that a combination of dietary micronutrient supplementation 
(vitamin E, vitamin C, lycopene, zinc, folic acid, selenium and green tea extract) 
ameliorates the detrimental effects that diet induced obesity has on sperm parameters 
beyond count, motility and morphology in the mouse. However, the length of time for 
the supplementation did modify the degree of improvement. Specifically, supplementing 
a HFD with micronutrients in obese male mice for 5 or 10 weeks improved sperm 
intracellular ROS, sperm oxidative DNA lesions, sperm morphology, sperm-oocyte 
binding and fertilization rates that are compromised by the consumption of a HFD. 
Furthermore, this study demonstrated that a HFD supplemented with micronutrients for 
two rounds of spermatogenesis (10 weeks) reduced oxidative DNA lesions in the germ 
cells of the testis. 
 
Mice fed a HFD for a total of 15 or 20 weeks (5 and 10 week HFD second dietary period) 
had increased adiposity without overt changes to their glucose homeostasis, as evidenced 
by no changes in glucose and insulin tolerance compared to CD fed mice, consistent with 
previous studies (Fullston et al. 2013; Fullston et al. 2012). Interestingly, mice fed a 
second period of a 10-week HFD had increased liver weight and increased serum 
triglyceride concentrations compared to CD fed mice, potentially indicative of hepatic 
steatosis (DeAngelis et al. 2005). Micronutrient supplementation in the HFD for 10 
weeks reduced adiposity compared to HFD fed mice. According to previous studies 
which separately assessed the intake of selenium, vitamin C, folic acid, zinc or green tea 
extract (all included in this dietary supplementation), this unexpected reduction in 
adiposity may be due to the anti-oxidative functions of the micronutrients to inhibit 
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adipocyte growth (Carillon et al. 2014; Kim et al. 2012; Stewart et al. 2009; Thornton et 
al. 2011; Wolfram et al. 2005). Lipid metabolism is regulated by oxidative stress; and 
micronutrients with anti-oxidative properties may reduce adipose tissue mass via the 
activation of adipocyte lipolysis pathways (Carillon et al. 2014; Thornton et al. 2011; 
Wolfram et al. 2005). 
 
Rodent models of HFD supplementation with probiotics, selenium-enriched probiotics or 
astaxanthin and vitamin E for durations varying between 6-12 weeks demonstrated 
improvements in conventional sperm parameters including motility, concentration and 
morphology compared to the HFD controls (Chen et al. 2013; Ibrahim et al. 2012; 
Mortazavi et al. 2014). However, this study only demonstrated an improvement in sperm 
morphology. This inconsistency may be due to the different animal species used whereby 
two of the three previous studies were rat models (Chen et al. 2013; Mortazavi et al. 
2014), different HFD compositions in which one study used a HFD composed of 60% 
fat, compared to 21% in this study (Mortazavi et al. 2014), potential metabolic 
differences and different impacts on serum testosterone seen between the studies, which 
regulates spermatogenesis (Ibrahim et al. 2012). In this study, 5 weeks of CD+S intake 
increased the percentage of morphologically normal sperm compared to CD fed mice. 
When supplements were administered for 10 weeks, normal sperm morphology increased 
in mice fed both the CD+S and HFD+S. These increases in normal sperm morphology 
were due to improvements in sperm head and tail morphology, which may be primarily 
due to selenium supplementation (Watanabe and Endo 1991). Although the pathways 
involved are unknown, selenium intake has been shown to enhance the supply of 
selenium to the testis (Hill et al. 2007), where it is required for spermatid development 
(Kehr et al. 2009) and microtubule organization to maintain proper head and tail 
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morphogenesis (O'Donnell and O'Bryan 2014). Furthermore, lycopene was included in 
the supplemented diet used in this study, and although the mechanism remains unknown, 
lycopene intake is associated with improved sperm morphology in both humans and rats 
(Ceribasi et al. 2010; Zareba et al. 2013).  
 
ROS in sperm are key mediators of sperm dysfunction (Agarwal et al. 2014) and are also 
suggested to be a mediator of reduced fertility and poorer subsequent embryo 
development from an obese male. In this study, micronutrient supplementation (HFD+S) 
to obese males fed a HFD reduced the increased intracellular ROS levels associated with 
HFD feeding (Bakos et al. 2010; Fullston et al. 2012; Palmer et al. 2012; Zhao et al. 
2014). These results align with previous reports from rat models where supplementation 
of a HFD with probiotics, which have antimicrobial and antioxidant properties, reduced 
sperm ROS, specifically nitric oxide, and increased enzymatic antioxidants (Chen et al. 
2013). The combination of micronutrients with anti-oxidative functions used in the 
present study may scavenge and reduce ROS from various sources within sperm, which 
most likely contribute to the observed reduction in intracellular ROS (Greco et al. 2005; 
Joshi et al. 2001; Suleiman et al. 1996). 
 
One of the sources of ROS in sperm are mitochondria whereby mitochondrial ROS 
generation, mainly superoxide anions (Koppers et al. 2008; Koppers et al. 2010), is 
associated with increased DNA damage and impaired sperm function in men (Aitken et 
al. 2012; Said et al. 2004). The percentage of sperm positive for MSR, an indicator of 
superoxide production, in HFD-induced obese mice was not elevated compared to the 
CD fed mice despite an observed reduction with 5 weeks of micronutrient 
supplementation (HFD+S) compared to sperm from mice fed the un-supplemented HFD. 
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Interestingly, the protective effect of micronutrient supplementation (HFD+S) did not 
persist when supplementation was extended until 10 weeks possibly due to the conversion 
of superoxide to hydrogen peroxide by superoxide dismutase (SOD) (Koppers et al. 2008; 
Li et al. 2011).  
 
8-OHdG is a modified guanine base formed in DNA by the oxidative attack of the 
guanine nucleobase by ROS (Noblanc et al. 2013; Valavanidis et al. 2009), and in sperm 
it is highly correlated with impaired chromatin protamination and DNA fragmentation 
(De Iuliis et al. 2009). For the first time, this study shows that micronutrient 
supplementation (both 5 and 10 week durations) reduces sperm 8-OHdG lesions 
associated with HFD feeding. This may be due to the protective effects of vitamin C 
supplementation, as vitamin C deficiency increases the incidence of 8-OHdG lesions in 
human sperm (Fraga et al. 1991). This is likely a consequence of the micronutrients 
crossing the blood testis barrier and/or the blood epididymal barrier during 
spermatogenesis and sperm maturation to reduce the susceptibility of maturing sperm to 
ROS and subsequent oxidative DNA modifications (Aitken and Roman 2008). The HFD 
fed animals also exhibited oxidative stress in the germ cells of the testes with increased 
8-OHdG lesions in elongating and elongated spermatids, which was reduced by 10 weeks 
of micronutrient supplementation. The observed oxidative damage to the nucleus of the 
maturing and elongating spermatids during spermatogenesis may be due to atrophy in 
seminiferous tubules, lack of cell adhesion between spermatogenic and Sertoli cells, and 
a damaged blood testis barrier, as found previously in HFD fed mice (Fan et al. 2015; 
Ibrahim et al. 2012). Collectively, these factors may contribute to the demonstrated 
elevated oxidative stress and impaired sperm function in mature sperm.  
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Human and animal studies support the link between obesity and reduced sperm-oocyte 
binding (Bakos et al. 2010; Palmer et al. 2012; Wegner et al. 2010), and reduced 
fertilization rates (Bakos et al. 2011; Mitchell et al. 2011). Sperm undergo capacitation 
to increase their oocyte binding affinity for successful fertilization to occur (Wassarman 
1999). In this study, 10 weeks of micronutrient supplementation improved sperm 
capacitation, which was associated with increased sperm-oocyte binding and fertilization 
of the inseminated oocytes. Selenium deficiency in mice reduced the in vitro fertilization 
capability of sperm (Sanchez-Gutierrez et al. 2008) and vitamin E supplementation in 
men increased fertilization rates (Geva et al. 1996) suggesting that these agents may 
contribute to the improvement in sperm function and subsequent fertilization rates. This 
may be due to the inhibition of lipid peroxidation of the sperm plasma membrane by 
vitamin E, which is a lipophilic antioxidant (Keskes-Ammar et al. 2003). Further, the 
anti-oxidative capacity of selenium, which is required for the synthesis of antioxidant 
enzymes (Ahmadi et al. 2016) may also contribute to the reduction in lipid peroxidation 
to maintain the sperm plasma membrane’s fluidity and integrity for successful sperm-
oocyte binding and fertilization. 
 
When comparing outcomes from the 5- and 10-week micronutrient supplementation 
durations, the longer-term treatment duration may be considered better due to the 
observed reduction in 8-OHdG lesions in testicular germ cells from obese male mice. In 
contrast, no effect was found with 5 weeks of micronutrient supplementation. However, 
it may be reasoned that both treatment durations were effective as reductions in 8-OHdG 
modifications from mature sperm were demonstrated in similar patterns in both 
micronutrient supplement durations. These outcomes may be considered clinically 
whereby micronutrient supplementation intake for a duration that spans one round of 
	 171	
spermatogenesis may reduce oxidative DNA lesions in mature sperm from obese men. 
Also, a longer-term treatment duration of micronutrient supplements may improve 
testicular germ cell DNA integrity in obese men in addition to maintaining DNA integrity 
in mature sperm, which could be investigated  with other fertility treatment outcomes in 
an ART setting in future studies. 
 
In conclusion, this study shows that impaired sperm quality and function resulting from 
male obesity can be improved by micronutrient supplementation. This study also 
demonstrates that there are additional benefits of supplement intake over two rounds of 
spermatogenesis to improve fertilization rates in both a CD and HFD. This study is the 
first to establish a spermatogenic effect from the intake of a combination of 
micronutrients, and illustrates that a reduction in sperm intracellular ROS and 8-OHdG 
lesions with micronutrient supplementation may be a result of reduced oxidative DNA 
modifications during spermatogenesis. In turn, these improvements in mature sperm 
quality can increase sperm-oocyte binding through enhanced capacitation and ultimately 
improve chances of fertilization. Further investigations beyond fertilization and into 
embryo development and offspring health are warranted. 
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Table 3.1: The effect of diet and 10 weeks of micronutrient supplementation on testicular 8-OHdG immunofluorescence from CD, 
CD+S, HFD and HFD+S fed male mice. 
CD: control diet, CD+S: control diet plus micronutrient supplementation, HFD: high fat diet, HFD+S: high fat diet plus micronutrient 
supplementation. Data are presented as mean fluorescence units ± SEM. Different letters denote significantly distinct groups at P<0.05. 
Stage Cell type CD CD+S HFD HFD+S 
I-V Spermatogonia  3.1 ± 1.5 a 3.1 ± 1.5 a 8.9 ± 2.1 b 4.8 ± 2.2 ab 
 Spermatocytes  2.1 ± 1.4 a 0.7 ± 0.5 a 3.2 ± 1.6 a 0.9 ± 0.3 a 
 Spermatids  6.8 ± 2.2 ab 11.2 ± 2.4 ab 12.1 ± 2.2 a 6.5 ± 3.1 b 
VI-VIII Spermatogonia  7.3 ± 1.3 a 9.8 ± 2.7 a 10.6 ± 2.7 a 7.4 ± 2.4 a 
 Spermatocytes  0.0 ± 0.0 a 0.0 ± 0.0 a 2.1 ± 1.5 a 0.0 ± 0.0 a 
 Spermatids  9.0 ± 2.7 a 10.9 ± 1.8 a 19.2 ± 2.3 b 10.1 ± 2.3 a 
IX-XII Spermatogonia  5.9 ± 2.4 a 9.4 ± 2.1 a 7.8 ± 2.2 a 7.1 ± 2.3 a 
 Spermatocytes  5.7 ± 1.3 a 5.9 ± 2.3 a 6.9 ± 2.3 a 5.6 ± 1.4 a 
 Spermatids  6.3 ± 1.7 a 6.9 ± 3.2 ab 13.4 ± 2.8 b 7.2 ± 2.1 ab 
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Table 3.2: The effect of diet and 5 weeks of micronutrient supplementation on capacitation, sperm binding and fertilization rates 
from CD, CD+S, HFD and HFD+S fed mice.  
CD: control diet, CD+S: control diet plus micronutrient supplementation, HFD: high fat diet, HFD+S: high fat diet plus micronutrient 
supplementation. Data are presented as mean ± SEM. Different letters denote significantly distinct groups at P<0.05. 
 CD CD+S HFD HFD+S 
Capacitated sperm (%) 91.8 ± 0.8 a 88.5 ± 1.8 a 86.8 ± 6.5 a 84.3 ± 2.4 a 
Non-capacitated sperm (%) 4.6 ± 0.3 a 5.1 ± 0.9 a 7.0 ± 2.5 a 7.2 ± 1.1 a 
Acrosome reacted (%) 4.3 ± 0.6 a 6.3 ± 1.1 a 6.7 ± 3.6 a 8.5 ± 1.5 a 
Mean number of sperm bound 15.1 ± 1.1 a 17.5 ± 0.7 a 9.6 ± 0.3 b 15.7 ± 1.6 a 
Fertilization rates (%) 54.6 ± 1.1 a 53.2 ± 1.4 a 47.5 ± 1.9 b 58.7 ± 1.6 a 
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Table 3.3: The effect of diet and 10 weeks of micronutrient supplementation on capacitation, sperm binding and fertilization rates from 
CD, CD+S, HFD and HFD+S fed mice.  
CD: control diet, CD+S: control diet plus micronutrient supplementation, HFD: high fat diet, HFD+S: high fat diet plus micronutrient 
supplementation. Data are presented as mean ± SEM. Different letters denote significantly distinct groups at P<0.05. 
 CD CD+S HFD HFD+S 
Capacitated sperm (%) 88.7 ± 1.8 a 88.9 ± 1.3 a 81.1 ± 2.1 b 87.0 ± 1.2 a 
Non-capacitated sperm (%) 6.0 ± 1.1 a 5.6 ± 0.5 a 9.0 ± 0.6 a 6.8 ± 0.8 a 
Acrosome reacted (%) 5.3 ± 1.0 a 4.9 ± 0.6 a 7.6 ± 1.2 a 6.2 ± 0.5 a 
Mean number of sperm bound 15.7 ± 1.1 a 15.8 ± 1.2 a 10.5± 0.6 b 15.0 ± 1.5 a 




(a) (b)  
Fig. 3.2. Sperm morphology at (a) 5 weeks of diet and micronutrient supplementation; 
and (b) at 10 weeks of diet and micronutrient supplementation from CD, CD+S, HFD 
and HFD+S fed mice. Data are presented as mean ± SEM. Different letters denote 
significantly distinct groups at P<0.05. CD, control diet; HFD, high fat diet; CD+S, 
control diet plus micronutrient supplements; HFD+S, high fat diet plus micronutrient 
supplements. 
 
(a) (b)  
Fig. 3.3. Sperm intracellular ROS levels relative to the CD at (a) 5 weeks of diet and 
micronutrient supplementation; and (b) 10 weeks of diet and micronutrient 
supplementation from CD, CD+S, HFD and HFD+S fed mice. Data are presented as 
mean ± SEM. Different letters denote significantly distinct groups at P<0.05. CD, control 
diet; HFD, high fat diet; CD+S, control diet plus micronutrient supplements; HFD+S, 
high fat diet plus micronutrient supplements. 
(a) (b)  
Fig. 3.4. Percentage of sperm positive for MitoSOX Red at (a) 5 weeks of diet and 
micronutrient supplementation; and (b) 10 weeks of diet and micronutrient 
supplementation from CD, CD+S, HFD and HFD+S fed mice. Data are mean ± SEM. 
Different letters denote significantly distinct groups at P<0.05 and an absence of the 
superscript letters denotes no statistical difference. CD, control diet; HFD, high fat diet; 




(a) (b)   
Fig. 3.5. Sperm 8-OHdG fluorescence relative to the CD at (a) 5 weeks of diet and 
micronutrient supplementation; and (b) 10 weeks of diet and micronutrient 
supplementation from CD, CD+S, HFD and HFD+S fed mice. Data are presented as 
mean ± SEM. Different letters denote significantly distinct groups at P<0.01. CD, control 
diet; HFD, high fat diet; CD+S, control diet plus micronutrient supplements; HFD+S, 
high fat diet plus micronutrient supplements. 
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3.10 SUPPLEMENTARY TABLES 
 
Table S.3.1. Body fat and lean mass in both mass and relative to total body weight 
(%) of CD and HFD fed mice at 9-10 weeks of the first dietary phase, as measured 
by dual-emission X-ray absorptiometry (DEXA).  
Data are mean ± SEM. ***P<0.001. CD, control diet; HFD, high fat diet. 
Body measure CD HFD 
Body Fat (g) 4.4 ± 0.1 8.1 ± 0.3*** 
Body Fat (%) 17.7 ± 0.3 27.3 ± 0.5*** 
Lean Mass (g) 20.3 ± 0.1 21.3 ± 0.2*** 
Lean Mass (%) 75.7 ± 0.5 67.3 ± 0.6*** 
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Table S.3.2. The effect of diet and 5 weeks of micronutrient supplementation on body composition from CD, CD+S, HFD and HFD+S fed 
male mice.  
Data are mean ± SEM. Different letters denote significantly distinct groups at P<0.05. CD, control diet; HFD, high fat diet; CD+S, control diet 
plus micronutrient supplements; HFD+S, high fat diet plus micronutrient supplements. 
 CD CD+S HFD HFD+S 
Total body weight (g) 28.8 ± 0.8 a 28.5 ± 0.5 a 36.2 ± 1.4 b 33.8 ± 0.7 b 
Adipose tissues (% of body weight) 
Peri-renal fat 0.06 ± 0.03 a 0.07 ± 0.02 ab 0.10 ± 0.02 b 0.09 ± 0.02 b 
Retroperitoneal fat 0.64 ± 0.05 a 0.60 ± 0.06 a 1.09 ± 0.10 b 1.26 ± 0.04 b 
Omental fat 1.18 ± 0.10 a 1.10 ± 0.05 a 1.53 ± 0.12 b 1.75 ± 0.06 b 
Dorsal fat 0.59± 0.06 a 0.49 ± 0.02 a 0.86 ± 0.07 b 0.64 ± 0.04 ab 
Gonadal fat 2.69 ± 0.13 a 2.39 ± 0.10 a 4.69 ± 0.10 b 4.34 ± 0.14 b 
Sum of adipose tissues 4.95 ± 0.24 a 4.57 ± 0.13 a 8.87 ± 0.35 b 8.25 ± 0.22 b 
Organs (% of body weight) 
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Testis  0.32 ± 0.01 a 0.30 ± 0.01 a 0.25 ± 0.01 a 0.25 ± 0.01 a 
Seminal Vesicles 0.99 ± 0.03 a 1.05 ± 0.03 a 0.90 ± 0.03 a 0.91 ± 0.04 a 
Vastus Lateralis 0.31 ± 0.07 a 0.32 ± 0.06 a 0.21 ± 0.04 a 0.33 ± 0.05 a 
Soleus  0.02 ± 0.00 a 0.02 ± 0.00 a 0.01 ± 0.00 a 0.01 ± 0.00 a 
Liver  4.80 ± 0.08 a 4.59 ± 0.07 a 4.73 ± 0.20 a 4.72 ± 0.13 a 
Pancreas  0.41 ± 0.02 a 0.40 ± 0.02 a 0.32 ± 0.01 a 0.39 ± 0.03 a 
Kidney  0.72 ± 0.01 a 0.71 ± 0.01 a 0.62 ± 0.01 a 0.65 ± 0.01 a 
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Table S.3.3 The effect of diet and 10 weeks of micronutrient supplementation on body composition from CD, CD+S, HFD and HFD+S fed 
male mice.  
Data are mean ± SEM. Different letters denote significantly distinct groups at P<0.05. CD, control diet; HFD, high fat diet; CD+S, control diet 
plus micronutrient supplements; HFD+S, high fat diet plus micronutrient supplements. 
 CD CD+S HFD HFD+S 
Total body weight (g) 31.5 ± 0.7 a 30.1 ± 1.0 a 35.7 ± 0.9 b 34.0 ± 0.9 b 
Adipose tissues (% of body weight) 
Peri-renal fat 0.06 ± 0.01 a 0.05 ± 0.01 a 0.10 ± 0.01 b 0.10 ± 0.01 b 
Retroperitoneal fat 0.95 ± 0.08 a 0.94 ± 0.01 a 1.63 ± 0.06 b 1.31 ± 0.05 ab 
Omental fat 1.27 ± 0.10 a 1.44 ± 0.09 ab 2.00 ± 0.42 b 1.43 ± 0.04 ab 
Dorsal fat 0.65± 0.03 a 0.70 ± 0.01 a 0.92 ± 0.03 b 0.82 ± 0.04 b 
Gonadal fat 3.11 ± 0.11 a 2.99 ± 0.18 a 5.13 ± 0.08 b 4.89 ± 0.14 b 
Sum of adipose tissues 6.30 ± 0.28 a 6.12 ± 0.32 a 9.11 ± 0.15 b 8.37 ± 0.29 c 
Organs (% of body weight) 
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Testis  0.27 ± 0.01 a 0.29 ± 0.01 a 0.24 ± 0.01 a 0.26 ± 0.01 a 
Seminal Vesicles 1.08 ± 0.02 a 1.09 ± 0.04 a 0.88 ± 0.03 a 0.90 ± 0.03 a 
Vastus Lateralis 0.21 ± 0.01 a 0.21 ± 0.01 a 0.17 ± 0.01 a 0.21 ± 0.03 a 
Soleus  0.02 ± 0.00 a 0.02 ± 0.00 a 0.02 ± 0.00 a 0.02 ± 0.00 a 
Liver  4.38 ± 0.10 a 4.60 ± 0.18 a 5.32 ± 0.24 b 5.61 ± 0.22 b  
Pancreas  0.35 ± 0.02 a 0.39 ± 0.02 a 0.31 ± 0.02 a 0.37 ± 0.02 a 




Table S.3.4. The effect of diet and 5 weeks of micronutrient supplementation on serum metabolites, testosterone and C-Reactive Protein 
concentrations from CD, CD+S, HFD and HFD+S fed male mice.  
Data are mean ± SEM. Different letters denote significantly distinct groups at P<0.05. CD, control diet; HFD, high fat diet; CD+S, control diet 
plus micronutrient supplements; HFD+S, high fat diet plus micronutrient supplements. 
 CD CD+S HFD HFD+S 
Cholesterol (mmol/L-1) 1.74 ± 0.08 a 1.72 ± 0.11 a 2.91 ± 0.18 b 2.92 ± 0.11 b 
Glucose (mmol/L-1) 6.59 ± 0.39 a 6.97 ± 0.39 a 7.45 ± 0.50 a 7.14 ± 0.34 a 
HDL (mmol/L-1) 1.49 ± 0.08 a 1.48 ± 0.08 a 2.47 ± 0.11 b 2.51 ± 0.07 b 
Triglycerides (mmol/L-1) 0.26 ± 0.02 a 0.26 ± 0.01 a 0.36 ± 0.03 b 0.32 ± 0.03 b 
NEFA (mmol/L-1) 0.34 ± 0.02 a 0.31 ± 0.02 a 0.32 ± 0.01 a 0.31 ± 0.01 a 
Testosterone (nmol/L-1) 0.07 ± 0.04 a 0.13 ± 0.06 a 0.05 ± 0.03 a 0.08 ± 0.07 a 
C-Reactive Protein (ng/mL) 14.49 ± 1.47 a 12.06 ± 0.64 a 12.59 ± 1.06 a 13.20 ± 1.42 a 
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Table S.3.5. The effect of diet and 10 weeks of micronutrient supplementation on serum metabolites, testosterone and C-Reactive Protein 
concentrations from CD, CD+S, HFD and HFD+S fed male mice.  
Data are mean ± SEM. Different letters denote significantly distinct groups at P<0.05. CD, control diet; HFD, high fat diet; CD+S, control diet 
plus micronutrient supplements; HFD+S, high fat diet plus micronutrient supplements. 
 CD CD+S HFD HFD+S 
Cholesterol (mmol/L-1) 1.48 ± 0.07 a 1.47 ± 0.13 a 2.75 ± 0.13 b 2.63 ± 0.18 b 
Glucose (mmol/L-1) 6.94 ± 0.52 a 6.29 ± 0.43 a 7.94 ± 0.35 b 7.73 ± 0.24 b 
HDL (mmol/L-1) 1.36 ± 0.07 a 1.22 ± 0.15 a 2.45 ± 0.10 b 2.55 ± 0.09 b 
Triglycerides (mmol/L-1) 0.24 ± 0.01 a 0.23 ± 0.01 a 0.30 ± 0.02 a 0.24 ± 0.01 a 
NEFA (mmol/L-1) 0.44 ± 0.03 a 0.46 ± 0.03 a 0.50 ± 0.04 a 0.46 ± 0.02 a 
Testosterone (nmol/L-1) 0.06 ± 0.02 a 0.06 ± 0.02 a 0.05 ± 0.02 a 0.11 ± 0.06 a 
C-Reactive Protein (ng/mL) 13.93 ± 0.64 a 17.90 ± 2.86 a 12.71 ± 1.38 a 15.61 ± 1.19 a 
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Table S.3.6. The effect of diet and 5 weeks of micronutrient supplementation on sperm concentration and motility from CD, CD+S, HFD 
and HFD+S fed male mice.  
Data are presented as mean fluorescence units ± SEM. No differences were found between diet groups. CD, control diet; HFD, high fat diet; CD+S, 
control diet plus micronutrient supplements; HFD+S, high fat diet plus micronutrient supplements. 
 CD CD+S HFD HFD+S 
Sperm motility (%) 53.33 ± 2.29 60.00 ± 3.86 47.33 ± 2.86 49.62 ± 2.79 




Table S.3.7. The effect of diet and 10 weeks of micronutrient supplementation on sperm concetration and motility from CD, CD+S, HFD 
and HFD+S fed male mice.  
Data are presented as mean fluorescence units ± SEM. Different letters denote significantly distinct groups at P<0.05. CD, control diet; HFD, high 
fat diet; CD+S, control diet plus micronutrient supplements; HFD+S, high fat diet plus micronutrient supplements. 
 CD CD+S HFD HFD+S 
Sperm motility (%) 65.00 ± 2.12 a 61.25 ± 1.87 a 50.14 ± 2.36 b 49.37 ± 2.31 b 





Table S.3.8. The effect of diet and 5 weeks of micronutrient supplementation on testicular 8-OHdG immunofluorescence from CD, CD+S, 
HFD and HFD+S fed male mice.  
Data are presented as mean fluorescence units ± SEM. No differences were found between diet groups. CD, control diet; HFD, high fat diet; CD+S, 
control diet plus micronutrient supplements; HFD+S, high fat diet plus micronutrient supplements. 
Stage Cell type CD CD+S HFD HFD+S 
I-V Spermatogonia  3.5 ± 1.7 4.9 ± 1.6 7.6 ± 2.2 3.2 ± 1.4 
 Spermatocytes  0.0 ± 0.0 0.0 ± 0.0 1.3 ± 0.3 0.0 ± 0.0 
 Spermatids  3.0 ± 1.1 3.9 ± 1.6 7.4 ± 2.3 4.1 ± 1.5 
VI-VIII Spermatogonia  7.8 ± 2.4 8.0 ± 1.5 10.8 ± 3.9 10.2 ± 3.1 
 Spermatocytes  0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
 Spermatids  8.2 ± 1.1 9.4 ± 0.7 13.0 ± 2.1 11.4 ± 1.4 
IX-XII Spermatogonia  9.0 ± 1.9 9.9 ± 1.8 8.4 ± 2.4 9.7 ± 1.9 
 Spermatocytes  5.0 ± 1.7 5.7 ± 1.1 6.4 ± 1.9 7.2 ± 2.2 
 Spermatids  7.6 ± 1.8 8.5 ± 2.0 8.6 ± 2.5 10.8 ± 2.5 
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3.11 SUPPLEMENTARY FIGURES 
(a) (b)  
(c) (d)  
Fig. S.3.1. Glucose tolerance test (GTT) and insulin tolerance test (ITT) performed at 9-
10 weeks of the first dietary phase from mice allocated to the 5-week micronutrient 
supplementation. GTT (a) Area Under the Curve (AUC) values and (b) blood glucose 
levels over time. ITT (c) Area Above the Curve (AAC) values and (d) blood glucose 
levels over time. Data are mean ± SEM. No difference was found between the diet groups. 










































































(a) (b)  
(c) (d)  
Fig. S.3.2. Glucose tolerance test (GTT) and insulin tolerance test (ITT) performed at 9-
10 weeks of the first dietary phase from mice allocated to the 10-week micronutrient 
supplementation. GTT (a) Area Under the Curve (AUC) values and (b) blood glucose 
levels over time. ITT (c) Area Above the Curve (AAC) values and (d) blood glucose 
levels over time. Data are mean ± SEM. No difference was found between the diet groups. 












































































(a) (b)  
Fig. S.3.3. The gain of total body weight over time. Micronutrient supplementation did 
not have an effect on total body weight from mice during the (a) 5-week second dietary 
phase and (b) 10-week second dietary phase. Data are mean ± SEM. *P<0.05, **P<0.01. 
CD, control diet; HFD, high fat diet; CD+S, control diet plus micronutrient supplements; 
HFD+S, high fat diet plus micronutrient supplements.  
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(a) (b)  
(c) (d)  
Fig. S.3.4. Glucose tolerance test (GTT) and insulin tolerance test (ITT) performed 
during the second dietary phase at 5 weeks post micronutrient supplementation. GTT (a) 
Area Above the Curve (AUC) values and (b) blood glucose levels over time. ITT (c) Area 
Above the Curve (AAC) values and (d) blood glucose levels over time. Data are mean ± 
SEM. No difference was found between the diet groups. CD, control diet; HFD, high fat 
diet; CD+S, control diet plus micronutrient supplements; HFD+S, high fat diet plus 
micronutrient supplements. 
















































































(a) (b)   
(c) (d)  
Fig. S.3.5. Glucose tolerance test (GTT) and insulin tolerance test (ITT) performed 
during the second dietary phase at 10 weeks post micronutrient supplementation. GTT 
(a) Area Under the Curve (AUC) values and (b) blood glucose levels over time. ITT (c) 
Area Above the Curve (AAC) values and (d) blood glucose levels over time. Data are 
mean ± SEM. No difference was found between the diet groups. CD, control diet; HFD, 
high fat diet; CD+S, control diet plus micronutrient supplements; HFD+S, high fat diet 
plus micronutrient supplements. 
 













































































































































































































































































































































































































































Chapter 4 (publication format) 
 
Short-Term Dietary Micronutrient Supplementation Reduces Sperm 
Oxidative Stress and Paternal Pronuclear Oxidative DNA Lesions of the 
Subsequent Embryo in a Mouse Model of Obesity 
 202 
4.1 Chapter Link 
 
The duration-based study in Chapter 3, which investigated dietary micronutrient 
interventions that spanned one or two rounds of spermatogenesis in diet-induced obese 
male mice, showed improvements in both immature (testicular) and mature (epididymal) 
sperm oxidative stress, sperm function and fertilization rates. This indicates that 
micronutrient intake may have a spermatogenic/ testicular effect in improving the quality 
of sperm compromised by a high fat diet and obesity. Given that spermatogenesis is a 
complex process composed of multiple stages that occur in different locations of the male 
reproductive tract, primarily the testis and epididymis, the next step was to investigate 
whether short term micronutrient supplementation may act on the epididymis resulting 
in improved sperm oxidative stress, sperm function, embryo development and pregnancy 
outcome.
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4.2 Statement of Authorship 
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4.3 Abstract  
The increased prevalence of male obesity worldwide occurs in parallel with a decline in 
fertility rates. Obesity often occurs in conjunction with micronutrient deficiencies, due to 
a calorie-dense but nutrient-poor diet. This study investigated whether short-term dietary 
supplementation of micronutrients (zinc, selenium, lycopene, vitamins E and C, folic acid 
and green tea extract) for 10 days to span the duration of epididymal transit could improve 
the compromised reproductive health found in a mouse model of diet-induced obesity. 
Mice were subjected to a range of metabolic and reproductive assessments with results 
showing that mice fed a high fat diet (HFD) supplemented with micronutrients had 
increased normal sperm morphology and sperm-oocyte binding in addition to reduced 
sperm intracellular reactive oxygen species and oxidative DNA modifications (8-OHdG) 
compared to mice fed an un-supplemented HFD. Interestingly, increased oxidative DNA 
lesions in sperm from HFD fed mice persisted to the paternal pronucleus of the 
subsequent embryo and these 8-OHdG lesions in the paternal pronucleus were also 
reduced with micronutrient supplementation. After natural mating and on day 18 of 
gestation, fetal and placental outcomes were assessed and fetal weight was increased with 
micronutrient supplementation of a paternal HFD in comparison with mice fed the un-
supplemented HFD. Overall, these results demonstrate that micronutrient 
supplementation for 10 days, to mimic epididymal transit, can reduce some detrimental 
effects of diet-induced obesity on oxidative stress in sperm, with subsequent 
improvements also seen in the paternal pronucleus of the embryo and during pregnancy. 
 
Keywords 
DNA damage, embryo, epididymis, micronutrient, obesity, pronucleus, reactive oxygen 
species, spermiogenesis, sperm maturation 
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4.4 Introduction  
 
The prevalence of obesity worldwide has more than doubled in the past three decades 
making adult obesity more common than under-nutrition (WHO 2015). Obese 
individuals can present with micronutrient deficiencies, which can influence systemic 
physiological functions (Astrup and Bugel 2010; Garcia et al. 2009) and the increased 
prevalence of obesity worldwide is occurring in parallel with a decline in fertility rates 
(Hammoud et al. 2012; Sallmen et al. 2006). Male obesity is associated with subfertility, 
characterized by changes in hormone profiles (Haffner et al. 1993; Handelsman and 
Swerdloff 1985; Magnusdottir et al. 2005), reduced sperm count (Bakos et al. 2011; Fejes 
et al. 2005; Hammoud et al. 2008; Jensen et al. 2004), reduced sperm motility (Bakos et 
al. 2011; Hammoud et al. 2008; Kort et al. 2006; Zhang et al. 2015) and increased sperm 
DNA damage (Chavarro et al. 2011; Kort et al. 2006). Although it must be noted that not 
all human studies support a link between male obesity and impaired conventional sperm 
parameters suggesting that there may be other contributing lifestyle factors such as 
metabolic syndrome (Aggerholm et al. 2008; Pauli et al. 2008; Rybar et al. 2011). To 
avoid the multitude of lifestyle factors that confound human studies, animal models have 
been devised to investigate the effects of obesity on sperm quality and function. Mouse 
models of diet-induced obesity have demonstrated that male obesity can lead to 
reductions in sperm motility (Bakos et al. 2010; Fullston et al. 2012; Ghanayem et al. 
2010; Palmer et al. 2012b), sperm capacitation, sperm binding and fertilization rates 
(Bakos et al. 2010; Palmer et al. 2012b) concomitant with increases to sperm intracellular 
reactive oxygen species (ROS) (Bakos et al. 2010; Fullston et al. 2012; Palmer et al. 
2012a), sperm DNA damage (Bakos et al. 2010; Fullston et al. 2012; Palmer et al. 2012a) 
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and delayed subsequent embryo development (Binder et al. 2012; McPherson et al. 2013; 
Mitchell et al. 2011). 
 
Given that obesity can alter both hormonal profiles and impair sperm quality and 
function, modifications to the tightly regulated process of spermatogenesis has been 
implicated as a causative factor (Reis and Dias 2012). Spermatogenesis is comprised of 
many stages and the final stage, post-testicular sperm maturation, is considered as one of 
the most crucial stages (Dacheux and Dacheux 2014; Whitfield et al. 2015). This is due 
to the fact that during the transit of the epididymal tubule, infertile testicular sperm mature 
and acquire forward motility and fertilizing competence (Cooper 1996). Also, during 
epididymal sperm maturation, sperm continue a remodeling process that includes 
migration of the cytoplasmic droplet along the sperm flagellum, acrosomal reshaping, 
nuclear chromatin condensation and structural changes to intracellular organelles 
(Bedford 2004; Olson et al. 2002). 
 
In the mouse, the process of sperm maturation during epididymal transit takes 
approximately 9.5 days (Oakberg 1957). The epididymis contains a semi-permeable 
barrier exposing developing sperm to possible damage from the physical and chemical 
environment (Hedger 2011). Further, during epididymal transit, sperm lack intracellular 
antioxidant enzyme protection due to cytoplasmic shedding, which makes epididymal 
sperm highly susceptible to oxidative stress and damage (Aitken and Baker 2002; Saleh 
and Agarwal 2002). Sperm oxidative stress, a characteristic found to be increased in 
obese males, has been shown to have many detrimental downstream effects including 
sperm oxidative DNA lesions and fragmentation (Aitken and Curry 2011; Horak et al. 
2003), reduced fertilization rates (Aitken and Fisher 1994; Aitken 1999; Saleh and 
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Agarwal 2002), reduced pregnancy rates (Aitken and Curry 2011; Zribi et al. 2011) and 
impaired offspring health in both humans and rodent models (Ji et al. 1997; Lane et al. 
2014; Reichenberg et al. 2006; Sipos et al. 2004). Therefore, dietary micronutrient and 
antioxidant supplementation has been used to mitigate sperm oxidative stress; and 
generally results in improved sperm parameters, reduced oxidative DNA lesions and 
improved pregnancy outcomes (Showell et al. 2011; Zini et al. 2009). Lycopene 
supplementation, which is a ROS scavenger, improves sperm morphology in both 
humans (Zareba et al. 2013) and rodents (Ceribasi et al. 2010).   Whilst selenium 
deficiency is associated with abnormal sperm morphology in addition to reduced sperm 
motility and concentration (Hardy and Hardy 2004; Olson et al. 2004; Sanchez-Gutierrez 
et al. 2008). Rat sperm motility and normal morphology was increased (Mosbah et al. 
2015), and sperm oxidative stress was reduced (Awoniyi et al. 2012) after two months 
and 10 weeks, respectively of green tea extract supplementation, a natural antioxidant. In 
men, sperm oxidative DNA modifications were reduced after 28 days of vitamin C 
supplementation (Fraga et al. 1991). Also, 3-6 months of zinc supplementation (both of 
which neutralize free radicals) reduced sperm oxidative stress, DNA damage and 
apoptosis (Omu et al. 2008; Wong et al. 2002). Further, combined folic acid and zinc 
supplementation for 6 months improved conventional sperm parameters including 
increased sperm count, motility and normal morphology in fertile and subfertile men 
(Wong et al. 2002). In a placebo-controlled trial, sperm motility and pregnancy rates were 
increased with 6 months of vitamin E supplementation, which also has antioxidant 
properties primarily the inhibition of lipid peroxidation, in subfertile men (Suleiman et 
al. 1996).  
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Although the effects of various long-term (6-12 weeks) micronutrient and antioxidant 
treatments on conventional sperm parameters in diet-induced obese males have been 
reported (Chen et al. 2013; Ibrahim et al. 2012; Mortazavi et al. 2014), the effects on 
sperm oxidative stress, oxidative DNA damage, sperm function and  subsequent paternal 
pronuclear oxidative DNA damage have not been assessed. Furthermore, the effects on 
blastocyst quality and fetal and placental growth measures have not been investigated. 
Therefore, given that sperm maturation in the epididymis is most vulnerable to oxidative 
damage, a treatment duration that approximates the period of epididymal transit was 
investigated to assess the effects of micronutrient supplementation on compromised 
sperm quality, sperm function, embryo development, pronuclear DNA integrity, 
blastocyst cell DNA integrity and fetal growth from obese males. 
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4.5 Materials and methods 
 
The experimental design is outlined below in Figure 4.1. Please refer to Chapter 2, section 
2.1 for experimental methods. 
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Fig. 4.1 Experimental design. All mice were allocated to a first dietary phase of a CD or a HFD for 10 weeks and underwent both a glucose 
tolerance test (GTT) and an insulin tolerance test (ITT). For the second dietary phase, mice were allocated to either a no intervention control 
group (CD, HFD) or a micronutrient supplementation intervention group (CD+S, HFD+S) for 10 days. After 10 days, mice underwent a 
GTT, ITT, body composition at post-mortem, serum metabolites and testosterone, conventional sperm analysis, sperm intracellular ROS and 
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pronuclear-staged embryo and blastocyst, and fetal and placental outcomes. CD, control diet; HFD, high fat diet; CD+S, control diet plus 




4.6.1 The effect of diet and micronutrient supplementation on glucose and insulin 
tolerance, body mass, body composition and serum metabolites  
After 10 weeks of the dietary phase of a CD or HFD to induce increased adiposity, the 
mice were assessed for metabolic health. There was no difference in fasting blood glucose 
concentration, glucose tolerance or insulin tolerance between mice fed a CD or HFD 
(P>0.05, Fig. S.4.1). Glucose and insulin tolerance tests were repeated after 10 days of 
micronutrient supplementation and there was no effect of diet or micronutrient 
supplementation on fasting blood glucose concentration, glucose tolerance or insulin 
tolerance (P>0.05, Fig. S.4.2). 
 
Consistent with previous studies, HFD fed mice had increased total body weight from 8 
weeks of diet exposure compared to CD fed mice (P<0.05, Fig. S3). After 10 days of 
micronutrient supplementation, there was no effect of supplementation on weight gain 
(P>0.05, Fig. S3). Body composition was assessed by post mortem dissection, which 
revealed that mice fed a HFD had increased retroperitoneal, omental, dorsal and gonadal 
fat masses and increased sum of these adipose depots relative to total body weight. No 
effect was observed on organ mass compared to CD fed mice (P<0.05, Table 4.1). 
Furthermore, there was no effect of micronutrient supplementation on any body 
composition measures.  
 
Mice fed a HFD had increased serum cholesterol, HDL and triglyceride concentrations 
compared to CD fed mice (P<0.05) with no effect observed for the other serum 
metabolites tested, nor for micronutrient supplementation (Table S.4.1). Serum 
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testosterone concentrations were not affected by either diet or micronutrient 
supplementation (P>0.05, Table S.4.1). 
 
4.6.2 The effect of diet and micronutrient supplementation on conventional sperm 
parameters 
Diet or micronutrient supplementation had no effect on sperm motility or sperm 
concentration (P>0.05, Table S.4.2).A reduction in morphologically normal sperm was 
found for HFD fed mice with increased abnormal tail morphology, compared to CD fed 
mice (P<0.05). Micronutrient supplementation for 10 days improved sperm morphology 
in mice fed the CD+S and HFD+S compared to mice fed the un-supplemented CD and 
HFD, respectively (P<0.05, Fig. 4.2).  
 
4.6.3 The effect of diet and micronutrient supplementation on sperm oxidative stress 
HFD fed mice had increased sperm intracellular ROS (2′,7′-dichlorodihydrofluorescein 
diacetate; H2DCFDA) compared to CD fed mice (P<0.05, Fig. 4.3). Interestingly, HFD+S 
consumption reduced sperm intracellular ROS compared to mice fed an un-supplemented 
HFD, equivalent to that of CD fed mice (P<0.05, Fig. 4.3). There was no effect of 
micronutrient supplementation on sperm intracellular ROS in CD+S fed mice compared 
to mice fed an un-supplemented CD (P>0.05). 
 
8-OHdG fluorescence was measured as a marker of oxidative lesions in sperm DNA, 
presumably resulting from oxidative attack from the elevated sperm intracellular ROS. 
Sperm from HFD fed mice had increased 8-OHdG fluorescence compared to mice fed a 
CD (P<0.05, Fig. 4.3). Mice fed the supplemented HFD (HFD+S) had reduced sperm 8-
OHdG fluorescence compared to sperm from mice fed an un-supplemented HFD 
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(P<0.05, Fig. 4.3). No effect was observed in mice fed a CD+S compared to CD fed mice 
(P>0.05, Fig. 4.3).  
 
4.6.4 The effect of diet and micronutrient supplementation on capacitation and 
sperm-oocyte binding 
Sperm capacitation was reduced in mice fed a HFD, concomitant with an increased 
percentage of acrosome reacted sperm, compared to CD fed mice (P<0.05, Table 4.2). 
Micronutrient supplementation did not have an effect on sperm capacitation or acrosome 
reaction in either dietary setting (P>0.05). Although sperm-oocyte binding was not 
different between CD and HFD fed mice, sperm binding was increased with 
supplementation (CD+S and HFD+S) compared to mice fed the un-supplemented diets 
(P<0.05, Table 4.2).  
 
4.6.5 The effect of diet and micronutrient supplementation on fertilization rates and 
embryo development  
Fertilization was determined by assessing cleavage to the 2-cell stage on day 2 of embryo 
development with the proportion of embryos that cleaved reduced after fertilization in 
male mice fed a HFD compared to CD fed mice (P<0.05, Table 4.3). However, HFD+S 
fed male mice produced embryos with increased day 2 cleavage rates (fertilization rates) 
compared to mice fed a HFD (P<0.05, Table 4.3). A difference in embryo development 
rate was not observed on day 3 with the percentage of embryos at the 6-8 cell stage not 
different between the diet groups (P>0.05, Table 4.3). Similarly, on day 4, the 
percentages of early and total blastocysts were not different between the CD and HFD 
groups and were not affected by micronutrient supplementation (P>0.05, Table 4.3). By 
day 5 of embryo development, the percentages of expanded, hatching and total 
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blastocysts were not different between the CD and HFD fed mice, however male mice 
fed the CD with micronutrient supplementation (CD+S) had an increased rate of total 
blastocyst development compared to mice fed the un-supplemented CD (P<0.05, Table 
4.3). Interestingly, this increase in blastocyst development rate was not observed in mice 
fed the HFD+S. 
 
4.6.6 The effect of diet and micronutrient supplementation on paternal pronuclear 
oxidative DNA damage in embryos 
8-OHdG fluorescence in paternal pronuclei was quantified to determine if the 8-OHdG 
lesions found in mature sperm DNA persisted to the paternal pronucleus following 
fertilization (18-19 hours post hCG injection/ 4-5 hours post fertilization). HFD fed mice 
produced embryos with increased paternal pronuclear 8-OHdG fluorescence compared 
to that from CD fed mice (P<0.05, Fig. 4.4). Paternal pronuclear 8-OHdG fluorescence 
was reduced with micronutrient supplementation in the HFD (HFD+S) compared to 
pronuclear 8-OHdG fluorescence from mice fed a HFD (P<0.05, Fig. 4.4). Moreover, 
this reduction in paternal pronuclear 8-OHdG fluorescence in embryos from mice fed a 
HFD supplemented with micronutrients was comparable to that from CD fed mice (Fig. 
4.4). 
 
4.6.7 The effect of diet and micronutrient supplementation on blastocyst quality  
8-OHdG fluorescence was further quantified in blastocyst cells (both trophectoderm and 
inner cell mass cells) to assess if the elevated 8-OHdG modifications found in the paternal 
pronucleus persisted in the blastocyst-stage embryo. Interestingly, there was no effect of 
diet or micronutrient supplementation on 8-OHdG fluorescence in blastocyst cells 
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(P>0.05), however the number of cells in the blastocyst was reduced in both the high fat 
diets (HFD, HFD+S) compared to the control diets (CD, CD+S) (P<0.05, Table 4.4). 
 
4.6.8 The effect of diet and micronutrient supplementation on fetal and placental 
development 
The average number of implantations (number of fetuses or resorptions) were not 
different between the diet groups. Further the percentage of fetuses and resorptions as a 
proportion of implantations was not affected by diet (P>0.05, Table 4.5). Fetal weight 
was increased in those sired by males fed a HFD supplemented with micronutrients 
compared to that from the un-supplemented HFD (P<0.05, Table 4.5). There was no 
effect of diet or micronutrient supplementation on placental weight, fetal:placental 
weight ratio or fetal crown-rump length (P>0.05, Table 4.5).  
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4.7 Discussion  
 
This study demonstrates that a short-term intake of dietary micronutrient supplementation 
(zinc, selenium, lycopene, vitamins E and C, folic acid and green tea extract) was 
sufficient to reduce sperm oxidative stress, evident by reduced sperm intracellular ROS 
and reduced oxidative DNA lesions. Furthermore, mice fed a HFD supplemented with 
micronutrients improved sperm morphology, increased sperm-oocyte binding capacity 
and fertilization rates in addition to reduced oxidative DNA lesions in the paternal 
pronucleus of the subsequent embryo. Further, fetal weight was increased with 
micronutrient supplementation of the paternal HFD compared to that fed the un-
supplemented HFD. 
 
Consistent with previous reports for diet-induced obesity of a similar duration, male mice 
demonstrated increased adiposity with increased serum cholesterol, HDL and triglyceride 
concentrations but without overt changes to glucose homeostasis as measured by GTT 
and ITT (Fullston et al. 2012; Palmer et al. 2012b). Serum testosterone concentrations 
did not differ between any of the diet groups, suggesting an unlikely or minimal 
contribution of testosterone driven changes in spermatogenesis (McLachlan et al. 2002; 
Walker 2011). 
 
This study shows that micronutrient supplementation, limited to 10 days duration, 
improves sperm morphology in both CD and HFD fed males by most likely maintaining 
the integrity of sperm morphogenesis during spermatogenesis. Although previous studies 
suggest a spermatogenic effect of micronutrient supplementation in improving sperm 
morphology (Ibrahim et al. 2012; Mortazavi et al. 2014; Tufek et al. 2015), this study 
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indicates that micronutrient supplement intake may also have a epididymal effect in 
increasing normal sperm morphology during sperm maturation and epididymal transit. 
The morphogenesis of sperm begins when round spermatids are differentiated into 
elongating spermatids, which are then released from the lumen of the seminiferous 
tubules of the testis into the epididymis where further morphological changes occur. 
These epididymal based morphological changes include the dimension and appearance 
of the sperm’s acrosome and flagellum to maintain normal sperm head and tail 
morphology, respectively (Olson et al. 2002). Micronutrient supplementation may 
support these epididymal based morphological changes by preventing the accumulation 
of oxidative damage and maintaining antioxidant enzyme activity in the epididymis 
(Olson et al. 2004), which ultimately may contribute to the observed improvement in 
normal sperm morphology. 
 
In addition to improvements in sperm morphology, mice fed a micronutrient 
supplemented HFD had reductions to sperm oxidative stress, demonstrated by reduced 
intracellular ROS and reduced oxidative DNA lesions (8-OHdG). One possible 
explanation for the observed reduction in sperm intracellular ROS is an increased 
secretion of micronutrients and antioxidants into the epididymis resulting in the 
protection of maturing sperm (Nonogaki et al. 1992; Perry et al. 1993; Rejraji et al. 2002). 
Sperm are protected from ROS by antioxidant enzymes including SOD through 
dismutation of reactive oxygen to hydrogen peroxide, which is then rapidly converted to 
water by the enzyme’s catalase activity or by GPx (Alvarez and Storey 1989). A key 
novel finding from this study is that micronutrient supplementation in mice fed a HFD 
reduced sperm DNA oxidative 8-OHdG modifications. Given that 8-OHdG is an oxidized 
base adduct resulting from the oxidative attack of ROS to the guanine nucleobase in 
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DNA, these results suggest that reduced sperm intracellular ROS with micronutrient 
supplementation may lead to reduced oxidative damage to sperm DNA. Most DNA 
damage is initially oxidatively induced compromising DNA integrity of the male germ 
line (De Iuliis et al. 2009; Santiso et al. 2010), which can perturb offspring growth and 
long-term health. Paternal micronutrient fortification during under-nutrition, has been 
reported to reduce sperm 8-OHdG lesions and subsequently prevented early growth 
restriction and dyslipidaemia in offspring (McPherson et al. 2016) illustrating the benefits 
of micronutrient supplementation of the paternal diet and their offspring health. 
 
Sperm function measures were also assessed in this study and a novel finding was that 
micronutrient supplementation increased sperm binding to the zona pellucida of the 
oocyte. An increase in sperm binding with vitamin E supplement intake has been 
observed in clinical studies (Geva et al. 1996; Kessopoulou et al. 1995). This observed 
increase in sperm binding with supplementation intake may be due to the inhibitory 
effects of micronutrients and antioxidants on the proliferation of lipid peroxidation and 
the restoration of fluidity to the sperm plasma membrane, which may ultimately improve 
sperm-oocyte binding (Aitken et al. 1989; Suleiman et al. 1996). In this study, 
fertilization rates were assessed by the presence of a two-cell embryo and interestingly; 
the percentage of two-cell embryos were increased from mice fed a HFD supplemented 
with micronutrients. This increase in fertilization rates may be a reflection of the observed 
increase in sperm-oocyte binding. Although day 3 and day 4 of embryo development 
were not affected by diet or supplementation, the rate of blastocyst development on day 
5 was increased from mice fed a CD with micronutrient supplementation. Curiously, this 
advancement in blastocyst development was not seen with micronutrient 
supplementation of the HFD, which may suggest a HFD’s burden on the subsequent 
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embryo’s development is beyond micronutrient-induced anti-oxidative repair (Campbell 
et al. 2015; Fan et al. 2015). Further, although the exact mechanisms involved in the 
influence of environmental conditions and/or diet on embryo development are unclear, 
recent studies have indicated that epididymosomes, small vesicles secreted by the 
epididymal epithelium that carry small molecular material to maturing sperm during 
epididymal transit, facilitate successful pre- and post-implantation embryo development 
(Conine et al. 2018; Sharma et al. 2018). Collectively, the results from this study suggest 
that micronutrient supplementation may implicate epididymosome function and 
ultimately embryo development, which could be investigated in detail in future studies. 
 
Elevated 8-OHdG modifications were detected in the paternal pronucleus in embryos 
from mice fed a HFD compared to CD fed mice, suggesting the persistence of 8-OHdG 
lesions from mature sperm to the subsequent embryo. Although previous studies have 
shown that sperm DNA damage is associated with abnormal chromatin decondensation 
patterns during pronucleus formation (Ward 2010), this is the first study to show the 
oxidized base, 8-OHdG, in mature sperm from HFD-induced obese mice persists to the 
paternal pronucleus. Micronutrient supplementation reduced 8-OHdG fluorescence in the 
paternal pronucleus in embryos from HFD fed mice in line with the reduced 8-OHdG in 
sperm. This reduction in 8-OHdG in the paternal pronucleus may lessen or prevent the 
potential for mutagenesis in the embryo resulting from the oxidized paternal chromatin 
by activating the maternal base excision repair (BER) enzymatic pathway in the oocyte 
to excise 8-OHdG in the embryo following fertilization (Bruner et al. 2000; Lord and 
Aitken 2015). Although DNA 8-OHdG lesions were elevated in the paternal pronucleus 
of embryos produced by HFD fed males, 8-OHdG fluorescence in the cells of the 
subsequent blastocyst was not increased. Whilst the exact mechanism is unknown, DNA 
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8-OHdG lesions from the paternal pronucleus from HFD-induced obese mice may have 
not persisted to the subsequent blastocyst cells due to the activation of the 8-OHdG 
excision pathway during DNA replications in the zygote and developing embryo as DNA 
replication has been shown to occur in the embryo even if 50% of the paternal DNA is 
damaged or removed (Shaman et al. 2007). 
 
Male mice were mated to assess implantation in addition to fetal and placental growth on 
day 18 of gestation. The number of fetuses and resorptions, placental weight and fetal 
crown to rump length were not affected by diet or micronutrient supplementation 
however, fetal weight was increased with supplementation of the HFD. An increase in 
fetal weight has been previously demonstrated whereby exercise in HFD-induced obese 
mice without or in combination with a change from a HFD to a CD was associated with 
an increase and restoration of fetal weight (McPherson et al. 2013). A theory that may 
explain the increase in fetal weight with supplementation of the HFD may be attributed 
to the observed reduction in 8-OHdG lesions in the paternal lineage. Subsequently, this 
may contribute to a reduced mutational load in the embryo and developing fetus (Chong 
et al. 2007) resulting in healthy fetal outcomes which is indicative of a reduced 
susceptibility to the onset of adult disease (Barker 2004; Johnson and Schoeni 2011). 
 
In summary, these outcomes establish that compromised sperm quality and function, due 
to diet-induced obesity, can be improved with short-term intake of dietary micronutrient 
supplementation. Obesity-induced sperm oxidative stress and subsequent oxidative 
sperm DNA damage is reduced with just 10 days of micronutrient supplementation with 
further reductions in oxidative DNA lesions of the paternal pronucleus from the 
subsequent embryo in addition to improvements in fetal weight. Although these results 
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represent early findings toward establishing the optimal duration of intake, it highlights 
some potential mechanisms that underlie sperm quality and function. The potential for 
micronutrient treatment in obese males to improve sperm quality/function and implicate 
epididymal sperm maturation is a key area of investigation. Further comparative and 
prospective studies in obese men, whereby epididymal transit time is 6-10 days (Amann 
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Table 4.1. The effect of diet and micronutrient supplementation on body composition relative to total body weight. 
Values are a mean ± SEM. CD, control diet; CD+S, control diet plus micronutrient supplements; HFD, high fat diet; HFD+S, high fat diet 
plus micronutrient supplements. Different letters denote significantly distinct groups at P<0.05.  
 CD CD+S HFD HFD+S 
Total body weight (g) 26.07 ± 0.61 a 24.84 ± 0.45 a 29.07 ± 0.45 b 29.71 ± 0.82 b 
Adipose tissues (% of body weight) 
Peri-renal fat 0.002 ± 0.000 a 0.002 ± 0.000 a 0.003 ± 0.000 ab 0.004 ± 0.000 b 
Retroperitoneal fat 0.005 ± 0.000 a 0.005 ± 0.000 a 0.009 ± 0.000 b 0.008 ± 0.000 b 
Omental fat 0.011 ± 0.001 a 0.009 ± 0.000 a 0.013 ± 0.001 b 0.015 ± 0.001 b 
Dorsal fat 0.006 ± 0.000 a 0.006 ± 0.000 a 0.008 ± 0.000 b 0.009 ± 0.000 b 
Gonadal fat 0.026 ± 0.002 a 0.022 ± 0.001 a 0.041 ± 0.001 b 0.043 ± 0.002 b 
Sum of adipose tissues 0.050 ± 0.004 a 0.044 ± 0.002 a 0.074 ± 0.002 b 0.079 ± 0.003 b 
Organs (% of body weight) 
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Testis 0.003 ± 0.000 a 0.004 ± 0.000 a 0.003 ± 0.000 a 0.003 ± 0.000 a 
Seminal vesicles 0.011 ± 0.001 a 0.011 ± 0.001 a 0.010 ± 0.000 a 0.011 ± 0.001 a 
Vastus lateralis 0.006 ± 0.000 a 0.006 ± 0.000 a 0.005 ± 0.000 a 0.005 ± 0.000 a 
Soleus 0.0004 ± 0.000 a 0.0004 ± 0.000 a 0.0004 ± 0.000 a 0.0003 ± 0.000 a 
Liver 0.046 ± 0.002 a 0.045 ± 0.002 a 0.041 ± 0.001 a 0.040 ± 0.002 a 
Pancreas 0.005 ± 0.000 a 0.005 ± 0.000 a 0.005 ± 0.000 a 0.005 ± 0.000 a 
Kidney 0.007 ± 0.000 a 0.007 ± 0.000 a 0.007 ± 0.000 a 0.006 ± 0.000 a 
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Table 4.2. The effect of diet and micronutrient supplementation on sperm 
capacitation and sperm-oocyte binding.  
Values are a mean ± SEM. CD, control diet; CD+S, control diet plus micronutrient 
supplements; HFD, high fat diet; HFD+S, high fat diet plus micronutrient supplements. 
Different letters denote significantly distinct groups at P<0.05. 
 CD CD+S HFD HFD+S 
Capacitated sperm (%) 90.6 ± 1.0 a 89.5 ± 1.1 ab 87.3 ± 0.9 b 86.9 ± 0.6 b 
Non-capacitated sperm (%) 4.2 ± 0.6 a 5.6 ± 0.6 ab 5.3 ± 0.5 ab 6.1 ± 0.4 b 
Acrosome reacted (%) 4.7 ± 0.4 a 4.9 ± 0.6 a 7.5 ± 0.6 b 7.1 ± 0.6 b 
Mean number of sperm 
bound (%) 
15.9 ± 0.6 a 19.9 ± 0.9 bc 18.2 ± 0.7 ab 21.0 ± 0.6 c 
 
 226 
Table 4.3. The effect of diet and micronutrient supplementation on fertilization and 
embryo development. 
Values are a proportion of total embryos for day 2 cleavage and a proportion of day 2 
cleaved-embryos for days 3-5 of development. CD, control diet; CD+S, control diet plus 
micronutrient supplements; HFD, high fat diet; HFD+S, high fat diet plus micronutrient 
supplements. Total blastocyst (%) included early, full, expanded and hatching 
blastocysts. Different letters denote significantly distinct groups at P<0.05.  
 CD CD+S HFD HFD+S 
Day 2  
Cleavage (%) 85.6 a 79.2 a 39.3 b 60.2 c 
Day 3 
6-8 cell (%) 46.5 a 51.9 a 55.2 a 46.3 a 
Day 4 
Early blastocyst (%) 14.9 a 16.4 a 18.8 a 12.4 a 
Total blastocyst (%) 53.2 ab 61.7 b 43.6 a 38.0 a 
Day 5 
Expanded blastocyst (%) 27.7 a 31.1 a 29.2 a 23.1 a 
Hatching blastocyst (%) 19.5 ab 27.3 a 15.8 ab 11.6 b 
Total blastocyst (%) 72.1 a 84.2 b 62.4 a 58.7 a 
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Table 4.4. The effect of diet and micronutrient supplementation on oxidative DNA 
lesion fluorescence in blastocyst cells. 
Values are a mean ± SEM for fluorescent units measures and total cell number (TCN); 
and as proportion of TCN for the number of cells positive for oxidative DNA lesions (8-
OHdG). CD, control diet; CD+S, control diet plus micronutrient supplements; HFD, high 
fat diet; HFD+S, high fat diet plus micronutrient supplements. Different letters denote 
significantly distinct groups at P<0.05.  
 CD CD+S HFD HFD+S 
Cells positive for 8-OHdG 
(fluorescent units) 
11.9 ± 0.5 a 12.1 ± 0.4 a 12.9 ± 0.3 a 12.9 ± 0.3 a 
Total cell number (TCN) 64.2 ± 1.1 a 64.2 ± 1.3 a 55.1 ± 1.6 b 53.1 ± 1.0 b 
Number of cells positive for 
8-OHdG (% of TCN) 
36.1 a 33.7 a 37.9 a 37.3 a 
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Table 4.5. The effect of diet and micronutrient supplementation on fetal and 
placental development measures at day 18 of gestation. 
Values are a mean ± SEM. CD, control diet; CD+S, control diet plus micronutrient 
supplements; HFD, high fat diet; HFD+S, high fat diet plus micronutrient supplements. 
The number of implantations reflect the number of fetuses and resorptions.  The number 
of fetuses and resorptions are a mean and in parenthesis are the total number of 
implantations, fetuses and resorptions. Different letters denote significantly distinct 
groups at P<0.05.  
 CD CD+S HFD HFD+S 
Number of implantations 4.3 (86) 4.4 (87) 4.3 (26) 4.4 (44) 
Number of fetuses 3.4 (68) 4.3 (86) 4.2 (25) 3.8 (38) 
Number of resorptions 0.9 (18) 0.1 (1) 0.2 (1) 0.6 (6) 
Fetuses/implantation (%) 80.5 99.4  96.7  89.8 
Fetal weight (mg) 767 ± 27 a 787 ± 9 ab 771 ± 25 a 842 ± 34 b 
Placental weight (mg) 85.7 ± 4.5 a 92.5 ± 1.5 a 98.1 ± 4.0 a 94.8 ± 5.5 a 
Fetal:placental weight 
ratio 
9.2 ± 0.5 a 8.6 ± 0.2 a 7.8 ± 0.4 a 9.1 ± 0.6 a 
Crown-rump length 
(mm) 





Fig. 4.2. The effect of diet and micronutrient supplementation on sperm morphology. 
Values are a mean ± SEM. CD, control diet; CD+S, control diet plus micronutrient 
supplements; HFD, high fat diet; HFD+S, high fat diet plus micronutrient supplements. 




Fig. 4.3. The effect of diet and micronutrient supplementation on sperm oxidative stress 
assessed by (a) sperm intracellular ROS levels normalised to CD fed mice, and (b) sperm 
8-OHdG fluorescence normalised to CD fed mice. Values are a mean ± SEM. CD, control 
diet; CD+S, control diet plus micronutrient supplements; HFD, high fat diet; HFD+S, 
high fat diet plus micronutrient supplements. Different letters denote significantly distinct 
groups at P<0.05. 
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(a)  8-OHdG Hoescht Overlay  (b) 
    
    
Fig. 4.4. The effect of diet and micronutrient supplementation on pronuclear oxidative DNA lesion fluorescence. (a) Representative images 
of 8-OHdG and nuclear fluorescence and (b) quantified fluorescent intensity of the paternal pronucleus normalized to the maternal pronucleus 
in the subsequent embryo. Values are a mean ± SEM. CD, control diet; CD+S, control diet plus micronutrient supplements; HFD, high fat 












4.11 Supplementary Tables 
 
Table S.4.1. The effect of diet and micronutrient supplementation on serum metabolites and testosterone. 
Values are a mean ± SEM. CD, control diet; CD+S, control diet plus micronutrient supplements; HFD, high fat diet; HFD+S, high fat diet 
plus micronutrient supplements. Different letters denote significantly distinct groups at P<0.05.  
 
 CD CD+S HFD HFD+S 
Cholesterol (mmol/L-1) 1.55 ± 0.08 a 1.49 ± 0.11 a 2.12 ± 0.11 b 2.13 ± 0.11 b 
Glucose (mmol/L-1) 5.31 ± 0.30 a 4.75 ± 0.13 a 5.36 ± 0.41 a 5.40 ± 0.35 a 
HDL (mmol/L-1) 1.35 ± 0.09 a 1.41 ± 0.03 a 1.88 ± 0.11 b 1.90 ± 0.14 b 
Triglycerides (mmol/L-1) 0.23 ± 0.02 a 0.23 ± 0.02 a 0.30 ± 0.02 b 0.31 ± 0.03 b 
NEFA (mmol/L-1) 0.37 ± 0.02 a 0.36 ± 0.03 a 0.36 ± 0.02 a 0.38 ± 0.02 a 




Table S.4.2. The effect of diet and micronutrient supplementation on sperm 
motility and concentration. 
Values are a mean ± SEM. CD, control diet; CD+S, control diet plus micronutrient 
supplements; HFD, high fat diet; HFD+S, high fat diet plus micronutrient supplements. 
No statistical differences were detected. 
 CD CD+S HFD HFD+S 
Motility (%) 64.5 ± 2.3 61.0 ± 1.9 59.8 ± 2.8 56.1 ± 2.9 
Concentration (106/ml) 41.9 ± 3.7 34.5 ± 1.6 39.6 ± 4.7 38.5 ± 4.5 
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4.12 Supplementary Figures 
 
(a) (b)  
(c) (d)  
Fig S.4.1. An intraperitoneal (ip) glucose tolerance test (GTT) and an ip insulin tolerance 
test (ITT) performed at 9-10 weeks of the first dietary phase. CD, control diet; HFD, high 
fat diet GTT (a) area under the curve (AUC) values, and (b) blood glucose concentration 
over time. ITT (c) area above the curve (AAC) values, and (d) blood glucose 




(c) (d)  
Fig. S.4.2. An intraperitoneal (ip) glucose tolerance test (GTT) and an ip insulin tolerance 
test (ITT) performed after 10 days of micronutrient supplementation. CD, control diet; 
CD+S, control diet plus micronutrient supplements; HFD, high fat diet; HFD+S, high fat 
diet plus micronutrient supplements. GTT (a) area under the curve (AUC) values, and (b) 
blood glucose concentration over time. ITT (c) area above the curve (AAC) values, and 
(d) blood glucose concentration over time. No statistical differences were detected. 
Values are a mean ± SEM. 
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Fig. S.4.3. Total body weight from control diet (CD) and high fat diet (HFD) fed mice 
following 10 weeks of diet exposure in addition to control diet plus micronutrient 
supplements (CD+S) and high fat diet plus micronutrient supplements (HFD+S) after one 










Aggerholm, A.S., Thulstrup, A.M., Toft, G., Ramlau-Hansen, C.H., and Bonde, J.P. (2008) 
Is overweight a risk factor for reduced semen quality and altered serum sex hormone 
profile? Fertil Steril 90, 619-626. [In eng] 
 
Aitken, J., and Fisher, H. (1994) Reactive oxygen species generation and human 
spermatozoa: the balance of benefit and risk. Bioessays 16, 259-267.  
 
Aitken, R.J. (1999) The Amoroso Lecture - The human spermatozoon - a cell in crisis? 
Journal of Reproduction and Fertility 115, 1-7. [In English] 
 
Aitken, R.J., and Baker, M.A. (2002) Reactive oxygen species generation by human 
spermatozoa: a continuing enigma. Int J Androl 25, 191-194.  
 
Aitken, R.J., Clarkson, J.S., and Fishel, S. (1989) Generation of reactive oxygen species, 
lipid peroxidation, and human sperm function. Biol Reprod 41, 183-197.  
 
Aitken, R.J., and Curry, B.J. (2011) Redox regulation of human sperm function: from the 
physiological control of sperm capacitation to the etiology of infertility and DNA damage 
in the germ line. Antioxid Redox Signal 14, 367-381.  
 
Alvarez, J.G., and Storey, B.T. (1989) Role of glutathione peroxidase in protecting 
mammalian spermatozoa from loss of motility caused by spontaneous lipid 
peroxidation. Gamete Res 23, 77-90.  
 
Amann, R.P., and Howards, S.S. (1980) Daily spermatozoal production and epididymal 
spermatozoal reserves of the human male. J Urol 124, 211-215.  
 
Astrup, A., and Bugel, S. (2010) Micronutrient deficiency in the aetiology of obesity. Int 
J Obes (Lond) 34, 947-948.  
 
Awoniyi, D.O., Aboua, Y.G., Marnewick, J., and Brooks, N. (2012) The effects of rooibos 
(Aspalathus linearis), green tea (Camellia sinensis) and commercial rooibos and green 
tea supplements on epididymal sperm in oxidative stress-induced rats. Phytother Res 
26, 1231-1239.  
 
Bakos, H.W., Henshaw, R.C., Mitchell, M., and Lane, M. (2011) Paternal body mass index 
is associated with decreased blastocyst development and reduced live birth rates 
following assisted reproductive technology. Fertil Steril 95, 1700-1704.  
 
Bakos, H.W., Mitchell, M., Setchell, B.P., and Lane, M. (2010) The effect of paternal diet-




Barker, D.J. (2004) The developmental origins of chronic adult disease. Acta Paediatr 
Suppl 93, 26-33.  
 
Bedford, J.M. (2004) Enigmas of mammalian gamete form and function. Biol Rev Camb 
Philos Soc 79, 429-460.  
 
Binder, N.K., Hannan, N.J., and Gardner, D.K. (2012) Paternal diet-induced obesity 
retards early mouse embryo development, mitochondrial activity and pregnancy health. 
PLoS One 7, e52304.  
 
Bruner, S.D., Norman, D.P., and Verdine, G.L. (2000) Structural basis for recognition and 
repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 403, 859-866.  
 
Campbell, J.M., Lane, M., Owens, J.A., and Bakos, H.W. (2015) Paternal obesity 
negatively affects male fertility and assisted reproduction outcomes: a systematic 
review and meta-analysis. Reproductive BioMedicine Online 31, 593-604.  
 
Ceribasi, A.O., Turk, G., Sonmez, M., Sakin, F., and Atessahin, A. (2010) Toxic effect of 
cyclophosphamide on sperm morphology, testicular histology and blood oxidant-
antioxidant balance, and protective roles of lycopene and ellagic acid. Basic Clin 
Pharmacol Toxicol 107, 730-736.  
 
Chavarro, J.E., Furtado, J., Toth, T.L., Ford, J., Keller, M., Campos, H., and Hauser, R. 
(2011) Trans-fatty acid levels in sperm are associated with sperm concentration among 
men from an infertility clinic. Fertil Steril 95, 1794-1797. [In eng] 
 
Chen, X.L., Gong, L.Z., and Xu, J.X. (2013) Antioxidative activity and protective effect of 
probiotics against high-fat diet-induced sperm damage in rats. Animal 7, 287-292.  
 
Chong, S., Vickaryous, N., Ashe, A., Zamudio, N., Youngson, N., Hemley, S., Stopka, T., 
Skoultchi, A., Matthews, J., Scott, H.S., et al. (2007) Modifiers of epigenetic 
reprogramming show paternal effects in the mouse. Nat Genet 39, 614-622. [In eng] 
 
Conine, C.C., Sun, F., Song, L., Rivera-Perez, J.A., and Rando, O.J. (2018) Small RNAs 
Gained during Epididymal Transit of Sperm Are Essential for Embryonic Development in 
Mice. Dev Cell.  
 
Cooper, T.G. (1996) Epididymis and sperm function. Andrologia 28 Suppl 1, 57-59.  
 
Dacheux, J.L., and Dacheux, F. (2014) New insights into epididymal function in relation 
to sperm maturation. Reproduction 147, R27-42.  
 
De Iuliis, G.N., Thomson, L.K., Mitchell, L.A., Finnie, J.M., Koppers, A.J., Hedges, A., 
Nixon, B., and Aitken, R.J. (2009) DNA damage in human spermatozoa is highly 
correlated with the efficiency of chromatin remodeling and the formation of 8-hydroxy-
2'-deoxyguanosine, a marker of oxidative stress. Biol Reprod 81, 517-524.  
 
 239 
Fan, Y., Liu, Y., Xue, K., Gu, G., Fan, W., Xu, Y., and Ding, Z. (2015) Diet-induced obesity 
in male C57BL/6 mice decreases fertility as a consequence of disrupted blood-testis 
barrier. PLoS One 10, e0120775.  
 
Fejes, I., Koloszar, S., Szollosi, J., Zavaczki, Z., and Pal, A. (2005) Is semen quality affected 
by male body fat distribution? Andrologia 37, 155-159. [In eng] 
 
Fraga, C.G., Motchnik, P.A., Shigenaga, M.K., Helbock, H.J., Jacob, R.A., and Ames, B.N. 
(1991) Ascorbic acid protects against endogenous oxidative DNA damage in human 
sperm. Proc Natl Acad Sci U S A 88, 11003-11006.  
 
Fullston, T., Palmer, N.O., Owens, J.A., Mitchell, M., Bakos, H.W., and Lane, M. (2012) 
Diet-induced paternal obesity in the absence of diabetes diminishes the reproductive 
health of two subsequent generations of mice. Hum Reprod 27, 1391-1400.  
 
Garcia, O.P., Long, K.Z., and Rosado, J.L. (2009) Impact of micronutrient deficiencies on 
obesity. Nutr Rev 67, 559-572.  
 
Geva, E., Bartoov, B., Zabludovsky, N., Lessing, J.B., Lerner-Geva, L., and Amit, A. (1996) 
The effect of antioxidant treatment on human spermatozoa and fertilization rate in an 
in vitro fertilization program. Fertil Steril 66, 430-434.  
 
Ghanayem, B.I., Bai, R., Kissling, G.E., Travlos, G., and Hoffler, U. (2010) Diet-induced 
obesity in male mice is associated with reduced fertility and potentiation of acrylamide-
induced reproductive toxicity. Biol Reprod 82, 96-104.  
 
Haffner, S.M., Valdez, R.A., Stern, M.P., and Katz, M.S. (1993) Obesity, body fat 
distribution and sex hormones in men. Int J Obes Relat Metab Disord 17, 643-649.  
 
Hammoud, A.O., Meikle, A.W., Reis, L.O., Gibson, M., Peterson, C.M., and Carrell, D.T. 
(2012) Obesity and male infertility: a practical approach. Semin Reprod Med 30, 486-
495.  
 
Hammoud, A.O., Wilde, N., Gibson, M., Parks, A., Carrell, D.T., and Meikle, A.W. (2008) 
Male obesity and alteration in sperm parameters. Fertil Steril 90, 2222-2225.  
 
Handelsman, D.J., and Swerdloff, R.S. (1985) Male gonadal dysfunction. Clin Endocrinol 
Metab 14, 89-124.  
 
Hardy, G., and Hardy, I. (2004) Selenium: the Se-XY nutraceutical. Nutrition 20, 590-593.  
 
Hedger, M.P. (2011) Immunophysiology and pathology of inflammation in the testis and 
epididymis. J Androl 32, 625-640.  
 
Horak, S., Polanska, J., and Widlak, P. (2003) Bulky DNA adducts in human sperm: 
relationship with fertility, semen quality, smoking, and environmental factors. Mutat 
Res 537, 53-65.  
 240 
 
Ibrahim, H.A., Zhu, Y., Wu, C., Lu, C., Ezekwe, M.O., Liao, S.F., and Huang, K. (2012) 
Selenium-enriched probiotics improves murine male fertility compromised by high fat 
diet. Biol Trace Elem Res 147, 251-260.  
 
Jensen, T.K., Andersson, A.M., Jorgensen, N., Andersen, A.G., Carlsen, E., Petersen, J.H., 
and Skakkebaek, N.E. (2004) Body mass index in relation to semen quality and 
reproductive hormones among 1,558 Danish men. Fertil Steril 82, 863-870.  
 
Ji, B.T., Shu, X.O., Linet, M.S., Zheng, W., Wacholder, S., Gao, Y.T., Ying, D.M., and Jin, F. 
(1997) Paternal cigarette smoking and the risk of childhood cancer among offspring of 
nonsmoking mothers. J Natl Cancer Inst 89, 238-244.  
 
Johnson, R.C., and Schoeni, R.F. (2011) Early-life origins of adult disease: national 
longitudinal population-based study of the United States. Am J Public Health 101, 2317-
2324.  
 
Kessopoulou, E., Powers, H.J., Sharma, K.K., Pearson, M.J., Russell, J.M., Cooke, I.D., and 
Barratt, C.L. (1995) A double-blind randomized placebo cross-over controlled trial using 
the antioxidant vitamin E to treat reactive oxygen species associated male infertility. 
Fertil Steril 64, 825-831.  
 
Kort, H.I., Massey, J.B., Elsner, C.W., Mitchell-Leef, D., Shapiro, D.B., Witt, M.A., and 
Roudebush, W.E. (2006) Impact of body mass index values on sperm quantity and 
quality. J Androl 27, 450-452. [In eng] 
 
Lane, M., McPherson, N.O., Fullston, T., Spillane, M., Sandeman, L., Kang, W.X., and 
Zander-Fox, D.L. (2014) Oxidative stress in mouse sperm impairs embryo development, 
fetal growth and alters adiposity and glucose regulation in female offspring. PLoS One 
9, e100832.  
 
Lord, T., and Aitken, R.J. (2015) Fertilization stimulates 8-hydroxy-2'-deoxyguanosine 
repair and antioxidant activity to prevent mutagenesis in the embryo. Dev Biol 406, 1-
13.  
 
Magnusdottir, E.V., Thorsteinsson, T., Thorsteinsdottir, S., Heimisdottir, M., and 
Olafsdottir, K. (2005) Persistent organochlorines, sedentary occupation, obesity and 
human male subfertility. Hum Reprod 20, 208-215.  
 
McLachlan, R.I., O'Donnell, L., Meachem, S.J., Stanton, P.G., de Kretser, D.M., Pratis, K., 
and Robertson, D.M. (2002) Identification of specific sites of hormonal regulation in 
spermatogenesis in rats, monkeys, and man. Recent Prog Horm Res 57, 149-179.  
 
McPherson, N.O., Bakos, H.W., Owens, J.A., Setchell, B.P., and Lane, M. (2013) 
Improving metabolic health in obese male mice via diet and exercise restores embryo 
development and fetal growth. PLoS One 8, e71459.  
 
 241 
McPherson, N.O., Fullston, T., Kang, W.X., Sandeman, L.Y., Corbett, M.A., Owens, J.A., 
and Lane, M. (2016) Paternal under-nutrition programs metabolic syndrome in offspring 
which can be reversed by antioxidant/vitamin food fortification in fathers. Sci Rep 6, 
27010.  
 
Mitchell, M., Bakos, H.W., and Lane, M. (2011) Paternal diet-induced obesity impairs 
embryo development and implantation in the mouse. Fertil Steril 95, 1349-1353.  
 
Mortazavi, M., Salehi, I., Alizadeh, Z., Vahabian, M., and Roushandeh, A.M. (2014) 
Protective Effects of Antioxidants on Sperm Parameters and Seminiferous Tubules 
Epithelium in High Fat-fed Rats. J Reprod Infertil 15, 22-28.  
 
Mosbah, R., Yousef, M.I., and Mantovani, A. (2015) Nicotine-induced reproductive 
toxicity, oxidative damage, histological changes and haematotoxicity in male rats: the 
protective effects of green tea extract. Exp Toxicol Pathol 67, 253-259.  
 
Nonogaki, T., Noda, Y., Narimoto, K., Shiotani, M., Mori, T., Matsuda, T., and Yoshida, O. 
(1992) Localization of CuZn-superoxide dismutase in the human male genital organs. 
Hum Reprod 7, 81-85.  
 
Oakberg, E.F. (1957) Duration of spermatogenesis in the mouse. Nature 180, 1137-1138.  
 
Olson, G.E., NagDas, S.K., and Winfrey, V.P. (2002) Structural Differentiation of 
Spermatozoa During Post-Testicular Maturation. In 'The Epididymis: From Molecules to 
Clinical Practice.' (Eds. B Robaire and BT Hinton) pp. 371-387. (Springer US)  
 
Olson, G.E., Winfrey, V.P., Hill, K.E., and Burk, R.F. (2004) Sequential development of 
flagellar defects in spermatids and epididymal spermatozoa of selenium-deficient rats. 
Reproduction 127, 335-342.  
 
Omu, A.E., Al-Azemi, M.K., Kehinde, E.O., Anim, J.T., Oriowo, M.A., and Mathew, T.C. 
(2008) Indications of the mechanisms involved in improved sperm parameters by zinc 
therapy. Med Princ Pract 17, 108-116.  
 
Palmer, N.O., Bakos, H.W., Fullston, T., and Lane, M. (2012a) Impact of obesity on male 
fertility, sperm function and molecular composition. Spermatogenesis 2, 253-263.  
 
Palmer, N.O., Bakos, H.W., Owens, J.A., Setchell, B.P., and Lane, M. (2012b) Diet and 
exercise in an obese mouse fed a high-fat diet improve metabolic health and reverse 
perturbed sperm function. Am J Physiol Endocrinol Metab 302, E768-780.  
 
Pauli, E.M., Legro, R.S., Demers, L.M., Kunselman, A.R., Dodson, W.C., and Lee, P.A. 
(2008) Diminished paternity and gonadal function with increasing obesity in men. Fertil 
Steril 90, 346-351. [In eng] 
 
 242 
Perry, A.C., Jones, R., and Hall, L. (1993) Isolation and characterization of a rat cDNA 
clone encoding a secreted superoxide dismutase reveals the epididymis to be a major 
site of its expression. Biochem J 293 ( Pt 1), 21-25.  
 
Reichenberg, A., Gross, R., Weiser, M., Bresnahan, M., Silverman, J., Harlap, S., 
Rabinowitz, J., Shulman, C., Malaspina, D., Lubin, G., et al. (2006) Advancing paternal 
age and autism. Arch Gen Psychiatry 63, 1026-1032.  
 
Reis, L.O., and Dias, F.G. (2012) Male fertility, obesity, and bariatric surgery. Reprod Sci 
19, 778-785.  
 
Rejraji, H., Vernet, P., and Drevet, J.R. (2002) GPX5 is present in the mouse caput and 
cauda epididymidis lumen at three different locations. Mol Reprod Dev 63, 96-103.  
 
Robaire, B., Hinton, B.T., and Orgebin-Crist, M. (2006) The Epididymis. In 'Knobil and 
Neill's Physiology of Reproduction.' (Ed. JD Neill). (Elsevier)  
 
Rybar, R., Kopecka, V., Prinosilova, P., Markova, P., and Rubes, J. (2011) Male obesity 
and age in relationship to semen parameters and sperm chromatin integrity. Andrologia 
43, 286-291.  
 
Saleh, R.A., and Agarwal, A. (2002) Oxidative stress and male infertility: from research 
bench to clinical practice. J Androl 23, 737-752.  
 
Sallmen, M., Sandler, D.P., Hoppin, J.A., Blair, A., and Baird, D.D. (2006) Reduced fertility 
among overweight and obese men. Epidemiology 17, 520-523. [In eng] 
 
Sanchez-Gutierrez, M., Garcia-Montalvo, E.A., Izquierdo-Vega, J.A., and Del Razo, L.M. 
(2008) Effect of dietary selenium deficiency on the in vitro fertilizing ability of mice 
spermatozoa. Cell Biol Toxicol 24, 321-329.  
 
Santiso, R., Tamayo, M., Gosalvez, J., Meseguer, M., Garrido, N., and Fernandez, J.L. 
(2010) Simultaneous determination in situ of DNA fragmentation and 8-oxoguanine in 
human sperm. Fertil Steril 93, 314-318.  
 
Shaman, J.A., Yamauchi, Y., and Ward, W.S. (2007) The sperm nuclear matrix is required 
for paternal DNA replication. J Cell Biochem 102, 680-688.  
 
Sharma, U., Sun, F., Conine, C.C., Reichholf, B., Kukreja, S., Herzog, V.A., Ameres, S.L., 
and Rando, O.J. (2018) Small RNAs Are Trafficked from the Epididymis to Developing 
Mammalian Sperm. Dev Cell.  
 
Showell, M.G., Brown, J., Yazdani, A., Stankiewicz, M.T., and Hart, R.J. (2011) 
Antioxidants for male subfertility. Cochrane Database Syst Rev, CD007411. [In eng] 
 
Sipos, A., Rasmussen, F., Harrison, G., Tynelius, P., Lewis, G., Leon, D.A., and Gunnell, D. 
(2004) Paternal age and schizophrenia: a population based cohort study. BMJ 329, 1070.  
 243 
 
Suleiman, S.A., Ali, M.E., Zaki, Z.M., el-Malik, E.M., and Nasr, M.A. (1996) Lipid 
peroxidation and human sperm motility: protective role of vitamin E. J Androl 17, 530-
537.  
 
Tufek, N.H., Altunkaynak, M.E., Altunkaynak, B.Z., and Kaplan, S. (2015) Effects of 
thymoquinone on testicular structure and sperm production in male obese rats. Syst 
Biol Reprod Med 61, 194-204.  
 
Walker, W.H. (2011) Testosterone signaling and the regulation of spermatogenesis. 
Spermatogenesis 1, 116-120.  
 
Ward, W.S. (2010) Function of sperm chromatin structural elements in fertilization and 
development. Mol Hum Reprod 16, 30-36.  
 
Whitfield, M., Pollet-Villard, X., Levy, R., Drevet, J.R., and Saez, F. (2015) Posttesticular 
sperm maturation, infertility, and hypercholesterolemia. Asian J Androl 17, 742-748.  
 
WHO (2015) Obesity and Overweight, Fact Sheet no. 311, Body Mass Index 
Classifications. World Health Organization. 
 
Wong, W.Y., Merkus, H.M., Thomas, C.M., Menkveld, R., Zielhuis, G.A., and Steegers-
Theunissen, R.P. (2002) Effects of folic acid and zinc sulfate on male factor subfertility: 
a double-blind, randomized, placebo-controlled trial. Fertil Steril 77, 491-498.  
 
Zareba, P., Colaci, D.S., Afeiche, M., Gaskins, A.J., Jorgensen, N., Mendiola, J., Swan, S.H., 
and Chavarro, J.E. (2013) Semen quality in relation to antioxidant intake in a healthy 
male population. Fertil Steril 100, 1572-1579.  
 
Zhang, E., Xu, F., Liang, H., Yan, J., Xu, H., Li, Z., Wen, X., and Weng, J. (2015) GLP-1 
Receptor Agonist Exenatide Attenuates the Detrimental Effects of Obesity on 
Inflammatory Profile in Testis and Sperm Quality in Mice. Am J Reprod Immunol.  
 
Zini, A., San Gabriel, M., and Baazeem, A. (2009) Antioxidants and sperm DNA damage: 
a clinical perspective. J Assist Reprod Genet 26, 427-432.  
 
Zribi, N., Chakroun, N.F., Elleuch, H., Abdallah, F.B., Ben Hamida, A.S., Gargouri, J., 
Fakhfakh, F., and Keskes, L.A. (2011) Sperm DNA fragmentation and oxidation are 



















Chapter 5 (conventional format) 
 
The Relationship Between Sperm Oxidative Stress and ART Outcomes 
and the Effectiveness of Dietary Micronutrient Supplementation in 
Reducing Obesity-Induced Sperm Oxidative Stress (Pilot Study) 
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5.1. Chapter Link 
 
As shown in the previous chapters, dietary micronutrient supplement intake in a mouse 
model of male obesity improved sperm oxidative stress, sperm function and pregnancy 
outcome. Micronutrient supplement intake in obese male mice reduced sperm 
intracellular ROS and improved sperm morphology and fertilization rates in addition to 
improved fetal outcomes, which may be explained by the observed reduction in oxidative 
DNA lesions in both mature sperm and the paternal pronucleus of the subsequent embryo. 
Given these findings in a mouse model, a clinical prospective study was conducted to 
establish the relationship between oxidative DNA lesions in human sperm and fertility 
treatment outcomes including pregnancy rates. Further, given that the diet-induced obese 
mouse models from previous chapters showed reductions in sperm oxidative stress with 
micronutrient supplementation of a high fat diet, the impact of dietary micronutrient 
supplement intake on sperm intracellular ROS and oxidative DNA modifications were 






The prevalence of male obesity is increasing worldwide and happens to occur with a 
concurrent reduction in male fertility and fecundity. Men with an increased BMI have 
been characterized with increased sperm oxidative stress with further reports 
demonstrating that sperm oxidative stress is a main contributor to male infertility. Also, 
sperm oxidative stress and subsequent oxidative DNA damage in the male germ line is 
linked to perturbed offspring health. The effectiveness of micronutrient and antioxidant 
supplements to improve sperm oxidative stress in the growing population of obese men 
is unknown. This prospective study examined the impact of dietary micronutrient 
supplementation on sperm oxidative stress markers and assisted reproductive technology 
(ART) fertility treatment outcomes in 131 non-smoking couples with a normal weight, 
overweight or obese male partner and a non-obese female partner. The male and female 
partners were aged <45 and <38 years old, respectively. Couples were stratified by the 
male partner’s BMI and whether the male partner was consuming micronutrient 
supplements. Sperm oxidative stress markers in live sperm cells were measured using the 
2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) and the MitoSOX Red (MSR) 
probe. Further, oxidative DNA lesions were assessed by detecting presence of 8-hydroxy-
2’-deoxyguanosine (8-OHdG). Conventional sperm parameters were also examined 
including sperm motility, concentration and morphology in addition to fertility treatment 
outcomes including fertilization rates, embryo development, blastocyst quality, embryo 
utilization, pregnancy rates and live birth rates. The results demonstrated that there was 
a positive association between sperm intracellular ROS and sperm 8-OHdG lesions and 
a negative association between sperm 8-OHdG lesions and fertilization rates. Also, men 
with increased sperm 8-OHdG lesions had a reduced chance of achieving a pregnancy. 
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Also, this study showed that micronutrient supplementation in obese men reduced sperm 
intracellular reactive oxygen species (ROS) and sperm oxidative DNA 8-OHdG lesions 
compared to obese men not consuming micronutrient supplements. Overall, these 
findings illustrate the effectiveness of dietary micronutrient supplementation in reducing 
obesity-induced sperm oxidative stress and sperm 8-OHdG lesions. However, further 
research determining the dietary and lifestyle habits of these couples and which 
micronutrient(s) are responsible for the improvements in fertility treatment outcomes are 





Parallel to the global increase in the prevalence of male obesity is a decrease in male 
fertility and fecundity (Swan et al. 2000). One of the main proposed mechanisms 
responsible for the compromised reproductive health and subfertility in obese males is 
sperm oxidative stress (McPherson and Lane 2015). Oxidative stress is an imbalance 
between reactive oxygen species and antioxidants whereby the levels or reactive oxygen 
species exceed that of antioxidants (Henkel 2011). Reactive oxygen species (ROS) 
include superoxide anions (O2-), hydroxyl radicals (OH) and hydrogen peroxide (H2O2). 
Many studies have reported an increase in ROS activity in sperm in several types of male 
infertility (Aitken et al. 1991; D'Agata et al. 1990; de Lamirande et al. 1995; Iwasaki and 
Gagnon 1992; Kodama et al. 1997; Sharma and Agarwal 1996; Shen et al. 1999; Zini et 
al. 1993) however, only in more recent years have researchers shown an increase of ROS 
activity in sperm and semen from obese men (Tunc et al. 2011; Yang et al. 2016).  
 
In sperm, ROS react with cellular components including lipids, proteins and DNA 
resulting in lipid peroxidation and DNA damage (Aitken et al. 1989; Alvarez et al. 1987; 
Hughes et al. 1996). Most DNA damage in sperm is oxidatively induced by ROS 
resulting in DNA lesions, mainly 8-hydroxy-2’-deoxyguanosine (8-OHdG) (De Iuliis et 
al. 2009a; Noblanc et al. 2013), an oxidized guanine residue within sperm DNA (Noblanc 
et al. 2013). Epidemiological studies suggest that oxidative stress in the male germ line, 
including oxidative DNA lesions (8-OHdG), is a mediator for perturbed offspring health 
from various paternal environmental and lifestyle factors such as cigarette smoking and 
drug exposure (Fraga et al. 1996; Ji et al. 1997; Trasler 2009).  
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Healthy dietary patterns, characterized by elevated intake of vegetables, fruits and 
legumes; have been shown to improve sperm quality, particularly sperm motility and 
concentration, in men from couples undergoing assisted reproductive technology (ART) 
treatment (Oostingh et al. 2017) and in men from the general population (Cutillas-Tolin 
et al. 2015; Liu et al. 2015). Although dietary micronutrient supplements are no substitute 
for a healthy diet (Troppmann et al. 2002), couples opt for dietary supplements to ensure 
adequate nutritional intake (NHMRC 2006). In infertile men, studies investigating the 
effects of antioxidant and micronutrient intake have demonstrated improved sperm 
quality (Zini et al. 2009) and increased pregnancy rates (Gharagozloo and Aitken 2011). 
One example of a sub-cellular effect of dietary supplementation on sperm include a 
reduction in sperm 8-OHdG lesions, which has been demonstrated with vitamin C 
supplementation as when the dose of supplementation was reduced, sperm 8-OHdG 
modifications increased (Fraga et al. 1991).  
 
Overall, investigative studies of sperm quality and function suggest a protective role of 
micronutrients in sperm oxidative stress and DNA integrity (Zini et al. 2009). However, 
the effectiveness of dietary micronutrient supplements, such as vitamin E, zinc, vitamin 
C, folic acid or lycopene, in improving sperm quality, sperm function and reproductive 
outcomes in the growing population of obese men remains unknown. Therefore, this 
prospective study examined the relationships between sperm intracellular ROS, sperm 8-
OHDG lesions, fertilization rates and pregnancy outcomes. Further investigations 
assessed the impact of micronutrient supplementation on sperm intracellular ROS and 
sperm oxidative DNA lesions in normal weight, overweight and obese men in addition 
to the effects of supplements on ART treatment outcomes stratified by the male partner’s 
BMI. The results demonstrate that micronutrient supplementation is most effective in 
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obese men for the reduction of sperm intracellular ROS and 8-OHdG lesions. Although 
the effect of supplements on pregnancy rates stratified by the male partner’s BMI could 
not be concluded as the data was statistically underpowered, there was a negative 
association between oxidative DNA lesions and achieving a pregnancy when analyzing 
couples as a whole population (i.e. not stratified by male BMI). 
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5.4. Materials and methods 
 
Please refer to Chapter 2, section 2.2 for the materials and methods. 
 
The experimental design is detailed in Figures 5.1 and 5.2. The distribution of participants 
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Figure 5.1 A flow chart outlining the experimental plan. After patient consent, all sperm assessments were conducted blinded and a semen 
analysis was performed using the (neat) pre-prepared sperm sample. Sperm intracellular ROS markers and 8-OHdG immunofluorescence 
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Figure 5.2 A flow chart outlining the experimental plan after sperm assessments were conducted. After patient ID numbers were un-blinded, 
the clinical database was used to identify patient characteristics including the male partner’s BMI and whether they were positive for 
multivitamin/ Menevit (micronutrient) supplement intake. Patient fertility treatment cycle outcomes were also obtained from their records 
including fertilization, embryo development and pregnancy outcomes. 
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Figure 5.3 The distribution of patients based on the male partner’s BMI and micronutrient supplementation stratification. The number of 
patients are outlined for each step of their fertility treatment cycle outcomes including >0 eggs collected at oocyte retrieval, >0 eggs fertilized, 
day 4 and day 5 embryo morphology assessments. Some embryos were day 4 on a Sunday and were not morphologically assessed. Day 5 
embryos that were assessed on day 4 and had embryos that were frozen or transferred on day 4 were not included in day 5 analysis. 
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Figure 5.4 The distribution of patients and pregnancy outcomes based on the male partner’s BMI and micronutrient supplementation 
stratification. Some couples did not undergo a fresh embryo transfer due to ovarian hyperstimulation syndrome (OHSS) or pre-implantation 
genetic screening for aneuploidy (PGT-A) without a fresh embryo transfer.
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5.5. Results  
 
5.5.1. Patient population characteristics 
The total number of couples included in the final analysis was 131 couples stratified by 
male BMI (i) normal weight men (n=43), (ii) overweight men (n=53), (iii) obese men 
(n=35), and each BMI category was divided by whether they consumed dietary 
supplementation intake in a 3 x 2 experimental design (Figure 5.3). Also, the distributions 
of participants at different levels of data analysis are illustrated in Figures 5.3 and 5.4.  
 
Patient population characteristics were not different between groups including paternal 
age, maternal BMI, maternal age, the number of previous ART treatment cycles the 
couple had undergone, and the female partner’s AMH and baseline FSH levels (Table 
5.1). Patient cycle characteristics were also investigated and there was no difference in 
the double embryo transfer rate, the number of patients that underwent preimplantation 
genetic screening for aneuploidy (PGT-A), men with a medical condition taking regular 
medication and the couple’s infertility diagnosis including unexplained conditions, 
polycystic ovary syndrome (PCOS), endometriosis, tubal issues, semen defect, 
anovulation/oligomenorrhea, diminished ovarian reserve and other conditions such as 
genetic and immunological conditions (Table 5.2). 
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Table 5.1 Patient population characteristics. 
 Normal weight Overweight Obese 












Number of patients 29 14 30 23 22 13 
Paternal BMI 23.4 ± 0.3 a 23.5 ± 0.3 a 26.9 ± 0.2 b 27.6 ± 0.3 b 34.1 ± 0.7 c 34.0 ± 0.9 c 
Paternal age 32.8 ± 0.6 35.6 ± 0.8 33.5 ± 0.9 34.3 ± 0.9 35.1 ± 0.9 33.2 ± 1.1 
Maternal BMI 24.6 ± 0.7 24.7 ± 1.3 24.6 ± 0.5 24.6 ± 0.9 25.6 ± 0.8 28.1 ± 1.4 
Maternal age 31.4 ± 0.6 33.6 ± 0.8 32.0 ± 0.7 31.8 ± 0.7 32.2 ± 0.7 31.7 ± 1.0 
Number of previous cycles 0.5 ± 0.1 1.1 ± 0.6 0.8 ± 0.2 0.5 ± 0.2 0.3 ± 0.1 0.6 ± 0.3 
AMH (pmol/L) 31.4 ± 5.6 26.4 ± 4.9 27.3 ± 3.8 29.3 ± 4.8 29.8 ± 3.7 30.2 ± 6.2 
Baseline FSH (mIU/mL) 6.9 ± 0.5 6.7 ± 0.5 6.9 ± 0.6 7.6 ± 0.6 7.9 ± 0.9 7.1 ± 0.6 
Data are expressed as mean ± SEM and analyzed by a 3x2 general linear model. Different letters denote significance at P<0.05 and an absence 




Table 5.2 Patient population and ART cycle characteristics. 













Double embryo transfer 1 (3.4%) 1 (7.1%) 0 1 (4.3%) 1 (4.5%) 0 
Preimplantation genetic screening (PGT-A)1 5 (17.2%) 3 (21.4%) 2 (6.7%) 2 (8.7%) 7 (31.8%) 3 (23.1%) 
Male medical condition/medication 3 (10.3%) 1 (7.1%) 4 (13.3%) 1 (4.3%) 2 (9.1%) 0 
Infertility factor - Female 19 (65.5%) 11 (78.6%) 21 (70%) 11 (47.8%) 14 (63.6%) 9 (69.2%) 
Infertility factor - Male 5 (17.2%) 1 (7.1%) 5 (16.7%) 7 (30.4%) 5 (22.7%) 2 (15.4%) 
Infertility factor- Female & Male 5 (17.2%) 2 (14.3%) 4 (13.3%) 5 (21.7%) 3 (13.6%) 2 (15.4%) 
Infertility diagnosis       
Unexplained  8 (27.6%) 3 (21.4%) 8 (26.7%) 7 (30.4%) 5 (22.7%) 4 (30.8%) 
Polycystic ovary syndrome (PCOS) 4 (13.8%) 1 (7.1%) 2 (6.7%) 2 (8.7%) 1 (4.5%) 3 (23.1%) 
Endometriosis 3 (10.3%) 2 (14.3%) 3 (10.0%) 1 (4.3%) 2 (9.1%) 0 
Tubal  1 (3.4%) 0  3 (10%) 0 3 (13.6%) 0 
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Semen defect  9 (31%) 3 (21.4%) 7 (23.3%) 11 (47.8%) 8 (36.4%) 4 (30.8%) 
Anovulation/oligomenorrhea 3 (10.3%) 2 (14.3%) 5 (16.7%) 2 (8.7%) 0 1 (7.7%) 
Diminished ovarian reserve 3 (10.3%) 3 (21.4%) 3 (10%) 3 (13%) 2 (9.1%) 2 (15.4%) 
Other (e.g. genetic, immunological, 
premature ovarian dysfunction, recurrent 
miscarriage, other) 
3 (10.3%) 2 (14.3%) 2 (6.7%) 2 (8.7%) 3 (13.6%) 1 (7.7%) 
1 Preimplantation genetic screening for aneuploidy (PGT-A) patients did not undergo an embryo transfer. 




5.5.2. Relationship between sperm oxidative DNA lesions and sperm intracellular 
ROS  
Sperm intracellular ROS fluorescence, measured by both H2DCFDA and MSR probes, 
and sperm 8-OHdG fluorescence from the washed sperm sample that was used for the 
couple’s ART procedure, were quantified. There was a positive association between 
sperm 8-OHdG fluorescence and H2DCFDA fluorescence, reflecting mainly sperm 
intracellular hydroxyl radicals and peroxynitrite (r=0.09, Figure 5.5). Also, there was a 
positive association between sperm 8-OHdG fluorescence and MSR fluorescence, 
representing primarily intracellular mitochondrial superoxide (r=0.15, Figure 5.5). 
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(a)  (b)  
Figure 5.5 The association between sperm 8-OHdG fluorescence and intracellular ROS. Sperm intracellular ROS was measured by (a) H2DCFDA 




5.5.3. Relationship between sperm oxidative DNA lesions and fertilization rates  
Given that 8-OHdG DNA lesions are a byproduct of sperm intracellular ROS and the 
positive association observed above between sperm 8-OHdG fluorescence and sperm 
intracellular ROS fluorescence (results section 5.5.2), the relationship between sperm 8-
OHdG DNA lesions and fertilization rates was assessed. There was a negative association 




Figure 5.6 The association between sperm 8-OHdG fluorescence and fertilization rates. 
Data analyzed by a Spearman correlation (r=-0.17, p<0.05). 
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5.5.4. Relationship between oxidative DNA lesions and pregnancy outcome 
There was a negative relationship between sperm 8-OHdG fluorescence and achieving a 
biochemical pregnancy (positive serum b-hCG test), implantation (presence of a fetal sac 
on ultrasound examination) and an ongoing pregnancy (presence of a fetal heart on 
ultrasound examination) (Figure 5.7).  
Given the negative relationship between sperm oxidative DNA lesions and achieving a 
pregnancy, sperm 8-OHdG fluorescence values were quartiled to assess the odds ratio for 
achieving a pregnancy. The odds of achieving a biochemical pregnancy, implantation 
(sac) and an ongoing (heartbeat) pregnancy were reduced as sperm 8-OHdG fluorescence 
increased (Table 5.3). Men with sperm from 8-OHdG Q3 and Q4 had reduced odds of 
achieving a biochemical pregnancy by 39% and 19% respectively, less than men with 
sperm from 8-OHdG Q1 (Table 5.3). Men with sperm from 8-OHdG Q2, Q3 and Q4 had 
reduced odds of achieving implantation by 16%, 49% and 35% respectively, less than 
men with sperm from 8-OHdG Q1 (Table 5.3). Also, men with sperm from 8-OHdG Q2, 
Q3 and Q4 had reduced odds of achieving an ongoing pregnancy by 29%, 22% and 38% 
respectively, less than men with sperm from 8-OHdG Q1 (Table 5.3). 
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(a)  (b)  (c)  
Figure 5.7 The association between sperm 8-OHdG fluorescence and pregnancy outcomes including (a) biochemical pregnancy (b) implantation 




Table 5.3 The odds of achieving a positive biochemical pregnancy, implantation and an 
ongoing pregnancy with increasing sperm 8-hydroxyguanosine (8-OHdG) fluorescence. 
All 8-OHdG fluorescence quartiles were compared to 8-OHdG quartile 1 (Q1); i.e. the 
lowest fluorescent values. 
 Odds ratio 95% Confidence Interval P value 
  Lower  Upper  
Biochemical Pregnancy    
8-OHdG Q2 0.895 0.725 1.097 0.214 
8-OHdG Q3 0.608 0.358 0.902 0.000 
8-OHdG Q4 0.814 0.625 1.037 0.013 
Implantation (sac)    
8-OHdG Q2 0.844 0.661 1.059 0.037 
8-OHdG Q3 0.508 0.207 0.865 0.000 
8-OHdG Q4 0.646 0.413 0.921 0.000 
Ongoing Pregnancy (heartbeat)    
8-OHdG Q2 0.708 0.495 0.959 0.000 
8-OHdG Q3 0.783 0.533 1.096 0.000 
8-OHdG Q4 0.622 0.375 0.914 0.000 




5.5.5. Effect of BMI and micronutrient supplementation on conventional sperm 
parameters  
Semen volume was recorded and sperm motility, sperm concentration and sperm 
morphology were assessed before the sample was prepared for the couple’s 
intracytoplasmic sperm injection (ICSI) or standard insemination procedure. Sperm 
motility and concentration were not different between BMI groups and were not affected 
by micronutrient supplementation (Table 5.4). The percentage of sperm with normal 
morphology however was increased with micronutrient supplementation in obese men 
compared to obese men not taking supplements (Table 5.4). Sperm morphology was  not 




Table 5.4 The effects of male BMI and dietary micronutrient supplementation on semen analysis measures including semen volume, sperm 
motility, sperm concentration and sperm morphology assessed before the sample was prepared for the couple’s ICSI or standard insemination 
procedure; i.e. the neat sperm sample. 
 Normal weight Overweight Obese 












Number of patients 29 14 30 23 22 13 
Semen volume (ml) 3.5 ± 0.3  3.5 ± 0.4  3.7 ± 0.3  3.0 ± 0.3 2.8 ± 0.3 3.4 ± 0.4  
Motility (%) 50.2 ± 3.4  50.0 ± 4.9  49.9 ± 3.4  39.8 ± 3.8  45.2 ± 4.0  54.0 ± 5.2  
Concentration (106/ml) 72.2 ± 10.4  77.8 ± 15.0  75.4 ± 10.5  57.6 ± 12.0  54.5 ± 12.3  52.8 ± 15.3  
Morphology (%) 5.0 ± 0.4 ab 6.1 ± 0.6 b 4.6 ± 0.5 a 4.2 ± 0.5 a 4.5 ± 0.5 a 6.4 ± 0.7 b 
Data are expressed as mean ± SEM and analyzed by a 3x2 general linear model. Different letters denote significance at P<0.05 and an absence of 
superscript letters denotes no statistical difference.
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5.5.6. Effect of BMI and micronutrient supplementation on sperm oxidative stress 
Sperm oxidative stress measures including intracellular ROS and oxidative DNA lesions 
were assessed using the prepared sperm sample used for standard insemination or ICSI. 
Sperm oxidative stress measures were assessed from the prepared sperm sample as it was 
the sample used to inseminate or inject the couple’s oocytes and limited the influence of 
seminal variables which may affect sperm intracellularly. 
 
5.5.6.1 Sperm total intracellular reactive oxygen species 
Quantified H2DCFDA fluorescence reflecting total intracellular ROS was increased in 
sperm from obese men compared to normal and overweight men (Table 5.5). Total sperm 
intracellular ROS was reduced with micronutrient supplementation in sperm from obese 
men to a level similar to that from normal and overweight men (Table 5.5). Micronutrient 
supplementation did not have an effect on sperm intracellular ROS from normal and 
overweight men (Table 5.5). 
 
5.5.6.2 Sperm mitochondrial reactive oxygen species   
Quantified MSR fluorescence in sperm increased as BMI increased with significantly 
higher levels in overweight compared to normal weight men and a further increase in 
obese men compared to overweight men (Table 5.6). MSR fluorescence was reduced 
with micronutrient supplementation in sperm from overweight and obese men compared 
to overweight and obese men not taking supplements (Table 5.6). There was no effect of 





5.5.6.3 Sperm DNA 8-hydroxyguanosine (8-OHdG) 
Quantified DNA 8-OHdG fluorescence in sperm increased as BMI increased with 
elevated levels in sperm from overweight men compared to normal weight men and a 
further increase in obese men compared to overweight and normal weight men (Table 
5.7). Sperm 8-OHdG fluorescence was reduced with micronutrient supplementation in 




Table 5.5 The effects of male BMI and dietary micronutrient supplementation on sperm intracellular total reactive oxygen species (ROS) 
fluorescence using the 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) probe assessed using the prepared sperm sample used for 
standard insemination or ICSI; i.e. the washed sperm sample. 
 Normal weight Overweight Obese 












Number of patients 29 14 30 23 22 13 
H2DCFDA fluorescence (fluorescent units) 5.8 ± 0.4a 7.5 ± 0.6a 7.1 ± 0.4a 6.6 ± 0.6a 23.2 ± 0.8b 5.8 ± 0.6a 
Data are expressed as mean ± SEM. Data are analyzed by a mixed effects (3x2) model adjusting for clustering in each male (100 sperm per 
male). Different letters denote significance at P<0.05. 
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Table 5.6 The effects of male BMI and dietary micronutrient supplementation on sperm intracellular reactive oxygen species (ROS) 
fluorescence using the MitoSOX Red (MSR) probe assessed using the prepared sperm sample used for standard insemination or ICSI; i.e. 
the washed sperm sample. 
 Normal weight Overweight Obese 












Number of patients 29 14 30 23 22 13 
MSR fluorescence (fluorescent units) 1.2 ± 0.1a 1.1 ± 0.1a 1.7 ± 0.1b 1.2 ± 0.1a 4.6 ± 0.2c 1.9 ± 0.2b 
Data are expressed as mean ± SEM. Data are analyzed by a mixed effects (3x2) model adjusting for clustering in each male (100 sperm per 
male). Different letters denote significance at P<0.05. 
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Table 5.7 The effects of male BMI and dietary micronutrient supplementation on sperm DNA 8-hydroxyguanosine (8-OHdG) fluorescence 
using the prepared sperm sample used for standard insemination or ICSI; i.e. the washed sperm sample. 
Data are expressed as mean ± SEM. Data are analyzed by a mixed effects (3x2) model adjusting for clustering in each male (100 sperm per 
male). Different letters denote significantly distinct groups at P<0.05. 
 
 Normal weight Overweight Obese 












Number of patients 29 14 30 23 22 13 
8-OHdG fluorescence (fluorescent units) 10.6 ± 0.3a 6.7 ± 0.4b 16.0 ± 0.3c 9.8 ± 0.3a 19.4 ± 0.3d 7.3 ± 0.4b 
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5.5.7. Fertilization rates 
Although both ICSI and standard insemination fertilization rates were not different 
between BMI groups and were not affected by micronutrient supplementation, the 
percentage of embryos with failed fertilization was reduced with supplementation in 
normal weight men compared to normal weight men not taking supplements (Table 5.8). 
There was no effect of BMI or micronutrient supplementation on fertilization rates when 
ICSI and standard insemination fertilization rates were analyzed separately (Table 5.8).  
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Table 5.8 The effects of male BMI and dietary micronutrient supplementation on fertilization rates (per patient) for intracytoplasmic sperm 
injection (ICSI), standard insemination (IVF) and both ICSI and IVF ART procedures. 
 Normal weight Overweight Obese 












ICSI fertilization rates 
Number of patients  24 14 27 23 21 11 
Mean number of oocytes  8.0 ± 1.1 7.3 ± 2.1 6.6 ± 0.8 7.3 ± 0.8 8.1 ± 1.3 8.6 ± 1.4 
Fertilization rate1 (%) 70.5 84.4 63.2 62.7 69.2 69.6 
Oocytes that failed to fertilize2 (%) 21.9 10.2 14.6 22.5 17.1 15.9 
Abnormal fertilization3 (%) 3.1 3.8 8.8 9.1 9.7 6.6 
Non-viable4 (%) 5.6 5.3 11.9 7.2 5.3 7.9 
IVF fertilization rates 
Number of patients 6 1 11 3 4 2 
Mean number of oocytes 8.5 ± 2.2 - 5.6 ± 0.8 8.0 ± 1.0 6.5 ± 1.2 9.5 ± 0.5 
Fertilization rate1 (%) 61.3 0.0 72.0 61.0 70.0 47.0 
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Oocytes that failed to fertilize2 (%) 25.8 100.0 18.3 16.0 22.3 45.1 
Abnormal fertilization3 (%) 10.1 0.0 9.3 12.3 0 7.9 
Non-viable4 (%) 0.8 0.0 4.2 8.3 6.7 0 
ICSI and IVF fertilization rates       
Number of patients 28 14 30 23 22 13 
Mean number of oocytes 8.0 ± 1.1 8.4 ± 2.4 7.9 ± 0.9 8.3 ± 0.9 8.9 ± 1.2 10.3 ± 1.7 
Fertilization rate1 (%) 66.9 80.8 65.8 61.3 68.5 66.2 
Oocytes that failed to fertilize2 (%) 23.8 a 10.2 b 15.7 ab 22.5 ab 17.3 ab 20.4 ab 
Abnormal fertilization3 (%) 4.7 3.8 8.0 9.1 9.2 6.8 
Non-viable4 (%) 4.8 5.3 10.7 7.2 5.0 6.7 
1 The presence of two pronuclei (2PN) and two polar bodies (2PB). 
2 Oocytes that lacked the presence of pronuclei (2PN) and two polar bodies (2PB). 
3 Abnormal fertilization rate reflecting parthenogenetic oocytes or the presence of three or more pronuclei. 
4 Non-viable rate reflecting the proportion of lysed eggs/embryos. 
Data are expressed as mean ± SEM and as proportion of patients (%), and analyzed by a binary logistic regression. Different letters denote 
significance at P<0.05 and an absence of superscript letters denotes no statistical difference.  
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5.5.8. Embryo development, blastocyst quality and embryo utilization 
On days 4 and 5 of culture, embryo morphology was morphologically assessed, as these 
time points are post-embryonic genome activation and therefore can be influenced by the 
quality of the male (paternal) genome. Day 4 embryo morphology was not affected by 
BMI however the proportion of grade 2A embryos (partially compacted morulae or early 
blastocysts) was increased and the proportion of grade 3 embryos (embryos with ³8 cells 
and no compaction) was reduced with micronutrient supplementation in normal weight 
men (Table 5.9). On day 5 of embryo culture, blastocyst development (Table 5.10) was 
assessed in addition to blastocyst inner cell mass (ICM) and trophectoderm (TE) quality 
(Table 5.11), however conclusive results were not attained due to underpowered 
statistical analysis. The statistical analyses on day 5 were underpowered due to reduced 
n values as many embryos were frozen or transferred (utilized) on day 4 of embryo 
culture. The percentage of transferred and/or frozen embryos was assessed to measure 
embryo utilization and was not different between BMI groups and not affected by 
micronutrient supplementation (Table 5.12). 
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Table 5.9 The effects of male BMI and dietary micronutrient supplementation on day 4 embryo morphology. 
 Normal weight Overweight Obese 












Number of patients 22 7 20 12 15 8 
Mean number of embryos 5.1 ± 0.8 4.4 ± 1.9 6.8 ± 0.9 6.5 ± 1.0 6.2 ± 0.9 9.0 ± 1.4 
Grade 11 (%) 18.8 19.4 17.0 15.4 23.7 27.8 
Grade 2A2 (%) 12.5 a 38.7 b 23.7 ab 12.8 ab 29.0 b 23.6 ab 
Grade 2B3 (%) 19.6  22.6  18.5  34.6  11.8  11.1 
Grade 34 (%) 31.3 a 9.7 b 29.6 a 26.9 a 14.0 b 23.6 ab 
Grade 45 (%) 17.9 9.7 11.1 10.3 21.5 13.9 
1 Early blastocysts or compacted morulae 
2 Partially compacted morulae (>70% compaction) with no anomalies or early blastocysts and compacted morulae with minimal anomalies 
3 Partially compacted morulae (<70% compaction) with no or minimal anomalies 
4 Embryos with ³8 cells and no compaction with no or minimal anomalies or early blastocysts and compacted morulae with above minimal 
anomalies 
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5 Embryos with <8 cells or embryos with ³8 cells, no compaction and above minimal anomalies 
Data are expressed as mean ± SEM and as a proportion of fertilized embryos (%) and analyzed by a binary logistic regression weighted to 
the total number of fertilized embryos per couple. Different letters denote significantly distinct groups at P<0.05 and an absence of superscript 




Table 5.10 The effects of male BMI and dietary micronutrient supplementation on day 5 embryo morphology.  
 Normal weight Overweight Obese 












Number of patients 6 7 9 10 6 5 
Mean number of embryos 7.2 ± 1.7 8.0 ± 3.6 3.6 ± 0.8 4.5 ± 0.9 7.8 ± 2.1 2.6 ± 0.7 
<16 cells (%) 16.3 17.9 15.6 20.2 14.8 15.3 
Morula (%) 13.8 12.3 15.6 11.2 16.5 13.7 
Early blastocyst (%) 34.9 27.1 21.9 25.8 22.8 30.1 
Full blastocyst (%) 14.0 14.1 25.1 23.2 24.8 17.7 
Expanded blastocyst (%) 21.0 28.6 22.0 20.0 21.3 23.0 
Data are expressed as a mean ± SEM and as a proportion of fertilized embryos (%) and analyzed by a binary logistic regression weighted to 
the total number of fertilized embryos per couple.  
Note: the analysis in the table above is not statistically powered. 
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Table 5.11 The effects of male BMI and dietary micronutrient supplementation on blastocyst inner cell mass and trophectoderm morphology. 
 Normal weight Overweight Obese 












Number of patients  4 3 8 8 4 3 
Mean number of blastocysts 2.5 ± 0.4 4.6 ± 1.6 1.4 ± 0.3 1.6 ± 0.3 2.4 ± 0.3 1.1 ± 0.2 
Inner cell mass       
Grade A1 (%) 35.4 63.5 75.0 29.2 54.2 50.0 
Grade B2 (%) 45.8 25.7 25.0 70.8 39.6 50.0 
Grade C3 (%) 18.8 10.8 0.0 0.0 6.3 0.0 
Trophectoderm       
Grade A4 (%) 47.9 55.0 43.8 41.7 50.0 33.4 
Grade B5 (%) 45.8 27.9 56.3 41.7 40.6 66.7 
Grade C6 (%) 6.3 17.1 0.0 16.7 9.4 0.0 
 
1 Many tightly packed cells 
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2 Several (loose) cells 
3 Very few cells 
4 Many cells forming a cohesive layer 
5 Few cells forming a loose epithelium 
6 Very few cells 
Data are expressed as a mean ± SEM and as a proportion of blastocyst-staged embryos (%) and analyzed by a binary logistic regression 
weighted to the total number of blastocyst-staged embryos per couple. Different letters denote significantly distinct groups at P<0.05 and an 
absence of superscript letters denotes no statistical difference. 




Table 5.12 The effects of male BMI and dietary micronutrient supplementation on embryo utilization. 
 Normal weight Overweight Obese 












Number of patients 28 13 29 22 21 13 
Mean number of embryos 5.5 ± 0.7 6.2 ± 2.1 5.6 ± 0.7 5.4 ± 0.7 6.4 ± 0.9 6.5 ± 1.2 
Transferred and/or frozen 
embryos (%) 
57.4 72.9 66.6 54.4 65.8 61.1 
Data are expressed as mean ± SEM and as a proportion of fertilized embryos (%) and analyzed by a binary logistic regression weighted to the total 
number of fertilized embryos per couple. No statistical differences were detected. 
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5.5.9. Pregnancy outcome 
Biochemical pregnancy rates (positive serum b-hCG test), implantation rates (presence 
of a fetal sac on ultrasound examination), ongoing pregnancy rates (presence of a fetal 
heart on ultrasound examination) and live birth rates were not different BMI groups and 
were not affected by micronutrient supplementation (Table 5.13). However, it must be 
acknowledged that the pregnancy outcomes analysis was statistically underpowered.
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Table 5.13 The effects of male BMI and dietary micronutrient supplementation on pregnancy outcomes. 
 Normal weight Overweight Obese 












Per embryo transfer       
Number of patients 18 9 24 19 14 10 
Biochemical pregnancy (%)  66.7 55.6 62.5 42.1 57.1 60.0 
Implantation (%)  61.1 55.6 58.4 31.6 50.0 60.0 
Ongoing pregnancy (%) 55.6 44.4 58.4 26.3 35.7 50.0 
Live birth (%) 50.0 33.4 54.2 21.1 28.6 40.0 
Per oocyte pick-up       
Number of patients 28 14 29 22 21 13 
Biochemical pregnancy (%)  42.9 35.7 51.7 36.4 38.1 46.2 
Implantation (%)  39.3 35.7 48.3 27.3 33.3 46.2 
Ongoing pregnancy (%) 35.7 28.6 48.3 22.7 23.8 38.5 
Live birth (%) 32.1 21.4 44.8 18.2 19.0 30.8 
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Data are expressed as a proportion of embryo transfers and oocyte pick-ups (%) and analyzed by a binary logistic regression. No statistical 
differences were detected. 




This study demonstrated that there is a negative association between sperm intracellular 
ROS and sperm oxidative DNA lesions in addition to negative associations between 
sperm oxidative DNA modifications and fertilization and pregnancy rates. Dietary 
micronutrient supplementation reduced sperm oxidative stress in these men primarily 
observed by reduced oxidative DNA lesions in normal weight, overweight and obese 
men. Also, dietary micronutrient supplementation was most effective in sperm oxidative 
stress in obese men whereby sperm intracellular ROS and oxidative DNA modifications 
were reduced with supplement intake compared to obese men not consuming 
supplements. These findings suggest that micronutrient supplementation is effective in 
the amelioration of sperm oxidative stress-induced subfertility. 
 
The oxidative DNA adduct, 8-OHdG, is formed as a result from ROS attack and 
therefore,  the sperm intracellular ROS data in addition to the 8-OHdG fluorescence data 
was combined regardless of male BMI and micronutrient supplementation to identify the 
association between sperm intracellular ROS and 8-OHdG lesions. This correlation 
analysis found that both H2DCFDA and MSR fluorescence had a positive association 
with 8-OHdG fluorescence. Previous studies have suggested that hydroxyl radicals are 
the main type of ROS contributing to the formation of 8-OHdG DNA adducts (Kasai et 
al. 1986; Takeuchi et al. 1997; Valavanidis et al. 2009). Specifically, the hydroxyl radical 
is most likely formed from mitochondrial-generated superoxide and the subsequent 
Fenton reaction resulting from normal respiration (Takeuchi et al. 1997) and 8-OHdG is 
induced by the hydroxyl radical at the C-8 position of deoxyguanosine in DNA (Kasai et 
al. 1986). Based on previous work in different cell types, it is plausible to suggest that 
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the extremely reactive hydroxyl radical most likely comes in reactive proximity to the 
nucleus from the midpiece, where the mitochondria are mainly located in the sperm cell, 
resulting in 8-OHdG formation (Bowen 2011). 
 
Given the observed positive associations between sperm intracellular ROS and oxidative 
DNA lesions (8-OHdG) and that 8-OHdG adducts are a byproduct of ROS attack on 
sperm, the association between sperm 8-OHdG lesions and sperm function measures such 
as fertilization rates was assessed. When correlating sperm 8-OHdG lesion fluorescence 
with fertilization rates from all couples regardless of the male partner’s BMI and 
supplementation status, there was a negative association between sperm 8-OHdG 
fluorescence and fertilization rates. Although previous studies, including a meta-analysis, 
have shown a negative correlation between sperm oxidative stress and successful 
fertilization following IVF/ICSI treatment (Agarwal et al. 2005), these studies measured 
ROS in semen as opposed to this study that investigated 8-OHdG lesions in sperm.  
 
Interestingly, the non-stratified data (regardless of male BMI and micronutrient 
supplement intake) indicates that sperm oxidative DNA modifications had an inverse 
relationship with pregnancy and implantation rates. As sperm 8-OHdG fluorescence 
increased, the likelihood of achieving a biochemical pregnancy, implantation and an 
ongoing pregnancy was reduced, which is consistent with previous reports of a reduced 
odds ratio of achieving a biochemical pregnancy with increased sperm oxidative DNA 
lesions (Loft et al. 2003). The negative association between sperm oxidative stress and 
pregnancy outcome implicates compromised DNA integrity as a potential contributor of 
pregnancy loss (Carrell et al. 2003). This may be due to oxidative DNA lesions/mutations 
and molecular alterations in the male germ line such as altered gene expression and 
 293 
epigenetic DNA methylation which may persist into the preimplantation embryo (Cirio 
et al. 2008; Trasler 2009). Also, the reduced odds ratio of achieving a positive pregnancy 
with increased sperm oxidative DNA damage may serve as a potential predictor for 
pregnancy outcomes in patients undergoing ART treatment. 
 
After assessing the relationships between sperm 8-OHdG lesions and fertility treatment 
outcomes including fertilization and pregnancy rates, the impact of micronutrient 
supplementation on ART outcomes were evaluated in these couples. Micronutrient 
supplementation did not have an effect on sperm motility or concentration however, there 
was an increase in normal sperm morphology with micronutrient supplement intake 
within the obese men category. Previous studies have shown no effect of supplement 
intake (zinc, vitamin E, vitamin C, selenium or carnitines) on sperm morphology, 
however these studies have been conducted in men diagnosed with either 
athenozoospermia (Omu et al. 2008), male factor infertility (Keskes-Ammar et al. 2003; 
Kodama et al. 1997; Vicari and Calogero 2001; Vicari et al. 2002), or high percentage of 
sperm DNA fragmentation (Greco et al. 2005a; Greco et al. 2005b). Further, most of 
these studies used different combinations of between 1 and 3 micronutrients including 
zinc (Omu et al. 2008), vitamins C and E (Greco et al. 2005a; Greco et al. 2005b; Kodama 
et al. 1997; Omu et al. 2008), vitamin E and selenium (Keskes-Ammar et al. 2003), and 
L-carnitine and acetyl-L-carnitine (Vicari and Calogero 2001) except for one study that 
used a combination of micronutrient supplements with a total of 60 men (Tremellen et 
al. 2007) as opposed to the 131 men recruited in this study. Therefore, the reasons 
contributing to this discrepancy in improved sperm morphology with micronutrient 
supplementation include patient cohort characteristics, different combinations of 
micronutrient supplements or a single micronutrient and different sample sizes. 
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In addition to conventional sperm parameters, this study examined intracellular ROS in 
live sperm from normal weight, overweight and obese men from the sperm sample used 
for the couple’s IVF/ICSI procedure as this limits the influence of variables from the 
seminal fluid that may affect sperm intracellularly. Sperm intracellular ROS was 
measured using two different probes reflecting mainly peroxynitrite and hydroxyl 
radicals concentrations (H2DCFDA) in addition to mitochondrial ROS primarily 
superoxide (MSR) concentrations (Purdey et al. 2015). Both probes showed increased 
sperm intracellular ROS in obese men compared to both overweight and normal weight 
men. These results illustrate that ROS production does not only occur in the seminal fluid 
from obese men (Tunc et al. 2011; Yang et al. 2016) but also develops in sperm 
intracellularly. This increase in oxidative stress in both sperm and seminal fluid may be 
due to the presence of leukocytes (Aitken et al. 1994; Aitken et al. 1995) and/or defective 
and immature sperm (Gomez et al. 1996; Sakkas et al. 2003). Obesity has been defined 
as a chronic state of inflammation (Johnson et al. 2012) and this immune activation may 
extend to the male reproductive tract increasing leukocyte activity, mainly neutrophils 
and macrophages, and seminal oxidative stress (Tunc et al. 2011). It is postulated that 
sperm intracellular ROS are generated by defective and immature sperm characterized 
with (i) large cytoplasmic residues containing NADPH (Aziz et al. 2004) and/or (ii) 
increased mitochondrial metabolism (Koppers et al. 2008). Interestingly, this study 
showed that micronutrient supplement intake in obese men reduces sperm intracellular 
ROS ultimately alleviating sperm oxidative stress. In semen from infertile men, there are 
lower levels of antioxidants and micronutrients compared to fertile men (Alkan et al. 
1997; Garrido et al. 2004; Lewis et al. 1995) suggesting that dietary micronutrient 
supplementation may lessen obesity-induced sperm oxidative stress by balancing the 
levels anti-oxidative micronutrients and reducing ROS generation. 
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An additional oxidative stress marker, oxidative DNA lesions (8-OHdG), was also 
assessed from the sperm sample used for the couple’s IVF/ICSI procedure. 8-OHdG, the 
most common oxidized base modification (De Iuliis et al. 2009b), is an oxidized guanine 
base adduct within sperm DNA resulting from ROS attack including hydroxyl radicals 
and superoxide (Noblanc et al. 2013) and is associated with subfertility and reduced 
pregnancy rates (Thomson et al. 2011), which is consistent with the findings in this study. 
When 8-OHdG fluorescence was quantified, a positive relationship was identified 
between BMI and sperm 8-OHdG lesions whereby 8-OHdG fluorescence increased as 
BMI increased. Interestingly, micronutrient supplementation showed to be an effective 
treatment option in all men despite BMI as sperm 8-OHdG fluorescence was reduced in 
normal weight, overweight and obese men. This reduction in sperm 8-OHdG lesions with 
micronutrient supplementation in men from all BMI categories may be due to factors 
beyond BMI whereby individuals from the normal weight and overweight BMI 
categories have sperm with oxidative DNA damage possibly due to low micronutrient 
and antioxidant food intake, perturbed metabolic profiles (Amiri et al. 2011), infection 
(Aitken and Roman 2008) or exposure to environmental pollutants (Xu et al. 2003). 
 Dietary vitamin C supplementation has been shown to reduce 8-OHdG lesions in sperm 
from smokers (Fraga et al. 1991). Further, a combination of vitamin C, vitamin E and 
glutathione supplement intake has also shown to reduce 8-OHdG adducts in sperm from 
infertile men (Kodama et al. 1997) suggesting that these micronutrients may contribute 
to the reduction in sperm oxidative DNA damage. Overall, this is the first demonstration 
of that sperm 8-OHdG modifications is increased with an increased BMI and that dietary 
micronutrient supplementation can reduce these lesions.  
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Sperm fertilization capacity and fertilization rates were not affected by BMI or 
micronutrient supplement intake however a difference may be detected in a larger cohort 
of participants. On day 4 of embryo development, the proportion of partially compacted 
morulae or early blastocysts was increased with micronutrient supplementation in normal 
weight men. There are some studies that report no effect of micronutrient supplement 
therapy in men undergoing fertility treatment on embryo morphology (Greco et al. 
2005b; Tremellen et al. 2007) whereas others report an improvement in embryo quality 
with anti-oxidative micronutrient therapy (Kacem 2014). However, these studies differed 
significantly in terms of micronutrient supplement composition; a combination of 
micronutrients (Kacem 2014; Tremellen et al. 2007) versus vitamins C and E only (Greco 
et al. 2005b), and the study methodology; same male before and after supplement therapy 
(Greco et al. 2005b; Kacem 2014) versus a treatment and placebo group (Tremellen et 
al. 2007). Further, these studies did not report the BMI of male participants and additional 
differences in other BMI categories from this study may be identified in a larger sample 
size of participants. Although pregnancy and live birth rates from the BMI and 
micronutrient supplementation stratified dataset could not be concluded due to a 
statistically underpowered analysis, the impact of micronutrient supplement intake on 
pregnancy outcomes has been reviewed and found that supplement intake increases 
pregnancy and live birth rates in subfertile couples undergoing ART treatment 
(Gharagozloo and Aitken 2011; Showell et al. 2011).  
 
Overall, these novel findings show that oxidative DNA damage in sperm is inversely 
associated with successful fertilization and pregnancy. Further, this study demonstrates a 
potential mechanism for dietary micronutrient supplementation in improving fertility 
treatment outcomes by reducing sperm oxidative stress-induced subfertility. However, it 
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is not possible to determine if dietary and lifestyle habits had an impact and which 
specific micronutrients contribute to the observed improvements in fertility treatment 
outcomes, which are limitations of this study. Future research with increased sample sizes 
to ensure adequate statistical power is required to conclude the impact of micronutrient 
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Chapter 6 (conventional format) 
 
Live Birth Rates from ART are Increased with Dietary Micronutrient 




6.1 Chapter link 
 
In Chapter 5, prospective data demonstrated that there is negative association between 
sperm oxidative DNA lesions and a successful pregnancy whereby the odds of achieving 
a pregnancy was reduced as sperm oxidative 8-OHdG lesion fluroscence increased. 
Further, the clinical data from the previous chapter showed that micronutrient supplement 
intake reduced sperm oxidative stress measures including sperm intracellular ROS and 
sperm oxidative DNA 8-OHdG lesions. However, the effectiveness of micronutrient 
supplement intake on pregnancy outcomes could not be concluded in the previous chapter 
due to small sample sizes and subsequent inadequate statistical power. Ideally, the golden 
standard of a multicentred double-blinded randomized controlled trial (RCT) could be 
considered to evaluate the effectiveness of micronutrient supplementation on ART 
outcomes and sperm oxidative stress measures in men undergoing fertility treatment 
however and unfortunately, a RCT is beyond the magnitude of a PhD project. Therefore, 
a retrospective study was conducted to address the inadequate statistical power from the 
previous chapter to establish the effectiveness of dietary micronutrient supplement intake 




6.2 Abstract  
 
Male obesity is strongly associated with subfertility and compromised assisted 
reproduction outcomes that include reduced live birth rates. It is apparent that obesity is 
increasingly associated with micronutrient deficiencies due to consumption of energy 
dense but nutrient deficient foods, creating the paradigm that sub-fertility in obese men 
could be in part related to micronutrient deficiencies. Micronutrient deficiencies can lead 
to impaired sperm quality but with micronutrient supplement intake, fertility treatment 
outcomes are improved in normal weight men. However, the effectiveness of this 
treatment in the growing population of obese men has not been established. This 
retrospective study investigated the effects of dietary micronutrient supplement intake on 
fertility treatment outcomes in non-smoking couples with a normal weight, overweight 
or obese male partner (aged <45 years) and a non-obese female partner (aged <38 years). 
Couples were stratified by the male partner’s BMI and whether they were consuming 
dietary micronutrient supplements. Fertility treatment outcomes were assessed and 
included semen volume, sperm motility, sperm concentration, fertilization rates, days 4 
and 5 embryo morphology, blastocyst inner cell mass (ICM) and trophectoderm (TE) 
quality, embryo utilization, biochemical and ongoing pregnancy rates, implantation rates, 
pregnancy loss, live birth rates and live birth outcomes including gestational length and 
gender of the infant and their weight at birth. The results demonstrated that micronutrient 
supplementation in obese men increased standard insemination fertilization rates and 
improved embryo morphology compared to obese men not consuming micronutrient 
supplements. Also, micronutrient supplement intake increased implantation, ongoing 
pregnancy and live birth rates in normal weight, overweight and obese men. Overall, 
these results demonstrate the effectiveness of dietary micronutrient supplementation on 
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assisted reproduction outcomes in men with varying BMIs, primarily alleviating the 
growing prevalence of obesity-induced male subfertility and achieving an ongoing 
pregnancy and live birth.  
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6.3 Introduction  
 
Obesity is a global epidemic with 37% of men worldwide having an elevated body mass 
index (BMI) and are thus categorized as overweight or obese (Ng et al. 2014). According 
to the World Health Organization (WHO 2015), being overweight or obese increases the 
risk of developing cardiovascular diseases, diabetes, musculoskeletal disorders, some 
cancers (including endometrial, prostate, liver and kidney) ultimately resulting in more 
deaths than being underweight (WHO 2015). Recently, there is increasing awareness of 
an obesity and malnutrition paradox as the excessive dietary calorie intake commonly 
associated with obesity is linked to high rates of micronutrient deficiencies (Kaidar-
Person et al. 2008). Parallel to the increase in the prevalence of obese men and their 
micronutrient deficiencies is a global decrease in male fertility and fecundity (Swan et 
al. 2000). Men with an increased BMI are more likely to be subfertile than normal weight 
men with reduced sperm motility and concentration (Hammoud et al. 2008; Hofny et al. 
2010; Jensen et al. 2004), increased sperm DNA damage (Chavarro et al. 2010; Kort et 
al. 2006), reduced fertilization rates (Bakos et al. 2011; Merhi et al. 2013) and reduced 
pregnancy rates (Bakos et al. 2011; Colaci et al. 2012; Keltz et al. 2010; Merhi et al. 
2013) leading to an overall reduced reproductive potential.  
 
There are several proposed mechanisms responsible for the effects of obesity on male 
subfertility including reproductive hormone imbalances and subsequent dysregulation of 
the hypothalamic pituitary gonadal (HPG) axis (Jarow et al. 1993; Roth et al. 2008), 
elevated scrotal temperature (Hjollund et al. 2000; Jung and Schuppe 2007), and 
increased reactive oxygen species (ROS) and oxidative stress (McPherson and Lane 
2015). The generation of ROS are a result of inflammation and/or oxidative stress, which 
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occurs when ROS concentrations exceed antioxidants levels (Agarwal et al. 2006a). 
Studies have shown a correlation between increased seminal ROS and an increased BMI 
(Tunc et al. 2011), which is associated with male infertility (Agarwal et al. 2006b). 
 
Lifestyle changes to achieve a healthy balance of energy expenditure and ultimately 
weight loss are recommended for the clinical management of infertility in overweight 
and obese men however, maintaining a nutrient-rich diet and exercise plan can be difficult 
for individuals with demanding lifestyles. Therefore, another treatment strategy includes 
the dietary intake of micronutrient supplements to reduce sperm oxidative stress and 
subsequently, improve sperm parameters and reproductive potential (Gharagozloo and 
Aitken 2011; Tremellen et al. 2007). To date, the efficacy of dietary micronutrient 
supplementation on pregnancy outcomes has only been established in men with severe 
male factor infertility and shown to increase pregnancy rates in couples (Tremellen et al. 
2007). Currently, the effectiveness of micronutrient supplementation has not been 
investigated in men who are overweight or obese.  
 
This retrospective study investigates the effectiveness of dietary micronutrient 
supplement intake by normal weight, overweight or obese male men on sperm motility, 
sperm concentration, and outcomes of their ART cycle including fertilization rates, 
embryo development, pregnancy outcomes and live birth rates. 
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6.4 Materials and methods 
 
Please refer to Chapter 2, section 2.2 for materials and methods. 
 
The experimental design is illustrated in Figure 6.1 and distribution of the number of 





•Repromed (Adelaide) ART treatment records 
from 2013-2014 obtained following HREC and 
Repromed SAC approval 
Age and BMI inclusion 
criteria implemented
•Female age <38 and male age <45 years old
•Female BMI <30 kg/m2





•Questionnaire was completed when sperm sample was produced 
for couple's IVF/ICSI treatment
•Micronutrient supplementation was classified as yes if 




•Cycle-related pre-treatment sperm motility and concentration assessed
•Fertilization outcomes were obtained from the clinical database




•Fresh embryos were transferred on 





•Pregnancy and live 
birth outcomes were 
obtained from the 
clinical database
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Figure 6.1 A flow chart outlining the experimental plan. The clinical database was used to implement the inclusion criteria, and to identify patient 
characteristics including the male partner’s BMI and whether they were positive for multivitamin (micronutrient) supplement intake. Fertility 
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Figure 6.2 The distribution of patients based on the male partner’s BMI and micronutrient supplementation stratification. The number of 
patients are outlined for each step of their fertility treatment cycle outcomes including ≥1 eggs collected at oocyte retrieval, ≥1 eggs fertilized, 
day 4 and day 5 embryo morphology assessments. Some embryos were day 4 on a Sunday and were not morphologically assessed. Day 5 
embryos that were assessed on day 4 and had embryos that were frozen or transferred on day 4 were not included in day 5 analysis to eliminate 
skewing of data. 
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Figure 6.3 The distribution of patients and pregnancy outcomes based on the male partner’s BMI and micronutrient supplementation stratification. 
Some couples did not undergo a fresh embryo transfer due to ovarian hyperstimulation syndrome (OHSS) or pre-implantation genetic screening 




6.5 Results  
 
6.5.1 Patient population 
A total of 471 couples were included in the final analysis stratified by male BMI (i) 
normal weight men (n=171), (ii) overweight men (n=159), (iii) obese men (n=141), and 
each BMI category was divided by whether they consumed dietary supplementation 
intake in a 3 x 2 experimental design as outlined in Figure 6.2 and Table 6.1. Also, the 
distributions of participants at different levels of data analysis are illustrated in Figures 
6.2 and 6.3.  
Patient population characteristics were analyzed and no differences in paternal age, 
maternal age, maternal BMI, number of previous ART cycles the couple had undergone, 
female AMH and baseline FSH levels were detected (Table 6.2). Further, there was no 
difference in most infertility etiologies (polycystic ovary syndrome (PCOS), 
endometriosis, tubal issues, semen defect, anovulation/oligomenorrhea and other 
conditions including genetic, immunological, premature ovarian dysfunction and 
recurrent miscarriage; Table 6.2) or the mean number of embryos transferred, proportion 
of double embryo transfers or the use of preimplantation genetic screening, However, the 
number and proportion of couples with unexplained and diminished ovarian reserve 
infertility diagnoses, respectively were different between the overweight men categories 
(with and without micronutrient supplements). Further, couples in the category of obese 
men with supplement intake had a reduced prevalence of diminished ovarian reserve as 
their infertility diagnosis compared to couples with an obese male partner.  
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Table 6.1 Distribution of patients by male BMI and dietary micronutrient supplementation. 
 Normal weight Normal weight + 
supplement 
intake 
Overweight Overweight + 
supplement 
intake 
Obese Obese + 
supplement 
intake 
Number of patients 119 52 108 51 94 47 
Paternal BMI 23.3 ± 0.1 23.3 ± 0.2 27.1 ± 0.1 27.2 ± 0.2 32.7 ± 0.3 33.1 ± 0.4 
Morbid obese (BMI > 40)     2 (2.1%) 1 (2.1%) 
Data are expressed as mean ± SEM and as n values (%: proportion of patients) for morbid obese men. 
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Table 6.2 Patient population characteristics. 













Paternal age 33.7 ± 0.4 34.2 ± 0.6 34.7 ± 0.4 34.2 ± 0.6 34.9 ± 0.4 34.2 ± 0.6 
Maternal age 33.6 ± 0.4 32.6 ± 0.5 32.5 ± 0.3 32.5 ± 0.4 32.5 ± 0.4 32.1 ± 0.6 
Maternal BMI 23.2 ± 0.3 22.2 ± 0.4 23.8 ± 0.3 24.4 ± 0.4 23.8 ± 0.3 24.5 ± 0.5 
Number of previous cycles 1.1 ± 0.1 1.1 ± 0.2 1.2 ± 0.2 0.9 ± 0.2 0.8 ± 0.1 0.6 ± 0.1 
AMH (pmol/L) 33.5 ± 2.8 38.7 ± 4.0 29.6 ± 2.1 26.3 ± 3.6 35.3 ± 2.9 34.9 ± 4.4 
Baseline FSH (mIU/mL) 7.7 ± 0.4 7.0 ± 0.3 7.0 ± 0.2 7.2 ± 0.5 7.1 ± 0.4 7.8 ± 0.4 
Number of embryos transferred 1.1 ± 0.03 1.1 ± 0.04 1.1 ± 0.03 1.1 ± 0.05 1.1 ± 0.04 1.1 ± 0.05 
Double embryo transfer 5 (4.2%) 2 (3.8%) 8 (7.4%) 4 (7.8%) 8 (8.5%) 3 (6.4%) 
Preimplantation genetic screening 
(PGT-A)1 
11 (9.2%) 10 (19.2%) 19 (17.6%) 6 (11.8%) 18 (19.1%) 6 (12.8%) 
Female smoker 3 (2.5%) 0 0 1 (2.0%) 0 1 (2.1%) 
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Male medical condition/medication  13 (10.9%) 6 (11.5%) 15 (13.9%) 4 (7.8%) 6 (6.4%) 2 (4.3%) 
Infertility factor- Female 63 (52.9%) 20 (38.5%) 63 (58.3%) 19 (37.3%) 54 (57.5%) 22 (46.8%) 
Infertility factor- Male 22 (18.5%) 18 (34.6%) 24 (22.2%) 20 (39.2%) 13 (13.8%) 13 (27.7%) 
Infertility factor- 
Female and Male 
34 (28.6%) 14 (26.9%) 21 (19.5%) 12 (23.5%) 27 (28.7%) 12 (25.5%) 
Infertility Diagnosis       
Unexplained  18 (15.1%) ab 13 (25.0%) ab 33 (30.6%) a 7 (13.7%) b 21(22.3%) ab 10(21.3%) ab 
Polycystic ovary syndrome (PCOS) 11 (9.2%) 7 (13.5%) 8 (7.4%) 2 (3.9%) 9 (9.6%) 3 (6.4%) 
Endometriosis 19 (16.0%) 3 (5.8%) 11 (10.2%) 3 (5.9%) 15 (16.0%) 10 (21.3%) 
Tubal  12 (10.0%) 5 (9.6%) 10 (9.3%) 6 (11.8%) 4 (4.3%) 0 
Semen defect  51 (42.9%) 30 (57.7%) 37 (34.3%) 31 (60.8%) 34 (36.2%) 24 (51.1%) 
Anovulation/oligomenorrhea 15 (12.6%) 2 (3.8%) 6 (5.6%) 1 (2.0%) 10 (10.6%) 2 (4.3%) 
Diminished ovarian reserve 8 (6.7%) ab 4 (7.7%) ab 10 (9.3%) a 10 (19.6%) b 14 (14.9%) b 3 (6.4%) a 
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Other (e.g. genetic, immunological, 
premature ovarian dysfunction, 
recurrent miscarriage, other) 
20 (16.8%) 3 (5.8%) 14 (13.0%) 4 (7.8%) 17 (18.1%) 8 (17.0%) 
Type of micronutrient supplementation      
Menevit - 37 (71%) - 36 (70%) - 31 (66%) 
Multivitamins - 13 (25%) - 11 (22%) - 10 (21%) 
Menevit and multivitamins - 2 (4%) - 4 (8%) - 6 (13%) 
1 Preimplantation genetic screening for aneuploidy (PGT-A) patients did not undergo an embryo transfer. 
Data are expressed as mean ± SEM and as n values (%: proportion of patients) and analyzed by a 3x2 general linear model. Different letters denote 
significance at P<0.05 and an absence of superscript letters denotes no statistical difference. 
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6.5.2 Pre-treatment sperm assessment   
Semen volume was not different between BMI groups and was not affected by 
micronutrient supplement intake (Table 6.3). Sperm concentration and sperm motility 
from the neat sperm sample (before sperm preparation) were also not affected by either 
BMI or micronutrient supplement intake (Table 6.3).  
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Table 6.3 The effects of male BMI and dietary micronutrient supplementation on cycle-related pre-treatment semen assessment. 













Semen volume (ml) 3.3 ± 0.1 3.0 ± 0.2 3.4 ± 0.1 3.3 ± 0.2 3.3 ± 0.1 2.9 ± 0.2 
Sperm concentration 
(106/ml) 
58.4 ± 3.7 56.8 ± 6.2 65.9 ± 5.6 53.8 ± 5.9 44.9 ± 3.8 60.4 ± 7.2 
Motility (%) 53.7 ± 1.5 52.6 ± 2.1 53.7 ± 1.4 49.8 ± 2.7 48.2 ± 1.9 54.9 ± 3.0 




6.5.3 Fertilization rates 
Fertilization rates after intracytoplasmic sperm injection (ICSI) were not different with 
male BMI and were not affected by micronutrient supplement intake (Table 6.4). 
However, fertilization rates resulting from the standard insemination procedure (IVF) 
were reduced in obese men compared to that from overweight men (Table 6.4) and were 
increased with micronutrient supplementation in obese men compared to obese men not 
consuming micronutrient supplements (Table 6.4). Fertilization rates from both the 
combined ICSI and IVF methods were not different between BMI groups and were not 
affected by supplement intake (Table 6.4). 
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Table 6.4 The effects of male BMI and dietary micronutrient supplementation on fertilization rates for intracytoplasmic sperm injection (ICSI), 
standard insemination (IVF) and both ICSI and IVF ART procedures. 













ICSI fertilization rates       
Number of patients 103 51 90 49 86 44 
Mean number of oocytes 7.2 ± 0.5 8.5 ± 0.8 7.9 ± 0.4 7.7 ± 1.4 7.8 ± 0.5 7.6 ± 0.6 
Fertilization rate1 (%) 73.7 74.0 72.1 69.2 72.1 70.8 
Non-viable2 (%) 6.9 6.7 7.5 6.7 9.8 6.9 
Abnormal fertilization3 (%) 4.9 5.8 6.0 6.3 4.6 3.9 
Oocytes that failed to 
fertilize4 (%) 
14.7 13.6 14.4 17.8 13.5 18.5 
IVF fertilization rates       
Number of patients 24 6 27 7 19 6 
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Mean number of oocytes 6.4 ± 0.7 8.7 ± 0.7 7.3 ± 0.5 8.1 ± 0.9 9.1 ± 0.6 7.8 ± 1.0 
Fertilization rate1 (%) 61.1 ab 52.0 a 67.4 b 59.6 ab 52.8 a 72.1 b 
Non-viable2 (%) 1.3 0.0 1.5 0.0 1.7 4.3 
Abnormal fertilization3 (%) 13.0 5.8 9.2 12.3 9.2 12.6 
Oocytes that failed to 
fertilize4 (%) 
24.7 ab 42.4 a 21.9 ab 28.3 ab 36.2 a 10.5 b 
ICSI and IVF fertilization rates      
Number of patients 114 52 108 51 94 47 
Mean number of oocytes 8.0 ± 0.6 9.3 ± 0.8 8.4 ± 0.5 8.5 ± 1.0 9.0 ± 0.5 8.1 ± 0.7 
Fertilization rate1 (%) 70.7 71.5 71.0 66.9 68.1 70.9 
Non-viable2 (%) 7.0 6.0 6.5 6.5 8.2 6.5 
Abnormal fertilization3 (%) 6.5 5.8 6.8 6.9 5.4 5.2 
Oocytes that failed to 
fertilize4 (%) 
15.8 16.7 15.7 19.6 18.3 17.3 
1 The presence of two pronuclei (2PN) and two polar bodies (2PB). 
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2 Non-viable rate reflecting the proportion of lysed or degenerate eggs/embryos. 
3 Abnormal fertilization rate reflecting parthenogenetic oocytes or the presence of three or more pronuclei. 
4 Oocytes that lacked the presence of two pronuclei (2PN) and two polar bodies (2PB). 
Data are expressed as n values, mean ± SEM or a proportion of patients (%) and analyzed by a 3x2 general linear model weighted to the total 
number of oocytes per couple. Different letters denote significance at P<0.05 and an absence of superscript letters denotes no statistical difference. 
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6.5.4 Embryo development, blastocyst quality and embryo utilization 
Embryo morphology was assessed on day 4 and day 5 of embryo development as these 
time points (post-embryonic genome activation) in embryo development may be affected 
by the quality of the male (paternal) genome. There was no effect of BMI on day 4 of 
embryo development however, micronutrient supplementation improved embryo 
morphological score in obese men (Table 6.5) with the percentage of grade 1 embryos 
(best quality) on day 4 (early blastocysts and compacted morulae) being increased with 
supplementation in obese men compared with obese men without micronutrient 
supplementation. The converse is observed with fewer poor grade embryos produced 
when obese men were consuming micronutrients compared to men who did not (Table 
6.5). On day 5 of culture, BMI and micronutrient supplementation did not have an effect 
on blastocyst development rates or blastocyst ICM and TE quality (Tables 6.6 and 6.7). 
The percentage of transferred and/or frozen embryos (embryo utilization), was not 
affected by BMI but was increased with micronutrient supplementation in normal weight 
men compared to normal weight men not taking supplements (Table 6.8). 
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Table 6.5 The effects of male BMI and dietary micronutrient supplementation on day 4 embryo morphology. 
 Normal weight Overweight Obese 












Number of patients 74 35 69 37 66 32 
Mean number of embryos 5.3 ± 0.5 6.5 ± 0.8 6.1 ± 0.5 5.4 ± 0.5 6.4 ± 0.4 6.4 ± 0.8 
Grade 11 (%) 8.7 ab 9.8 ab 11.7 ab 6.9 a 6.4 a 14.4 b 
Grade 2A2 (%) 20.7 15.2 19.2 19.7 18.2 16.7 
Grade 2B3 (%) 18.5 17.4 18.1 16.6 13.8 18.0 
Grade 34 (%) 33.0 ab 28.1 a 23.7 ac 28.1 a 39.2 b 20.8 c 
Grade 45 (%) 18.9  29.3 26.8 29.3 22.6 29.9 
1 Early blastocysts or compacted morulae 
2 Partially compacted morulae (>70% compaction) with no anomalies or early blastocysts and compacted morulae with minimal 
anomalies 
3 Partially compacted morulae (<70% compaction) with no or minimal anomalies 
4 Embryos with ³8 cells and no compaction with no or minimal anomalies  
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5 Embryos with <8 cells or embryos with ³8 cells, no compaction and above minimal anomalies 
Data are expressed as n values, mean ± SEM or a proportion of fertilized embryos (%) and analyzed by a 3x2 general linear model weighted 
to the total number of fertilized embryos per couple. Different letters denote significance at P<0.05 and an absence of superscript letters 
denotes no statistical difference. 
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Table 6.6 The effects of male BMI and dietary micronutrient supplementation on day 5 embryo morphology.  
 Normal weight Overweight Obese 












Number of patients 42 19 38 18 31 17 
Mean number of embryos 6.4 ± 0.4 7.5 ± 0.5 6.4 ± 0.3 7.4 ± 0.7 5.1 ± 0.3 5.1 ± 0.5 
<16c (%) 30.0 33.0 30.0 32.0 31.0 30.0 
Morula (%) 16.0 12.0 20.0 16.0 19.0 12.0 
Early blastocyst (%) 22.0 26.0 22.0 26.0 24.0 27.0 
Full blastocyst (%) 13.0 14.0 16.0 15.0 15.0 16.0 
Expanded blastocyst (%) 19.0 15.0 12.0 11.0 11.0 15.0 
Full blastocyst  
(% total blastocysts) 
33.0 34.0 33.0 25.0 32.0 23.0 
Expanded blastocyst  
(% total blastocysts) 
33.0 27.0 23.0 24.0 28.0 29.0 
 331 
Data are expressed as n values, mean ± SEM or a proportion of fertilized embryos/total blastocysts (%) and analyzed by a 3x2 general linear 
model weighted to the total number of fertilized embryos per couple. No statistical differences were detected. 
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Table 6.7 The effects of male BMI and dietary micronutrient supplementation on blastocyst inner cell mass and trophectoderm grading. 













Number of patients  27 13 25 7 16 10 
Mean number of blastocysts 3.0 ± 0.4 3.7 ± 0.7 2.6 ± 0.3 3.3 ± 0.7 2.6 ± 0.4  1.5 ± 0.2 
Inner cell mass       
Grade A1 (%) 47.5 37.5 54.7 34.8 57.1 40.0 
Grade B2 (%) 45.0 60.4 37.5 58.2 33.4 46.7 
Grade C3 (%) 7.5 2.1 7.8 7.0 9.5 13.3 
Trophectoderm       
Grade A4 (%) 47.5 41.7 43.8 56.5 52.4 46.7 
Grade B5 (%) 42.5 52.1 46.9 43.5 38.1 33.3 
Grade C6 (%) 10.0 6.3 9.4 0.0 9.5 20.0 
 
1 Many tightly packed cells 
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2 Several (loose) cells 
3 Very few cells 
4 Many cells forming a cohesive layer 
5 Few cells forming a loose epithelium 
6 Very few cells 
Data are expressed as n values, mean ± SEM or a proportion of blastocyst-staged embryos (%) and analyzed by a 3x2 general linear model 
weighted to the total number of blastocyst-staged embryos per couple. No statistical differences were detected.  
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Table 6.8 The effects of male BMI and dietary micronutrient supplementation on embryo utilization. 
 Normal weight Overweight Obese 












Number of patients 111 51 104 49 93 45 
Mean number of embryos 5.8 ± 0.4 6.3 ± 0.6 6.0 ± 0.4 5.2 ± 0.7  5.9 ± 0.4 5.3 ± 0.6 
Transferred and/or frozen 
embryos (%) 
51.6 a 62.2 b 52.2 a 57.6 ab 55.8 ab 56.1 ab 
Data are expressed as n values, mean ± SEM or a proportion of fertilized embryos (%) and analyzed by a 3x2 general linear model weighted to the 




6.5.5 Pregnancy and live birth outcomes 
Pregnancy outcomes were analyzed as a proportion of couples that underwent an embryo 
transfer in addition to as a proportion of patients that underwent an oocyte retrieval (Table 
6.9). In both analyses (per embryo transfer and per oocyte retrieval), implantation rates, 
measured by a positive sac upon ultrasound examination, were not affected by BMI but 
increased with micronutrient supplementation in all men regardless of their BMI category 
(Table 6.9). Ongoing pregnancy rates, measured by the presence of a fetal heart on 
ultrasound examination, were also increased with micronutrient supplementation but in 
normal weight and obese men compared to normal weight and obese men not taking 
supplements in both analyses (per embryo transfer and per oocyte retrieval, Table 6.9). 
Although not affected by BMI, live birth rates as a proportion of patients that underwent 
an embryo transfer were increased with micronutrient supplement intake in all BMI 
categories (Table 6.9). However, live birth rates as a proportion of patients that underwent 
an oocyte retrieval was only increased in normal weight men with micronutrient 
supplement intake compared to normal weight men not taking supplements (Table 6.9). 
Live birth outcomes were also assessed and there was no effect of BMI or micronutrient 
supplementation on gestational length, sex ratios and infant weight (Table 6.10). 
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Table 6.9 The effects of male BMI and dietary micronutrient supplementation on pregnancy outcomes. 
 Normal weight  Overweight  Obese  












Per embryo transfer       
Number of patients 86 39 80 39 70 35 
Biochemical pregnancy (%)  51.2 61.5 63.8 64.1 41.4 54.3 
Implantation (%)  43.0 a 59.0 b 51.2 a 59.0 b 35.7 a 51.4 b 
Ongoing pregnancy (%) 38.4 a 59.0 b 46.3 abc 48.7 abc 34.3 a 45.7 c 
Pregnancy loss1 (%) 15.9 a 4.2 b 19.6 a 8.0 b 17.2 a 5.3 b 
Live birth (%) 33.7 a 56.4 b 37.5 c 48.7 b 32.9 a 37.1 c 
Per oocyte retrieval2       
Number of patients 102 41 89 44 76 40 
Biochemical pregnancy (%)  43.1 58.5 56.2 59.1 38.2 47.5 
Implantation (%)  37.3 ab 56.1 c 46.1 b 54.5 c 32.9 a 45.0 c 
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Ongoing pregnancy (%) 32.4 a 53.7 b 41.6 c 45.5 c 32.9 a 40.0 c 
Pregnancy loss1 (%) 34.1 a 8.3 b 34.0 a 26.9 a 20.7 a 31.6 a 
Live birth (%) 28.4 a 53.7 b 37.1 ab 43.2 ab 30.3 a 32.5 ab 
1 Pregnancy loss was defined as a loss that occurred between a positive β-hCG test and live birth. 
2 Per oocyte retrieval rates referred to couples with the intention to treat and excluded couples with non-paternal factors that could contribute to a 
loss of pregnancy such as couples that did not undergo an embryo transfer due to ovarian hyperstimulation syndrome (OHSS) or PGT-A. 
Data are expressed as n values and a proportion of embryo transfers and oocyte retrieval (%) and analyzed by a binary logistic regression. Different 




Table 6.10 The effects of male BMI and dietary micronutrient supplementation on live birth outcomes. 
 Normal weight Overweight Obese 












Number of patients 29 22 30 19 23 13 
Gestational length (weeks) 39.2 ± 0.6 38.0 ± 0.7 38.6 ± 0.5 38.3 ± 0.5 39.5 ± 0.6 38.4 ± 0.6 
Male infant (%) 31.0 50.0 30.0 42.1 26.1 53.8 
Female infant (%) 69.0 50.0 70.0 57.9 73.9 46.2 
Male weight at birth (kg) 3.13 ± 0.21 3.05 ± 0.47 3.45 ± 0.30 3.22 ± 0.17 3.21 ± 0.15 3.53 ± 0.23 
Female weight at birth (kg) 3.08 ± 0.15 3.22 ± 0.14 3.13 ± 0.31 3.00 ± 0.17 3.16 ± 0.30 3.10 ± 0.29 
Data are expressed as n values, mean ± SEM or a proportion of live birth (%) and analyzed by a 3x2 general linear model for quantitative data 





This study illustrates that dietary micronutrient supplement intake was effective in 
improving fertility treatment outcomes in normal weight, overweight and obese men 
albeit to differing degrees. In obese men, micronutrient supplementation improved 
fertilization rates and embryo morphology, in addition to subsequent increases in 
implantation rates, and ongoing pregnancy and live birth rates.  
 
Although previous investigations in men with unspecified BMIs have shown 
improvements in sperm motility with the intake of vitamin C (Dawson et al. 1990), 
vitamin E (Suleiman et al. 1996), zinc (Omu et al. 1998), a combination of selenium and 
vitamins A, C and E (Keskes-Ammar et al. 2003; Nozha et al. 2001; Scott et al. 1998), 
L-carnitine (Balercia et al. 2005; Biagiotti et al. 2003; Lenzi et al. 2004; Lombardo et al. 
2002), and coenzyme Q10 (Balercia et al. 2009; Safarinejad 2009), the data from this 
study showed no effect of micronutrient supplementation on sperm motility and 
concentration. This is likely due to differences in study designs whereby the majority of 
previous studies were prospective randomised controlled trials whereas this study was 
retrospective in design. Also, the micronutrients and antioxidants used in previous studies 
were different as this study included supplements such as multivitamins. 
 
Standard insemination fertilization rates were increased with micronutrient 
supplementation in obese men. The distinction of fertilization rates based on standard 
insemination method suggests that obesity has an impact on the sperm’s capacity to 
undergo acrosomal reaction and sperm-oocyte binding which are improved by 
micronutrient supplementation. In contrast, ICSI fertilization rates were not altered 
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whereby these events are by-passed. This increase in standard insemination fertilization 
rates with micronutrient supplementation may be due to a reduction of ROS generation 
in sperm cells (Agarwal et al. 2014), which in turn reduces lipid peroxidation of the sperm 
plasma membrane and maintains membrane fluidity and integrity, which is crucial for 
successful sperm-oocyte binding, fusion and ultimately fertilization (Aitken et al. 1989; 
Geva et al. 1996).  
 
On days 4 and 5 of culture, embryos were graded based on morphological characteristics. 
Micronutrient supplementation in obese men appeared to increase the rate of 
development post-compaction with more embryos reaching the morulae/blastocyst stage 
on day 4 of embryo culture, a time point post-embryonic genome activation (Braude et 
al. 1988). This may be explained by potential reductions in sperm oxidative stress and 
oxidative DNA damage with micronutrient supplementation, which reductions may 
persist to the subsequent embryo through the paternal pronucleus and result in timely 
embryo developmental competence (Conine et al. 2018). Although the effects of paternal 
BMI on day 4 embryo development have not been previously investigated (Campbell et 
al. 2015), blastocyst development is known to be reduced by an increasing BMI (Bakos 
et al. 2011). The improvements in embryo morphology with micronutrient supplement 
intake did not persist to day 5 of culture and did not have an effect on blastocyst 
development or quality, determined by the ICM size and shape and TE cell number. 
Embryo utilization, reflected by the percentage of transferred and frozen embryos, was 
increased with micronutrient supplement intake in normal weight men which has not been 
previously investigated. This may be due to reduced oxidative DNA lesions in sperm and 
improved DNA integrity in the male germline in the subsequent embryos from normal 
weight men (Takahashi 2012), which may increase the overall quality and utilisation of 
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embryos produced by normal weight men consuming micronutrient and anti-oxidative 
supplements. 
 
Implantation rates, indicated by the presence of a fetal sac; ongoing pregnancy rates, 
indicated by the presence of a fetal heartbeat; and live birth rates were increased with 
micronutrient supplement intake in all men regardless of BMI. Previous investigations 
demonstrate that pregnancy rates are increased with the intake of vitamin E (Suleiman et 
al. 1996), L-carnitine and acetyl L-carnitine (Cavallini et al. 2004; Li et al. 2005) and 
Menevit, a combination of anti-oxidative micronutrients including vitamin C, zinc, 
vitamin E, folic acid, lycopene, selenium and garlic oil (Tremellen et al. 2007); which 
are all micronutrients and anti-oxidative agents used by men in this study. Further, some 
studies have reported increased live birth rates in men of unspecified BMI with the intake 
of vitamin E (Kessopoulou et al. 1995; Suleiman et al. 1996)  and zinc (Omu et al. 1998). 
The range of micronutrient supplements taken among the men from this study were 
consistent and contain similar components and doses (Appendix, Table A9), which is in 
line with the recommendations of the couple’s clinicians. Unfortunately, due to the nature 
of this retrospective study, it is impossible to determine the dietary and lifestyle habits of 
men from each BMI category and which micronutrient(s) specifically are associated with 
the observed increases in pregnancy and live birth rates. These factors are the main 
limitations of this study as for example, some men may have implemented dietary 
changes due to clinical advice to include more micronutrient intake from increased fruit 
and vegetable intake instead of consuming micronutrient supplements. Subsequently, 
these men would confound their allocated BMI category without supplementation group. 
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Micronutrient supplement intake has been reported as a supportive therapy for the 
treatment of infertility in men based on the protective effects of anti-oxidative 
micronutrients including, and not limited to, vitamins A, C and E and carnitine, and 
micronutrients such as zinc and selenium (Gharagozloo and Aitken 2011; Walczak-
Jedrzejowska et al. 2013). Although the exact mechanisms involved in the protection of 
fertility treatment outcomes by anti-oxidative micronutrients are unknown, it is becoming 
apparent that sperm oxidative stress may be a critical and underlying factor for paternal 
DNA damage and defective male reproductive potential (Aitken et al. 2003; Trasler 
2009). Sperm DNA integrity is impaired with oxidative stress and increased levels of 
intracellular ROS as oxidized residues within sperm DNA are formed, including 8-
hydroxy-2’-deoxyguanosine (8-OHdG) (Noblanc et al. 2013). These oxidative DNA 
residues and adducts have destabilizing effects on the DNA backbone leading to DNA 
strand breaks (Mitchell et al. 2011). Also, oxidative DNA lesions cannot be repaired 
completely as sperm cells do not possess all the enzymes required for DNA base excision 
and repair (Bruner et al. 2000; Smith et al. 2013). Due to this limited DNA repair 
capacity, sperm DNA damage may be transmitted to the oocyte, if fertilization occurs, 
and may contribute to impaired offspring health (Frans et al. 2008; Ji et al. 1997; Lee et 
al. 2009; Sipos et al. 2004). Previous studies have investigated the effects of 
micronutrient supplement intake on sperm DNA fragmentation and found a combination 
of both vitamins C and E (Greco et al. 2005) and zinc, (without or in combination with 
vitamins C and E) (Omu et al. 2008) supplementation reduced sperm DNA 
fragmentation. Also, a study investigating the effects of increasing and reducing the dose 
of vitamin C supplement intake found a negative association between vitamin C intake 
and oxidative DNA damage in sperm (Fraga et al. 1991). Therefore, a potential 
mechanism for the observed improvement in fertilization rates, embryo developmental 
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competence and live birth rates with micronutrient supplementation may be reduced 
sperm oxidative stress and DNA damage. This reduced damage from the male germ line 
may persist into the subsequent embryo and ultimately lessen mutational load in the 
embryo’s genome to produce a healthy fetus (Takahashi 2012; Trasler 2009).  
 
Interestingly, this study demonstrates that micronutrient supplement intake in all men 
benefits the couple’s fertility treatment outcomes and ultimately pregnancy and live birth 
rates. Overall, these novel findings elucidate the effectiveness of micronutrient 
supplementation on fertility treatment outcomes in men with an increased BMI, which is 
vital given the concurrent obesity epidemic and prevalence of infertility among men with 
an increased BMI. Future research into the effects of micronutrient supplement intake 
and its anti-oxidative impact on the subcellular components of sperm (intracellular ROS 
and oxidative DNA damage) and their association with pregnancy outcomes are 
warranted. These future findings could clarify potential mechanisms for the mode of 
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The Role of Sperm Oxidative Stress in Male Obesity and the 




7.1. Introduction  
 
The burgeoning health problem of obesity has continued despite several government 
initiatives with almost 2 in 3 Australian adults now classified as overweight or obese 
(AIHW 2016). In men, it is estimated that the odds of infertility increase 10% for every 
9kg a man is overweight (Sallmen et al. 2006). Given the increasing evidence in animal 
models and human cohorts regarding male obesity at preconception and its association 
with poorer health outcomes in children, is vital that treatments are assessed for their 
effectiveness in treating obesity-induced subfertility and the transmission of impaired 
health to the next generation. 
 
Male obesity is associated with elevated sperm oxidative stress in both humans and in 
animal models of HFD-induced obesity (Palmer et al. 2012; Tunc et al. 2011). Sperm 
oxidative stress occurs when there is an imbalance between reactive oxygen species 
(ROS) production (elevated) and cellular enzymatic and non-enzymatic antioxidant 
activity (reduced). Specifically, male obesity is associated with increased sperm 
intracellular ROS and increased sperm DNA damage and fragmentation which in turn, 
is linked to poor fertilization rates, delayed embryo development, poor pregnancy rates, 
increased birth defects and impaired offspring health (Aitken and Curry 2011; Bakos et 
al. 2011; Bakos et al. 2010; Fullston et al. 2012; McPherson et al. 2013). Sperm DNA 
integrity is compromised by the oxidative attack of intracellular ROS resulting in not 
just DNA breaks, but importantly DNA base modifications and mutations that can be 
transmitted to potential offspring via the male germ line (Soubry et al. 2014). Therefore, 
the regulation of sperm ROS levels are vital not only for male fertility, but potentially 
for the lasting health consequences of his children. 
 351 
Meta-analyses have demonstrated the efficacy of oral micronutrient and antioxidant 
supplement intake for the improvement of sperm quality, fertilization rates and 
pregnancy rates, in subfertile and infertile men with unspecified BMIs (Barratt et al. 
2017; Gharagozloo and Aitken 2011; Ross et al. 2010; Showell et al. 2011; Zini et al. 
2009). However, the effectiveness of micronutrient supplement intake in the growing 
population of obese males and the aetiology of obesity-induced subfertility and sperm 
oxidative stress has not been investigated until now. Therefore, it was hypothesized that 
dietary micronutrient supplementation in obese males improves fertilization rates, 
embryo development, implantation and pregnancy rates by reducing sperm oxidative 
stress and oxidative DNA damage.  
 
7.2. Male obesity and sperm oxidative stress 
 
One of the primary mechanisms linking male obesity to subfertility is sperm oxidative 
stress (Aitken et al. 2014). This is because sperm cells are extremely susceptible to 
oxidative stress due to their limited cytoplasmic capacity for antioxidants and antioxidant 
enzymes, as the bulk of the cytoplasm is shed during their maturation process during 
spermatogenesis (Rengan et al. 2012). Sources of endogenous ROS in semen and sperm 
include leukocytes (neutrophils and macrophages) (Aitken and Fisher 1994; Aitken et al. 
1995), which have been found to be elevated in semen from obese men (Tunc et al. 2011). 
Also, excess residual cytoplasm in morphologically abnormal sperm (Gomez et al. 1996; 
Sakkas et al. 2003) along with mitochondrial electron leakage metabolism (Koppers et 
al. 2008; Vernet et al. 2001) have been shown to contribute to the excessive production 
of ROS. 
 
Similar to the human phenotype, HFD-induced obese mice display increased sperm 
oxidative stress, characterised by elevated sperm intracellular ROS (Fullston et al. 2012; 
Palmer et al. 2012), which was also shown in data from Chapters 3 and 4 where sperm 
intracellular ROS was increased in HFD-induced obese mice compared to CD-fed mice. 
Furthermore, these chapters extended these findings and demonstrated that 8-hydroxy-
deoxy-guanosine (8-OHdG) immunofluorescence, which detected oxidized guanine base 
adducts, was elevated in both mature sperm and in testicular spermatogenic sperm from 
HFD-fed mice. 8-OHdG is an abnormal DNA lesion that can impact transcription and 
interfere with methylation marks (Shen et al. 1999; Valavanidis et al. 2009). These 
findings suggest that at least a proportion of this damage is initiated in the testes in which 
developing germ cells, particularly spermatogonia and elongating spermatids, from diet-
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induced obese mice had elevated 8-OHdG fluorescence (Chapter 3). One of the proposed 
mechanisms for these findings include disruption of the blood-testes barrier (BTB) and 
the infiltration of serum cytokines, leukocytes and ROS through seminal vesicles and into 
the testicular tissue (La Vignera et al. 2012). Another proposed mechanism is the 
increased gonadal adipose tissue accumulation, associated scrotal heat and increased 
serum levels of cholesterol, glucose, HDLs and triglycerides observed in HFD-fed mice 
(McPherson and Lane 2015), which may contribute to the atrophy of seminiferous 
tubules from the testes and impair the BTB permeability, as observed with diet-induced 
obesity (Fan et al. 2015). Further studies examining BTB permeability may explain 
which vascular/serum molecules, such as ROS and any of the other increased serum 
levels (cholesterol, glucose, triglycerides) observed in Chapter 3, may pass through the 
perturbed BTB resulting in 8-OHdG lesions of testicular spermatogenic sperm and 
reduced protection of germ cells from harmful products from the vascular environment 
(Haverfield et al. 2014). 
 
The duration of a HFD intake also had an impact on the degree of sperm intracellular 
ROS production and 8-OHdG lesions. Male mice that consumed a HFD for 20 weeks 
(Chapter 3) produced sperm with more intracellular ROS than those that consumed a 
HFD for 15 weeks (Chapter 3) or 11 weeks (Chapter 4). Furthermore, sperm 8-OHdG 
lesions were greater in male mice fed a HFD for 20 or 15 weeks (Chapter 3) than those 
fed a HFD for 11 weeks (Chapter 4). Although all 3 HFD intake durations increased 
adiposity, there was also an increase in serum metabolites as the duration of a HFD intake 
increased. Male mice that consumed a HFD for 20 weeks (Chapter 3) had increased serum 
cholesterol, glucose, high density lipoproteins (HDLs) and triglycerides whereas mice 
fed a HFD for 15 weeks (Chapter 3) or 11 weeks (Chapter 4) displayed increased serum 
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cholesterol and HDLs only. The additional increases in glucose and triglycerides with the 
20 week intake of a HFD may be due to a pre-diabetic state, insulin resistance and 
impaired triglyceride metabolism in these mice (Burgeiro et al. 2017). Overall, these 
differences in the degrees of damage to sperm intracellular ROS and sperm oxidative 
DNA lesions as the duration of HFD intake increased suggest that adiposity is not the 
only factor contributing to their increase in sperm oxidative stress and that their metabolic 
profile may also play an important role. 
 
The increased sperm intracellular ROS and sperm 8-OHdG lesions observed from HFD-
induced obese mice (Chapters 3 and 4) were similar to that seen in sperm from overweight 
and obese men (Chapter 5). Sperm oxidative stress measures were examined in men and 
showed that increased BMI was associated with increased sperm intracellular ROS. 
These findings are consistent with previous studies that demonstrated increased ROS 
content in semen (Tunc et al. 2011) and sperm (Yang et al. 2016) from men with an 
elevated BMI. In addition to elevated sperm intracellular ROS in obese men, sperm 8-
OHdG fluorescence increased as male BMI increased, indicating a concomitant elevation 
of oxidative DNA lesions in sperm from overweight and obese men. There is prior 
evidence for a strong association between intracellular ROS and oxidative DNA 
modifications including 8-OHdG formation in sperm with chemically-induced oxidative 
stress (Aitken et al. 1998; De Iuliis et al. 2009; Oger et al. 2003) and in sperm from men 
undergoing ART treatment (Oger et al. 2003). The findings from Chapter 5 that 
demonstrated a positive association between sperm intracellular ROS (both H2DCFDA 
and MSR probes) and 8-OHdG fluorescence are consistent with previous studies 
confirming a biochemical link whereby sperm intracellular ROS lead to the formation of 
8-OHdG DNA base adducts (De Iuliis et al. 2009; Noblanc et al. 2013). Given the 
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positive relationship between intracellular ROS generation and the formation of oxidative 
DNA lesions, as observed in Chapter 5 and consistent with previous literature, future 
studies could investigate the mutations produced by the modifications of DNA bases 
induced by ROS. These mutations may include genetic and epigenetic mutations that may 




7.3. Sperm oxidative stress, embryo development and pregnancy 
 
Sperm have a limited capacity to repair DNA adducts and lesions as sperm cells contain 
only one of the enzymes involved in the base excision repair (BER) pathway, 8-
oxoguanine DNA glycosylase (OGG1) to repair DNA lesions by excising lesions from 
the DNA backbone (Bruner et al. 2000; Smith et al. 2013). The OGG1 enzyme excises 
base adducts such as 8-OHdG however, the nucleotide is not replaced due to the lack of 
the remaining BER enzymes (APE1, XRCC1) (Smith et al. 2013). Although 8-OHdG 
base mutations may compromise sperm DNA integrity and sperm cells are not able to 
completely repair 8-OHdG lesions, the zygote is able to excise 8-OHdG adducts and 
ultimately repair some of the oxidative DNA damage post-fertilization (Lord and Aitken 
2015). However, the repair of this damage in the zygote is limited and cannot completely 
eliminate and excise all 8-OHdG mutagenic adducts, which is elevated in obese and 
subfertile males (Lord and Aitken 2015). Sperm 8-OHdG lesions are associated with 
reduced blastocyst formation rates (Meseguer et al. 2008) and asymmetry and 
fragmentation in the embryo (Meseguer et al. 2006). Further, sperm 8-OHdG is 
associated with perturbed offspring health including cancers and neurological disorders 
in children (Aitken et al. 2014; Lee et al. 2009). These associations may be explained by 
the findings observed in Chapter 4, which revealed that increased 8-OHdG 
immunofluorescence in mature sperm persisted to the paternal pronucleus in the 
subsequent embryo. This demonstration of inheritance of the 8-OHdG into the 
preimplantation embryo may suggest that this could be a part of the mechanism for the 
transmission of male obesity and compromised reproductive and metabolic health to the 
next generation (Fullston et al. 2013; Fullston et al. 2012). Chapter 4 ultimately 
highlights the transmission of compromised DNA integrity through the obese male germ 
 357 
line to embryos with the potential to harm the health of the next generation. The excision 
and repair of paternally-derived 8-OHdG lesions in the subsequent embryo is vital to 
reduce the potential for mutagenesis (Bruner et al. 2000; Chabory et al. 2009; Ohno et 
al. 2014) and reduce the susceptibility of offspring to impaired health including metabolic 
syndrome (Lane et al. 2014; Meseguer et al. 2008). Future studies could further 
investigate the extent of oocyte repair capacity to reduce the risk of mutations post-
fertilization in the zygote and to determine if this repair prevents mutagenesis in the 
embryo. 
 
Similar to the data observed in the mouse models (Chapters 3 and 4), Chapter 5 
demonstrated that fertilization rates and pregnancy rates were compromised with 
increased sperm 8-OHdG lesions (regardless of male BMI). Although 8-OHdG was not 
assessed in the paternal pronucleus of the human embryo, Chapter 5 indicated that 
fertilization rates were reduced with increased sperm oxidative DNA lesions. This may 
be due to elevated sperm oxidative stress and subsequent DNA modifications, which are 
beyond the oocyte’s capacity for low level sperm DNA damage repair and consistent with 
previous findings (Lewis and Aitken 2005; Sukcharoen et al. 1995). Chapter 5 also 
indicated that the odds of achieving a pregnancy (biochemical, implantation or an 
ongoing pregnancy) were reduced by up to 49% with increases in sperm 8-OHdG lesions 
regardless of male BMI. Although the association between sperm 8-OHdG DNA 
modifications and live birth outcomes was not assessed due to statistical power 
limitations, previous studies have indicated that impaired sperm DNA integrity and 
subsequent mutations in sperm from paternal smoking is linked to recurrent pregnancy 
loss and congenital malformations, neurological disorders and cancers in children 
(Aitken et al. 2003; Aitken and Krausz 2001). Given the link between sperm oxidative 
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DNA damage, perturbed sperm DNA integrity and poor offspring health, future studies 
with larger sample sizes to address the power limitations in Chapter 5 could be conducted 
to evaluate the relationship and impact of sperm 8-OHdG DNA lesions on live birth 
outcomes and long-term offspring health. 
 
One of the strengths of this project is that sperm intracellular ROS and 8-OHdG lesions 
were examined from the prepared (washed) sperm sample used to inseminate or inject 
the couple’s oocytes (Chapter 5). By doing this, correlation analyses between treatment 
cycle outcomes and sperm oxidative stress assessments are restricted to the washed sperm 
sample used for oocyte insemination/injection limiting the influence of seminal variables 
which may affect sperm intracellularly. Overall, the sperm oxidative stress measurements 
assessed, primarily 8-OHdG, could be used as a clinical marker and laboratory sperm 
quality evaluation test to predict the odds of achieving a pregnancy and even a live birth 
whereby as sperm oxidative DNA damage levels increase, the chances of pregnancy 




7.4 Role of micronutrient supplementation in overweight and obese males  
 
The data outlined in this project showed that micronutrient supplement intake improved 
sperm oxidative stress, primarily sperm 8-OHdG lesions, in both diet-induced obese mice 
(Chapters 3 and 4) and overweight and obese men (Chapters 5 and 6). As obesity is 
associated with overnutrition, many obese inviduals are actually micronutrient deficient, 
as a result of consumption of energy-dense and micronutrient-low diets. This led to the 
hypothesis investigated thereby creating a paradigm that in males with diets with 
micronutrient deficiencies, dietary supplementation may improve sperm oxidative stress 
parameters (sperm intracellular ROS and oxidative DNA lesions). In the mouse models, 
outcomes were differentiated based on the duration of micronutrient supplement 
treatment. Investigating different durations of intake throughout this project was vital to 
understand potential locations of damage (testes versus epididymis) and how 
micronutrient supplements may improve different aspects of sperm quality, sperm 
function, and if the damage found in sperm persisted to the paternal pronucleus of the 
subsequent embryo and affected pregnancy outcomes. Although the maximum 
investigated duration of 10 weeks of micronutrient supplementation (Chapter 3), a 
duration that spans two rounds of spermatogenesis, in obese male mice reduced adiposity 
relative to total body weight and improved normal sperm morphology, the reduction in 
sperm intracellular ROS was evident from as little as 10 days of supplement intake 
(Chapter 4).  
 
It is clear from the data in Chapter 3 that a HFD causes damage to the sperm during the 
period of spermatogenesis. The increased 8-OHdG lesions observed in testicular sperm 
(elongating and elongated spermatids) from HFD-fed mice was reduced with 10 weeks 
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of micronutrient supplement intake. Interestingly, the reduction of 8-OHdG 
modifications with micronutrient supplementation in testicular sperm persisted to mature 
sperm (collected from the epididymis) and the paternal pronucleus of embryos derived 
from obese male mice. Ten days of micronutrient supplement intake spans the duration 
of sperm maturation during epididymal transit (Robaire et al. 2006), which suggests that 
supplement intake in obese males may reduce sperm oxidative stress and oxidative DNA 
lesions by improving the epididymal environment and antioxidant defence mechanisms 
during sperm maturation (Figure 7.1). Additionally, given that 10 and 5 weeks of 
micronutrient supplement intake in obese male mice also reduced sperm oxidative stress 
and oxidative DNA lesions to similar levels to that observed in Chapter 4 (10 day 
treatment) further indicates that micronutrient supplement intake may also affect 
spermatogenesis in the testis (Figure 7.1). Collectively, these findings highlight the 
possibility of a combination effect of micronutrient supplementation in both the 
epididymis and testes. 
 
A possible explanation for the observed reductions in sperm 8-OHdG lesions with 
micronutrient supplement intake may be the observed reductions in sperm intracellular 
ROS in both testicular spermatogenic and mature epididymal sperm (Chapters 3 and 4). 
When comparing outcomes from treatment durations, the degree of reductions in sperm 
intracellular ROS and 8-OHdG lesions with micronutrient supplementation in diet-
induced obese mice were relative to the duration of HFD consumption. Mice fed a HFD 
with micronutrient supplements for 10 days or 5 weeks had reduced sperm intracellular 
ROS that was at a level similar to that from CD-fed mice (almost restoring sperm 
intracellular ROS). However, 10 weeks of micronutrient supplementation in HFD-fed 
mice did not have an additive effect and almost restore sperm intracellular ROS as seen 
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in the other treatment durations albeit reducing sperm intracellular ROS compared to that 
from mice fed a HFD alone. This suggests that long-term intake (10 weeks) of 
micronutrient supplements can only reduce sperm intracellular ROS to certain degree and 
can not fully overcome the effects of the concurrent long-term intake of a HFD. Overall 
and regardless of the duration of micronutrient treatment, this finding is encouraging for 
mitigating effects in offspring sired by diet-induced obese fathers with elevated sperm 
oxidative stress, highlighting a potential treatment for the reduction or prevention of 
sperm oxidative DNA lesion transmission to the subsequent embryo and minimising 
offspring effects (Barker 2004; Fullston et al. 2013; Fullston et al. 2012; Ng et al. 2010). 
Therefore, future studies assessing the impact of dietary micronutrient supplementation 
on the health of offspring produced by diet-induced obese mice are warranted. 
 
Micronutrients may pass the blood testis (selectively permeable) barrier and/or blood 
epididymal (semi-permeable) barrier  through the vascular system and enhance 
antioxidant enzyme activity in the testes and epididymis (Chabory et al. 2009; Haverfield 
et al. 2014) to reduce the excess of ROS in sperm observed in diet-induced obese males. 
Antioxidants and antioxidant enzymes are dependent on micronutrients such as 
glutathione peroxidase (GPx), which is regulated by and contains the micronutrient 
selenium (Walczak-Jedrzejowska et al. 2013); and zinc is an essential component of the 
antioxidant enzyme superoxide dismutase (SOD) (Walczak-Jedrzejowska et al. 2013). 
Serum levels of the supplemented micronutrients could be examined in future studies in 
addition to real-time PCR analysis of antioxidant enzymes expressed in the testis and 
epididymis to further investigate this proposed mechanism. Also, the superiority of active 
ingredients and their concentrations in dietary micronutrient and antioxidant supplements 
need to be explored as the current literature differs considerably in terms of the use of a 
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single micronutrient or a combination/ formulation of micronutrients and their doses, 
study designs and selection criteria (Barratt et al. 2017). A combination of micronutrients 
including lipophilic and hydrophilic antioxidants seems more appropriate and effective 
given that oxidative stress is a non-localized heterogeneous occurrence (Gharagozloo and 
Aitken 2011). Additionally, given the inconsistency in literature regarding duration of 
dietary micronutrient and antioxidant supplementation, future studies could evaluate an 
optimal duration of intake to highlight a potential epididymal effect or if more benefits 
are observed with a longer duration of intake. 
 
Given the reductions in sperm intracellular ROS and 8-OHdG lesions with the relatively 
short duration (10 days) of micronutrient supplementation observed in Chapter 4, future 
translational clinical studies could investigate sperm oxidative stress markers from men 
consuming micronutrient supplements for 10 days, which is also the duration spanning 
epididymal transit in humans (Robaire et al. 2006). Also, the design of these future 
investigations could include the man serving as their own control (longitudinal design) 
in which sperm oxidative DNA lesions (8-OHdG) could be assessed before and after 
micronutrient supplement intake in contrast to the data from Chapters 5 and 6 whereby 
men were stratified by BMI and micronutrient supplementation. Moreover, Chapter 5 
suggests that 8-OHdG is a viable biomarker and predictor for a successful pregnancy as 
8-OHdG was reduced and live birth rates were increased with micronutrient 
supplementation in men across all BMIs. However, future studies are required to confirm 
this potential marker with the assessment of sensitivity and specificity to confirm validity 
and reliability before sperm 8-OHdG immunofluorescence quantification were to be 
applied as a diagnostic and/or predictive test. 
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Data from Chapter 6 showed that micronutrient supplement intake is associated with 
increased standard insemination fertilization rates in obese men. This is consistent with 
previous studies that have shown obese men have reduced standard insemination 
fertilization rates (Yang et al. 2016) and a reduced chance of achieving a pregnancy after 
standard insemination but not ICSI (Keltz et al. 2010). This difference in fertilization 
rates based on the insemination method is most likely due to the ability of sperm to 
capacitate, undergo acrosome reaction, and enact sperm-oocyte fusion during the 
standard insemination method as opposed to the ICSI method in which these processes 
are surpassed (Anifandis et al. 2014). In the subsequent embryo, the embryonic genome 
is activated at the 4-8 cell stage (Braude et al. 1988; Desai et al. 2009), and any 
improvements in embryo morphology and development would be expected after this time 
point (day 4 of embryo development) after the effects of the activation of a damaged 
paternal genome would most likely be seen. This was the case in obese men whereby day 
4 on-time morula and early blastocyst-staged embryo development and morphology was 
improved with micronutrient supplement intake. Interestingly, Chapter 6 showed for the 
first time that pregnancy and live birth rates can be improved with micronutrient 
supplementation in overweight and obese men. This may ultimately be due to the reduced 
sperm intracellular ROS and reduced oxidative 8-OHdG lesions observed in Chapter 5. 
Although these improved pregnancy outcomes were observed in couples undergoing 
ART treatment, similar outcomes would be expected in couples conceiving naturally in 
which micronutrient supplement intake in obese men may improve spermatogenesis and 
sperm maturation during epididymal transit (Chapters 3 and 4) optimising DNA integrity 
and ultimately increasing the likelihood of achieving a successful pregnancy and live 
birth. On a translational clinical basis, the data from Chapter 5 suggests that a feasible 
sperm oxidative stress test could be formulated to assess sperm intracellular ROS and 8-
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OHdG, which could ultimately be used as a predictive biomarker for couples undergoing 
ART treatment. Furthermore, micronutrient supplementation could be suggested as a 
treatment option for the clinical management of men with obesity-induced subfertility 
and elevated sperm oxidative stress. 
 
Unfortunately, one of the limitations from Chapters 5 and 6 is that food intake and dietary 
habits from these men were not recorded. Future studies could record more detailed 
information regarding lifestyle habits primarily dietary patterns, exercise and adherence 
to the consumption of micronutrient supplements, which may influence pregnancy 
outcomes. Also, future investigations could examine the effects of dietary micronutrient 
supplement intake on the health and developmental competence of children from 
overweight and obese men given that paternal obesity, sperm oxidative stress and 
impaired sperm DNA integrity is associated with perturbed offspring health (Soubry et 
al. 2013; Yeung et al. 2017).  
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Figure 7.1: Potential pathways, spermatogenic (testes) and/or sperm maturation (epididymis), for the effects of micronutrient supplement 
intake on sperm quality, sperm function, embryo quality and pregnancy outcomes in diet-induced obese males. This diagram also highlights 
the data identified by the project and the generation of new knowledge gaps for future research.  
7.5 Role of micronutrient supplementation in a normal/healthy weight males 
 
Adherence to a healthy diet, characterised by an increased intake of vegetables and fruits, 
has been shown to increase sperm motility and concentration among men with 
unspecified BMIs in Asia, Europe, and the USA (Cutillas-Tolin et al. 2015; Liu et al. 
2015; Oostingh et al. 2017). However, a healthy diet can be difficult to comply with due 
to busy work/life schedules and low compliance rates in men (Mardby et al. 2016; Vitale 
et al. 2016). Therefore, micronutrient supplementation is an option for individuals to 
achieve adequate micronutrient intake if a well balanced diet is not regularly maintained. 
In infertile men, micronutrient and antioxidant supplement intake is associated with 
improved male reproductive health outcomes including increased sperm motility, 
concentration, normal morphology (Ahmadi et al. 2016; Zareba et al. 2013) and 
increased pregnancy and live birth rates (Showell et al. 2011; Showell et al. 2014). 
Cochrane reviews support the efficacy of micronutrient and antioxidant supplements 
(Showell et al. 2011; Showell et al. 2014) however, a recent meta-analysis states that the 
effect is uncertain due to low-quality evidence and that further randomized placebo-
controlled trials are required to draw a conclusion (Barratt et al. 2017).  
 
In rodent models, whereby confounding lifestyle factors are controlled, micronutrient and 
antioxidant supplement intake have been shown to improve conventional sperm 
parameters including sperm morphology (Ceribasi et al. 2010; Mosbah et al. 2015). 
Further, sperm 8-OHdG lesions were reduced with the intake of a combination of 
micronutrient supplements (selenium, lycopene, vitamin E, vitamin C, green tea extract, 
zinc and folic acid) in undernourished mice (McPherson et al. 2016). In Chapter 3, CD 
fed mice, to model normal healthy weight males, were supplemented with micronutrients 
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for 10 weeks and had improved fertilization rates compared to mice fed the same un-
supplemented CD. However, mice fed a short-term intake of micronutrient supplements 
for 10 days (Chapter 4) did not improve fertililzation rates. The increase in fertilization 
rates with the longer treatment duration of 10 weeks may be due to the observed 
improvement in normal sperm morphology (Chapter 3), which can optimise the acrosome 
reaction process, sperm-oocyte fusion, and ultimately improve the odds of achieving 
successful fertilization (Liu and Baker 2000). Although these findings were not observed 
in men (Chapters 5 and 6), the percentage of day 4 embryos (post embryonic genome 
activation) that reached the partially compacted morula stage was improved in normal 
weight men that consumed micronutrient supplements compared to their normal 
counterparts that did not consume micronutrient supplements (Chapter 5). Also, normal 
weight men had improved embryo utilisation rates and increased  implantation, ongoing 
pregnancy, and live birth rates compared to normal weight men not consuming 
supplements (Chapter 6). The observed improvements in on-time embryo development, 
embryo utilisation, implantation, pregnancy and live birth rates demonstrated in Chapter 
6 may be explained by the intracellular investigations of Chapter 5, whereby normal 
weight men that consumed micronutrient supplements displayed reduced sperm 
intracellular ROS and oxidative DNA lesions. The reduction in sperm oxidative stress 
and 8-OHdG adducts may in turn transmit optimal sperm DNA integrity to the 
subsequent embryo and may contain less genomic abnormalities increasing the proper 
development and morphology of embryos (Meseguer et al. 2006; Meseguer et al. 2008) 
and increasing the chance of a live birth (Loft et al. 2003; Thomson et al. 2011).  
 
It was unanticipated yet interesting to see that normal weight men had improvements with 
micronutrient supplement intake in not only sperm oxidative stress markers but also 
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clinical outcomes including live birth. These findings suggest that normal weight men 
may also be micronutrient deficient or may have other underlying pathologies that induce 
high levels of ROS. Secondary markers should be investigated in future studies that 
assess the systemic profiles of all men. A blood examination may provide better insight 
into micronutrient deficiencies, metabolic markers, inflammatory markers and other 
pathologies (beyond an increasd BMI) that may impact the effectiveness of micronutrient 
supplementation. Given that subfertility is multifactorial (McPherson and Lane 2015), 
future studies should investigate adiposity and muscle mass using a body composition 
analysis in addition to systemic serum analyses, including lipids, glucose, insulin, leptin 
and inflammatory markers, in all men despite their BMI classification.  
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7.6 Clinical relevance and significance   
 
The role of micronutrient supplement intake in male obesity, in both a mouse model of 
HFD-induced obesity and in overweight and obese men, has shown to be effective in 
improving sperm intracellular ROS, sperm oxidative DNA damage, fertilization rates, 
embryo development and pregnancy outcomes. Interestingly, there were also benefits 
observed in CD-fed mice and normal weight men whereby micronutrient 
supplementation reduced sperm oxidiatve DNA damage and improving fertilization 
rates, embryo development, embryo utilisation and pregnancy rates. 
 
Male mice fed a HFD supplemented with micronutrients had reduced sperm intracellular 
ROS and reduced sperm 8-OHdG lesions in addition to improvements in sperm 
morphology, sperm binding, and fertilization rates. These improvements were observed 
from as little as 10 days of intake, which spanned the duration of epididymal transport, 
as opposed to 5 or 10 weeks of intake, durations that covered one or two rounds of 
spermatogenesis respectively. Moreover, male mice that were treated with 10 days of 
dietary micronutrient supplementation produced embryos with reduced oxidative DNA 
lesions in the paternal pronucleus and had increased implantation rates and increased fetal 
weight. In men, dietary micronutrient supplementation was associated with increased 
fertilization rates in obese men in addition to improved embryo morphology and 
pregnancy outcomes including increased implantation, ongoing pregnancy and live birth 
rates in all men regardless of BMI. Although additional dietary and lifestyle factors were 
not reported, there was an obvious increase in sperm intracellular ROS and oxidative 8-




Overall, the mouse model suggests that dietary micronutrient supplementation may 
impact the testes (spermatogenesis) and/or the epididymis (sperm maturation) as a 
potential mode of action, which should be investigated further in future studies. 
Furthermore and to address the project’s hypothesis, the combined mouse and clinical 
data highlight the effectiveness of dietary micronutrient supplement intake in improving 
subfertility in obese males, primarily improving fertilization rates, embryo development, 
implantation, pregnancy and live birth rates in addition to alleviating compromised sperm 
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A1: Saline for injection (0.9% sodium chloride) 
0.9g of sodium chloride (Sigma-Aldrich, St. Louis, MO, USA) was added to 100ml of 
MilliQ water (Merck Millipore, Darmstadt, Germany) filtered through a 0.25μm nylon 
filter and stored at 4°C. 
 
A2: Preparation of 25% glucose solution 
2.5g of glucose (Sigma-Aldrich) was dissolved in 10ml of saline, filtered with 2μM filter 
and stored at 4°C for up to a week. 
 
A3: Preparation of 1 IU insulin 
10ul of insulin (Actapid; Novo Nordisk, Bagsvaerd, Denmark) was added to 10ml of 
saline and stored at 4°C. 
 
A4: Avertin anesthetic stock solution 
0.5g of 2-2-2 tribromethanol (Avertin; Sigma-Aldrich, St. Louis, MO, USA) was 
dissolved into 0.5ml of 2-methyl-2-butanol (tet-amyl-alcohol, Sigma-Aldrich) and stored 
at 4°C. 
 
Avertin anesthetic working solution 
0.2ml of Avertin stock solution was added to 10ml of saline for injection. The solution 
was dissolved at 37°C for 4 hours. 0.015ml of 0.02% Avertin was injected per 1g of 
mouse weight. 
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Figure A5: Immunofluorescence of 8-OHdG in malignant lesions from mouse ventral prostate tissue as a positive control for the mouse anti-
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1. I! understand! the! nature! and! purposes! of! the! study! described! in! the! Patient!
Information!Sheet!and!agree!to!participate.!
2.! I!understand!that!I!may!not!directly!benefit!by!participating!in!this!study.!




5.! I! consent! to! information! regarding! my! cycle! at! Repromed! being! accessed! by!
investigators! as! part! of! this! study.! I! understand! I! will! not! be! identified! and! all!
information!will!be!kept!strictly!confidential.!!!!
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Please answer the following questions immediately following the production of the sample and return this form 
with your sample to an Andrology Staff Member. 
 
 1.  When was your sample produced? Time:  ……………….. am/pm Date:  ………………..    
 2.  Did you collect the entire sample when you ejaculated? □  YES     □  NO   
 3.  Were there difficulties in producing the sample? □  YES     □  NO   
 4.  Approximately how many days is it since you last ejaculated? ………………… days   
 5.  Where was the sample produced? □  Repromed □  Brought in  
 6.  Production of sample: □  Masturbation □  Repromed Condom                □ Interrupted intercourse                              
(not recommended) 
 
 7.  Was a lubricant used?  □  YES     □  NO  
      If YES, what?  …………………………………………………………………………………………………………    
 8.  Have you been ill during the last two 
months? 
 □  YES     □  NO  
      If YES, what?  …………………………………………………………………………………………………………    
 9.  Have you taken drugs, medication, antioxidant supplements or any other 
supplements in the last three months? 
□  YES     □  NO   
      If YES, what?  …………………………………………………………………………………………………………    
      If YES, how often?  …………………………………………………………………………………..………..……..    
10.  Do you smoke?  □  YES     □  NO  
      If YES, what?  ……………………………………………………………………………………………..…………..  
      If YES, how often?  …………………………………………………………………………………..………..……..  
 
I confirm that I/my partner produced this semen sample into the collection container which is labelled with my 
name/his name and other identifying information. 
 
  
     Laboratory use only:  Custody of Gametes 
     Sample received/identity confirmed by:  …………… 
     Time:  …………… am/pm     Date:  ……………. 
 
Name:  …………………………………………………….. 
 
Sign:  ………………………………………………………. 
 
Patient Label Patient Label 
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Table A9: Composition of micronutrients supplements consumed by men undergoing 
ART treatment. 
Menevit Swisse Men’s multivitamin Nature’s Own multivitamin  
Vitamin C 100 mg Vitamin C 165 mg Vitamin C 175 mg 
Zinc 25 mg Zinc 6 mg Zinc 15 mg 
Vitamin E 400 IU Vitamin E 50 IU Vitamin E 50 IU 
Folic acid 500 µg Folic acid 500 µg Folic acid 300 µg 
Lycopene 6 mg Lycopene 120 µg Lycopene 120 µg 
Garlic oil 333 µg   
Selenium 26 µg Selenium 26 µg Selenium 26 µg 
 Betacarotene 5 mg Betacarotene 6 mg 
 Vitamin D 200 IU Vitamin D 200 IU 
 Vitamin B 60 mg Vitamin B 70 mg 
 Nicotinamide 30 mg Nicotinamide 40 mg 
 Biotin 50 µg Biotin 50 µg 
 Calcium 21 mg Calcium 25 mg 
 Magnesium 58 mg Magnesium 75 mg 
 Potassium 4 mg Potassium 4 mg 
 Iron 3 mg Iron 5 mg 
 Copper 28 µg Copper 28 µg 
 Iodine 50 µg Iodine 50 µg 
 Co enzyme Q10 1 mg  




Table A10: Sperm intracellular esterase activity in normal weight, overweight and obese 
men measured using 5-(and 6-) carboxy-2’,7’-dichlorofluorescein diacetate (carboxy-
DCFDA; Molecular Probes). 
 Normal weight Overweight  Obese  
carboxy-DCFDA 
(fluorescent units)1 
50.38 ± 1.87 49.85 ± 1.36 55.09 ± 1.82 
Data are expressed as mean ± SEM. N=30 live sperm per male. Carboxy-DCFDA 
fluorescent units were not different (P>0.05) between BMI categories as analyzed by a 
one-way ANOVA.  
 
                                                        
1 Sperm were incubated in 1μM carboxy-DCFDA in the dark for 1 hour at 37°C before 
being washed twice in PBS/PVP at 500g. Sperm were then incubated in 1μM propidium 
iodide (PI; Molecular Probes), a vitality stain, in the dark for 5 minutes at room 
temperature. Sperm were washed again in PBS/PVP for 5 minutes at 500g, loaded onto 
slides in 10μl drops and imaged under fluorescent microscopy. Thirty live sperm 
(negative for PI) were imaged per male patient. Sperm fluorescence was quantified 
using ImageJ software (Version 1.48, NIH) and results were expressed as a mean of 
fluorescence for carboxy-DCFDA (minus background). 
